"","outcome","exposure","nsnp","b","se","pval","pmid","year","author","consortium","subcategory","ncase","ncontrol","sample_size","unit","sex","population"
"1","Father’s age at death","APOC3 inhibitor",1,0.045636442516269,0.0398765726681128,0.252440192037158,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"2","Father’s age at death","APOC3 inhibitor",1,0.045636442516269,0.0398973336342641,0.252687124056188,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"3","Mother’s age at death","APOC3 inhibitor",1,-0.0381790021691974,0.0443843817787419,0.38968430610645,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"4","Mother’s age at death","APOC3 inhibitor",1,-0.0381790021691974,0.0443974377732782,0.389823737536067,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"5","Parents' age at death","APOC3 inhibitor",1,-0.0622893709327549,0.0664459869848156,0.348530378448148,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"6","Parents' age at death","APOC3 inhibitor",1,-0.0622893709327549,0.0664692003517266,0.348698739034701,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"7","Top 1 % survival","APOC3 inhibitor",1,-0.0104770932754881,0.00732650759219089,0.152709677256767,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"8","Top 1 % survival","APOC3 inhibitor",1,-0.0104770932754881,0.00733246233516496,0.153043255213693,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"9","Birth weight","APOC3 inhibitor",1,-0.0507592190889371,0.0304024780485681,0.0950034683720744,27680694,2016,"Horikoshi",NA,"Anthropometric",NA,NA,153781,NA,"Males and females","Mixed"
"10","Birth weight","APOC3 inhibitor",1,-0.0507592190889371,0.0303687635574837,0.0946370563859538,27680694,2016,"Horikoshi",NA,"Anthropometric",NA,NA,153781,NA,"Males and females","Mixed"
"11","Body fat","APOC3 inhibitor",1,-0.00390455531453362,0.0373101952277657,0.916652615524897,26833246,2016,"Lu",NA,"Anthropometric",NA,NA,100716,"SD","Males and females","European"
"12","Body fat","APOC3 inhibitor",1,-0.00390455531453362,0.0373103576964078,0.916652977139617,26833246,2016,"Lu",NA,"Anthropometric",NA,NA,100716,"SD","Males and females","European"
"13","Body mass index","APOC3 inhibitor",1,0.00824295010845987,0.0251637634328773,0.743235121479944,25673413,2015,"Locke AE","GIANT","Anthropometric",NA,NA,339224,"SD (kg/m^2)","Males and females","Mixed"
"14","Body mass index","APOC3 inhibitor",1,0.00824295010845987,0.0251626898047722,0.743224552275968,25673413,2015,"Locke AE","GIANT","Anthropometric",NA,NA,339224,"SD (kg/m^2)","Males and females","Mixed"
"15","Child birth length","APOC3 inhibitor",1,-0.0216919739696312,0.070718480765529,0.759043571704883,25281659,2015,"van der Valk RJ","EGG","Anthropometric",NA,NA,28459,"SD (cm)","Males and females","European"
"16","Child birth length","APOC3 inhibitor",1,-0.0216919739696312,0.0707158351409978,0.759034836237932,25281659,2015,"van der Valk RJ","EGG","Anthropometric",NA,NA,28459,"SD (cm)","Males and females","European"
"17","Child birth weight","APOC3 inhibitor",1,-0.0477223427331887,0.06941431670282,0.491767700760523,23202124,2013,"Horikoshi M","EGG","Anthropometric",NA,NA,26836,"g","Males and females","European"
"18","Child birth weight","APOC3 inhibitor",1,-0.0477223427331887,0.0694273606344262,0.491849072556795,23202124,2013,"Horikoshi M","EGG","Anthropometric",NA,NA,26836,"g","Males and females","European"
"19","Childhood obesity","APOC3 inhibitor",1,-0.268546637744035,0.226030368763557,0.234794089971226,22484627,2012,"Bradfield JP","EGG","Anthropometric",5530,8318,13848,"log odds","Males and females","European"
"20","Childhood obesity","APOC3 inhibitor",1,-0.268546637744035,0.226157193999618,0.23505665638812,22484627,2012,"Bradfield JP","EGG","Anthropometric",5530,8318,13848,"log odds","Males and females","European"
"21","Difference in height between adolescence and adulthood","APOC3 inhibitor",1,0.110724623524078,0.172948086333778,0.522030334928039,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,4282,"SD","Males","European"
"22","Difference in height between adolescence and adulthood","APOC3 inhibitor",1,0.110724623524078,0.172919898421258,0.521962497777134,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,4282,"SD","Males","European"
"23","Difference in height between childhood and adulthood","APOC3 inhibitor",1,0.0969675766707158,0.157320091098812,0.537649542773053,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,5043,"SD","Males","European"
"24","Difference in height between childhood and adulthood","APOC3 inhibitor",1,0.0969675766707158,0.157296325073319,0.537588094346441,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,5043,"SD","Males","European"
"25","Extreme body mass index","APOC3 inhibitor",1,-0.52060737527115,0.299709020290083,0.0823796285918344,23563607,2013,"Berndt SI","GIANT","Anthropometric",7962,8106,16068,"log odds","Males and females","European"
"26","Extreme body mass index","APOC3 inhibitor",1,-0.52060737527115,0.299349240780911,0.0820118223274952,23563607,2013,"Berndt SI","GIANT","Anthropometric",7962,8106,16068,"log odds","Males and females","European"
"27","Extreme height","APOC3 inhibitor",1,-0.286334056399132,0.286334056399132,0.317310507862914,23563607,2013,"Berndt SI","GIANT","Anthropometric",8097,8099,16196,"log odds","Males and females","European"
"28","Extreme height","APOC3 inhibitor",1,-0.286334056399132,0.286447882419018,0.317502850264424,23563607,2013,"Berndt SI","GIANT","Anthropometric",8097,8099,16196,"log odds","Males and females","European"
"29","Extreme waist-to-hip ratio","APOC3 inhibitor",1,-0.13882863340564,0.325403160411744,0.669644627621993,23563607,2013,"Berndt SI","GIANT","Anthropometric",4774,5481,10255,"log odds","Males and females","European"
"30","Extreme waist-to-hip ratio","APOC3 inhibitor",1,-0.13882863340564,0.325379609544469,0.669622132604936,23563607,2013,"Berndt SI","GIANT","Anthropometric",4774,5481,10255,"log odds","Males and females","European"
"31","Height","APOC3 inhibitor",1,0.0164859002169197,0.0251669840423853,0.512428724015588,25282103,2014,"Wood AR","GIANT","Anthropometric",NA,NA,253288,"SD (m)","Males and females","European"
"32","Height","APOC3 inhibitor",1,0.0164859002169197,0.0251626898047722,0.512356753300256,25282103,2014,"Wood AR","GIANT","Anthropometric",NA,NA,253288,"SD (m)","Males and females","European"
"33","Hip circumference","APOC3 inhibitor",1,-0.0112798264642082,0.0295027993813849,0.702216072749884,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"34","Hip circumference","APOC3 inhibitor",1,-0.0112798264642082,0.0295010845986985,0.702199590874297,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"35","Infant head circumference","APOC3 inhibitor",1,0.0616052060737527,0.119739696312364,0.606907525397384,22504419,2012,"Taal HR","EGG","Anthropometric",NA,NA,10768,"SD (cm)","Males and females","European"
"36","Infant head circumference","APOC3 inhibitor",1,0.0616052060737527,0.119752297999197,0.606945368846992,22504419,2012,"Taal HR","EGG","Anthropometric",NA,NA,10768,"SD (cm)","Males and females","European"
"37","Obesity class 1","APOC3 inhibitor",1,-0.117136659436009,0.108459869848156,0.280142180177538,23563607,2013,"Berndt SI","GIANT","Anthropometric",32858,65839,98697,"log odds","Males and females","European"
"38","Obesity class 1","APOC3 inhibitor",1,-0.117136659436009,0.108510158590752,0.280365126864512,23563607,2013,"Berndt SI","GIANT","Anthropometric",32858,65839,98697,"log odds","Males and females","European"
"39","Obesity class 2","APOC3 inhibitor",1,-0.212581344902386,0.195227765726681,0.276202886617978,23563607,2013,"Berndt SI","GIANT","Anthropometric",9889,62657,72546,"log odds","Males and females","European"
"40","Obesity class 2","APOC3 inhibitor",1,-0.212581344902386,0.195319781279584,0.276429191014936,23563607,2013,"Berndt SI","GIANT","Anthropometric",9889,62657,72546,"log odds","Males and females","European"
"41","Obesity class 3","APOC3 inhibitor",1,0.052060737527115,0.347074688463241,0.880765673969721,23563607,2013,"Berndt SI","GIANT","Anthropometric",2896,47468,50364,"log odds","Males and females","European"
"42","Obesity class 3","APOC3 inhibitor",1,0.052060737527115,0.3470715835141,0.880764615259515,23563607,2013,"Berndt SI","GIANT","Anthropometric",2896,47468,50364,"log odds","Males and females","European"
"43","Overweight","APOC3 inhibitor",1,-0.0281995661605206,0.0780911062906724,0.718016387438887,23563607,2013,"Berndt SI","GIANT","Anthropometric",93015,65840,158855,"log odds","Males and females","European"
"44","Overweight","APOC3 inhibitor",1,-0.0281995661605206,0.0780951550958372,0.718030382309876,23563607,2013,"Berndt SI","GIANT","Anthropometric",93015,65840,158855,"log odds","Males and females","European"
"45","Sitting height ratio","APOC3 inhibitor",1,-0.0433839479392625,0.0824385794239489,0.59870907830319,25865494,2015,"Chan",NA,"Anthropometric",NA,NA,21590,"SD","Males and females","European"
"46","Sitting height ratio","APOC3 inhibitor",1,-0.0433839479392625,0.0824295010845987,0.598668814257765,25865494,2015,"Chan",NA,"Anthropometric",NA,NA,21590,"SD","Males and females","European"
"47","Waist circumference","APOC3 inhibitor",1,0.0017353579175705,0.027765769805581,0.950164739242615,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"48","Waist circumference","APOC3 inhibitor",1,0.0017353579175705,0.027765726681128,0.950164661941506,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"49","Waist-to-hip ratio","APOC3 inhibitor",1,0.00954446854663774,0.0273332123919256,0.726947109490592,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD","Males and females","Mixed"
"50","Waist-to-hip ratio","APOC3 inhibitor",1,0.00954446854663774,0.0273318872017354,0.726934399917106,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD","Males and females","Mixed"
"51","Weight","APOC3 inhibitor",1,-0.0117136659436009,0.0520617854415911,0.821982797456102,23754948,2013,"Randall JC","GIANT","Anthropometric",NA,NA,60586,"SD (kg)","Males","European"
"52","Weight","APOC3 inhibitor",1,-0.0117136659436009,0.052060737527115,0.821979274262541,23754948,2013,"Randall JC","GIANT","Anthropometric",NA,NA,60586,"SD (kg)","Males","European"
"53","Crohn's disease","APOC3 inhibitor",1,0.00651247777123644,0.191323210412148,0.972845938621493,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",5956,14927,20883,"log odds","Males and females","European"
"54","Crohn's disease","APOC3 inhibitor",1,0.00651247777123644,0.191323298553479,0.972845951126352,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",5956,14927,20883,"log odds","Males and females","European"
"55","Eczema","APOC3 inhibitor",1,0.142602254330586,0.153629966270716,0.353293978352013,26482879,2014,"Paternoster","EAGLE","Autoimmune / inflammatory",10788,30047,40835,"log odds","Males and females","European"
"56","Eczema","APOC3 inhibitor",1,0.142602254330586,0.153682587057225,0.353458830738998,26482879,2014,"Paternoster","EAGLE","Autoimmune / inflammatory",10788,30047,40835,"log odds","Males and females","European"
"57","Gout","APOC3 inhibitor",1,-0.0737527114967462,0.273326784903831,0.787288381568519,23263486,2013,"Köttgen","GUGC","Autoimmune / inflammatory",2115,67259,69374,"log odds","Males and females","European"
"58","Gout","APOC3 inhibitor",1,-0.0737527114967462,0.273318872017354,0.787282371350769,23263486,2013,"Köttgen","GUGC","Autoimmune / inflammatory",2115,67259,69374,"log odds","Males and females","European"
"59","Inflammatory bowel disease","APOC3 inhibitor",1,0.145358258383514,0.142792035105988,0.308691379825324,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",12882,21770,34652,"log odds","Males and females","European"
"60","Inflammatory bowel disease","APOC3 inhibitor",1,0.145358258383514,0.142733188720174,0.308491965926853,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",12882,21770,34652,"log odds","Males and females","European"
"61","Juvenile idiopathic arthritis","APOC3 inhibitor",1,0.769236507462039,0.436065133978308,0.0777251798949915,23603761,2013,"Hinks",NA,"Autoimmune / inflammatory",2816,13056,15872,"log odds","Males and females","European"
"62","Juvenile idiopathic arthritis","APOC3 inhibitor",1,0.769236507462039,0.436604340136978,0.0780926505685649,23603761,2013,"Hinks",NA,"Autoimmune / inflammatory",2816,13056,15872,"log odds","Males and females","European"
"63","Multiple sclerosis","APOC3 inhibitor",1,-0.0431684635712364,0.140174437433843,0.758110903029063,24076602,2013,"Beecham","IMSGC","Autoimmune / inflammatory",14498,24091,38589,"log odds","Males and females","European"
"64","Multiple sclerosis","APOC3 inhibitor",1,-0.0431684635712364,0.140169151430803,0.75810206577002,24076602,2013,"Beecham","IMSGC","Autoimmune / inflammatory",14498,24091,38589,"log odds","Males and females","European"
"65","Narcolepsy","APOC3 inhibitor",1,-0.173036588715401,0.301033509335358,0.565420887655263,23459209,2013,"Faraco",NA,"Autoimmune / inflammatory",1886,10421,12307,"log odds","Males and females","European"
"66","Narcolepsy","APOC3 inhibitor",1,-0.173036588715401,0.301073053953121,0.56547195480452,23459209,2013,"Faraco",NA,"Autoimmune / inflammatory",1886,10421,12307,"log odds","Males and females","European"
"67","Primary biliary cirrhosis","APOC3 inhibitor",1,-0.217966231829501,0.266637812856686,0.413664559491671,26394269,2015,"Cordell",NA,"Autoimmune / inflammatory",2764,10475,13239,"log odds","Males and females","European"
"68","Primary biliary cirrhosis","APOC3 inhibitor",1,-0.217966231829501,0.266566958059436,0.413540444395953,26394269,2015,"Cordell",NA,"Autoimmune / inflammatory",2764,10475,13239,"log odds","Males and females","European"
"69","Psoriasis","APOC3 inhibitor",1,-0.25277617410846,0.269350169746681,0.348004604828236,23143594,2012,"Tsoi",NA,"Autoimmune / inflammatory",10588,22806,33394,"log odds","Males and females","European"
"70","Psoriasis","APOC3 inhibitor",1,-0.25277617410846,0.269255831904555,0.34783572924005,23143594,2012,"Tsoi",NA,"Autoimmune / inflammatory",10588,22806,33394,"log odds","Males and females","European"
"71","Rheumatoid arthritis","APOC3 inhibitor",1,0.0876473202494577,0.0903958021761388,0.33224839272699,24390342,2014,"Okada Y",NA,"Autoimmune / inflammatory",19234,61565,80799,"log odds","Males and females","Mixed"
"72","Rheumatoid arthritis","APOC3 inhibitor",1,0.0876473202494577,0.0904295855277843,0.332429050070122,24390342,2014,"Okada Y",NA,"Autoimmune / inflammatory",19234,61565,80799,"log odds","Males and females","Mixed"
"73","Systemic lupus erythematosus","APOC3 inhibitor",1,0.177101928504555,0.265040473940564,0.504001399062091,26502338,2015,"Bentham",NA,"Autoimmune / inflammatory",7219,15991,23210,"log odds","Males and females","European"
"74","Systemic lupus erythematosus","APOC3 inhibitor",1,0.177101928504555,0.265087522972711,0.504077095137464,26502338,2015,"Bentham",NA,"Autoimmune / inflammatory",7219,15991,23210,"log odds","Males and females","European"
"75","Type 1 diabetes","APOC3 inhibitor",1,-0.197940034821258,0.192324984109641,0.303387751422,25751624,2015,"Onengut-Gumuscu",NA,"Autoimmune / inflammatory",9563,9369,18932,"log odds","Males and females","European"
"76","Type 1 diabetes","APOC3 inhibitor",1,-0.197940034821258,0.192405967324249,0.303591314700133,25751624,2015,"Onengut-Gumuscu",NA,"Autoimmune / inflammatory",9563,9369,18932,"log odds","Males and females","European"
"77","Ulcerative colitis","APOC3 inhibitor",1,0.208669863301518,0.181440347718664,0.250113310384647,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",6968,20464,27432,"log odds","Males and females","European"
"78","Ulcerative colitis","APOC3 inhibitor",1,0.208669863301518,0.181344902386117,0.249864109376172,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",6968,20464,27432,"log odds","Males and females","European"
"79","Age of smoking initiation","APOC3 inhibitor",1,0.00911062906724512,0.0186550976138829,0.625286305140081,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,47961,"log years","Males and females","European"
"80","Age of smoking initiation","APOC3 inhibitor",1,0.00911062906724512,0.0186568666368494,0.625319099516175,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,47961,"log years","Males and females","European"
"81","Alcohol dependence","APOC3 inhibitor",1,-0.322824707218655,0.478160009587852,0.499587143392356,22978509,2012,"Olfson",NA,"Behavioural",1897,1932,3829,"log odds","Males and females","Mixed"
"82","Alcohol dependence","APOC3 inhibitor",1,-0.322824707218655,0.478246661028773,0.499664856941262,22978509,2012,"Olfson",NA,"Behavioural",1897,1932,3829,"log odds","Males and females","Mixed"
"83","Cigarettes smoked per day","APOC3 inhibitor",1,-0.0112798264642082,0.684164859002169,0.986845872671216,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,68028,"Cigarettes per day","Males and females","European"
"84","Cigarettes smoked per day","APOC3 inhibitor",1,-0.0112798264642082,0.684164932945483,0.986845874092761,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,68028,"Cigarettes per day","Males and females","European"
"85","Ever vs never smoked","APOC3 inhibitor",1,-0.0498915401301518,0.0971800433839479,0.607676541071858,20418890,2010,"Furberg","TAG","Behavioural",41969,32066,74035,"log odds","Males and females","European"
"86","Ever vs never smoked","APOC3 inhibitor",1,-0.0498915401301518,0.0971902271598968,0.607714163614016,20418890,2010,"Furberg","TAG","Behavioural",41969,32066,74035,"log odds","Males and females","European"
"87","Former vs current smoker","APOC3 inhibitor",1,-0.0498915401301518,0.131894705749963,0.705231550911003,20418890,2010,"Furberg","TAG","Behavioural",23554,18415,41969,"log odds","Males and females","European"
"88","Former vs current smoker","APOC3 inhibitor",1,-0.0498915401301518,0.131887201735358,0.705215564241825,20418890,2010,"Furberg","TAG","Behavioural",23554,18415,41969,"log odds","Males and females","European"
"89","Paget's disease","APOC3 inhibitor",1,0.194111930585683,0.512207124202148,0.704708986560886,21623375,2011,"Albagha OM",NA,"Bone",741,2699,3440,"log odds","Males and females","European"
"90","Paget's disease","APOC3 inhibitor",1,0.194111930585683,0.512177874186551,0.704692914794229,21623375,2011,"Albagha OM",NA,"Bone",741,2699,3440,"log odds","Males and females","European"
"91","Lung adenocarcinoma","APOC3 inhibitor",1,-0.137948252253796,0.225553145336226,0.540802589006934,24880342,2014,"Wang Y","ILCCO","Cancer",3442,14894,18336,"log odds","Males and females","European"
"92","Lung adenocarcinoma","APOC3 inhibitor",1,-0.137948252253796,0.225586688659171,0.540862773861081,24880342,2014,"Wang Y","ILCCO","Cancer",3442,14894,18336,"log odds","Males and females","European"
"93","Lung cancer","APOC3 inhibitor",1,-0.0484271896143167,0.145895878524946,0.739942268591921,24880342,2014,"Wang Y","ILCCO","Cancer",11348,15861,27209,"log odds","Males and females","European"
"94","Lung cancer","APOC3 inhibitor",1,-0.0484271896143167,0.145902269702087,0.739953248063595,24880342,2014,"Wang Y","ILCCO","Cancer",11348,15861,27209,"log odds","Males and females","European"
"95","Melanoma","APOC3 inhibitor",1,-0.205211597041215,0.45860484186,0.654536234308929,21926416,2011,"Amos CI","MDACC","Cancer",1804,1026,2830,"log odds","Males and females","European"
"96","Melanoma","APOC3 inhibitor",1,-0.205211597041215,0.458568329718004,0.654510515314266,21926416,2011,"Amos CI","MDACC","Cancer",1804,1026,2830,"log odds","Males and females","European"
"97","Small cell lung carcinoma","APOC3 inhibitor",1,0.152312977793059,0.240949348680103,0.527297415663249,NA,NA,NA,"TRICL","Cancer",2791,20580,23371,NA,"Males and females","European"
"98","Small cell lung carcinoma","APOC3 inhibitor",1,0.152312977793059,0.240911062906725,0.527231778968881,NA,NA,NA,"TRICL","Cancer",2791,20580,23371,NA,"Males and females","European"
"99","Squamous cell lung cancer","APOC3 inhibitor",1,-0.134933929176573,0.226481561822126,0.551320010663549,24880342,2014,"Wang Y","ILCCO","Cancer",3275,15038,18313,"log odds","Males and females","European"
"100","Squamous cell lung cancer","APOC3 inhibitor",1,-0.134933929176573,0.226513523803719,0.551376180184886,24880342,2014,"Wang Y","ILCCO","Cancer",3275,15038,18313,"log odds","Males and females","European"
"101","Thyroid cancer","APOC3 inhibitor",1,1.7677358384859,0.681218980647477,0.00946019956810563,23894154,2013,"Kohler A",NA,"Cancer",649,431,1080,"log odds","Males and females","European"
"102","Thyroid cancer","APOC3 inhibitor",1,1.7677358384859,0.67939262472885,0.00926992650302154,23894154,2013,"Kohler A",NA,"Cancer",649,431,1080,"log odds","Males and females","European"
"103","Coronary heart disease","APOC3 inhibitor",1,-0.186772234273319,0.0659058012870677,0.00459798242012132,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",60801,123504,184305,"log odds","Males and females","Mixed"
"104","Coronary heart disease","APOC3 inhibitor",1,-0.186772234273319,0.065695010845987,0.00446882563833363,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",60801,123504,184305,"log odds","Males and females","Mixed"
"105","Myocardial infarction","APOC3 inhibitor",1,-0.170562255965293,0.0728424948587228,0.0192053281415605,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",43676,128199,171875,"log odds","Males and females","Mixed"
"106","Myocardial infarction","APOC3 inhibitor",1,-0.170562255965293,0.0726835267305857,0.0189434187543355,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",43676,128199,171875,"log odds","Males and females","Mixed"
"107","Type 2 diabetes","APOC3 inhibitor",1,-0.0859116151678959,0.0868471550772234,0.322551727829366,24509480,2014,"Mahajan A","DIAGRAM","Diabetes",26488,83964,110452,"log odds","Males and females","Mixed"
"108","Type 2 diabetes","APOC3 inhibitor",1,-0.0859116151678959,0.0868809396603936,0.322739927526445,24509480,2014,"Mahajan A","DIAGRAM","Diabetes",26488,83964,110452,"log odds","Males and females","Mixed"
"109","Childhood intelligence","APOC3 inhibitor",1,0.184381778741866,0.112484659836608,0.101177306643741,23358156,2014,"Benyamin B","SSGAC","Education",NA,NA,12441,"SD","Males and females","European"
"110","Childhood intelligence","APOC3 inhibitor",1,0.184381778741866,0.11236442516269,0.100812644089042,23358156,2014,"Benyamin B","SSGAC","Education",NA,NA,12441,"SD","Males and females","European"
"111","College completion","APOC3 inhibitor",1,-0.0302629663185683,0.0824295010845987,0.713516407944084,23722424,2013,"Rietveld CA","SSGAC","Education",20044,75383,95427,"log odds","Males and females","European"
"112","College completion","APOC3 inhibitor",1,-0.0302629663185683,0.0824339186556029,0.713531082966449,23722424,2013,"Rietveld CA","SSGAC","Education",20044,75383,95427,"log odds","Males and females","European"
"113","Years of schooling","APOC3 inhibitor",1,0.00867678958785249,0.0216933539093077,0.689175257751041,27225129,2016,"Okbay","SSGAC","Education",NA,NA,293723,"SD (years)","Males and females","European"
"114","Years of schooling","APOC3 inhibitor",1,0.00867678958785249,0.0216919739696312,0.689156516779352,27225129,2016,"Okbay","SSGAC","Education",NA,NA,293723,"SD (years)","Males and females","European"
"115","2hr glucose","APOC3 inhibitor",1,-0.13882863340564,0.156231270958938,0.374212839716493,20081857,2010,"Saxena R","MAGIC","Glycemic",NA,NA,15234,"mmol/L","Males and females","European"
"116","2hr glucose","APOC3 inhibitor",1,-0.13882863340564,0.156182212581345,0.374062797490882,20081857,2010,"Saxena R","MAGIC","Glycemic",NA,NA,15234,"mmol/L","Males and females","European"
"117","AUCins","APOC3 inhibitor",1,-0.160520607375271,0.186605886589655,0.3896722369166,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4324,"SD (mU*min/l)","Males and females","European"
"118","AUCins","APOC3 inhibitor",1,-0.160520607375271,0.186550976138829,0.389532704716716,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4324,"SD (mU*min/l)","Males and females","European"
"119","AUCins/AUCglu","APOC3 inhibitor",1,-0.0780911062906724,0.190889370932755,0.682472947499482,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4213,"SD","Males and females","European"
"120","AUCins/AUCglu","APOC3 inhibitor",1,-0.0780911062906724,0.190902072631659,0.682492921852478,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4213,"SD","Males and females","European"
"121","Corrected insulin response","APOC3 inhibitor",1,-0.156182212581345,0.17353579175705,0.368120250693519,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5318,"SD","Males and females","European"
"122","Corrected insulin response","APOC3 inhibitor",1,-0.156182212581345,0.173591672094569,0.368274449160132,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5318,"SD","Males and females","European"
"123","Fasting glucose","APOC3 inhibitor",1,-0.000867678958785249,0.00563996630814549,0.877732183089172,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,58074,"mmol/L","Males and females","European"
"124","Fasting glucose","APOC3 inhibitor",1,-0.000867678958785249,0.00563991323210412,0.877731041501716,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,58074,"mmol/L","Males and females","European"
"125","Fasting insulin","APOC3 inhibitor",1,-0.00130151843817787,0.0052060737527115,0.802587348634153,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,51750,"log pmol/L","Males and females","European"
"126","Fasting insulin","APOC3 inhibitor",1,-0.00130151843817787,0.00520620312456363,0.80259215290399,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,51750,"log pmol/L","Males and females","European"
"127","Fasting proinsulin","APOC3 inhibitor",1,0.0281995661605206,0.0607375271149675,0.64244305767423,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,10701,"log pmol/L","Males and females","European"
"128","Fasting proinsulin","APOC3 inhibitor",1,0.0281995661605206,0.0607427326334861,0.642471560671996,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,10701,"log pmol/L","Males and females","European"
"129","HbA1C","APOC3 inhibitor",1,0.0112798264642082,0.0295027993813849,0.702216072749884,20858683,2010,"Soranzo N","MAGIC","Glycemic",NA,NA,46368,"%","Males and females","European"
"130","HbA1C","APOC3 inhibitor",1,0.0112798264642082,0.0295010845986985,0.702199590874297,20858683,2010,"Soranzo N","MAGIC","Glycemic",NA,NA,46368,"%","Males and females","European"
"131","HOMA-B","APOC3 inhibitor",1,0.00433839479392625,0.0264642082429501,0.869782765494109,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"132","HOMA-B","APOC3 inhibitor",1,0.00433839479392625,0.0264644910249575,0.869784144489432,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"133","HOMA-IR","APOC3 inhibitor",1,-0.0234273318872017,0.0325379609544469,0.471524995558502,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"134","HOMA-IR","APOC3 inhibitor",1,-0.0234273318872017,0.0325446669835405,0.471616346330881,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"135","Incremental insulin at 30 minutes","APOC3 inhibitor",1,-0.00121475054229935,0.182212584564864,0.994680809090088,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4447,"SD","Males and females","European"
"136","Incremental insulin at 30 minutes","APOC3 inhibitor",1,-0.00121475054229935,0.182212581344902,0.994680808996092,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4447,"SD","Males and females","European"
"137","Insulin at 30 minutes","APOC3 inhibitor",1,-0.0997830802603037,0.182234306576775,0.583998345214828,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4409,"SD","Males and females","European"
"138","Insulin at 30 minutes","APOC3 inhibitor",1,-0.0997830802603037,0.182212581344902,0.58395350774479,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4409,"SD","Males and females","European"
"139","Insulin disposition index","APOC3 inhibitor",1,0.010412147505423,0.173536040153915,0.952155703093347,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5130,"SD","Males and females","European"
"140","Insulin disposition index","APOC3 inhibitor",1,0.010412147505423,0.17353579175705,0.952155634691786,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5130,"SD","Males and females","European"
"141","Insulin sensitivity index","APOC3 inhibitor",1,0.225596529284165,0.186659417747465,0.226816644975132,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4769,"SD","Males and females","European"
"142","Insulin sensitivity index","APOC3 inhibitor",1,0.225596529284165,0.186550976138829,0.226546717741115,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4769,"SD","Males and females","European"
"143","Insulin-like growth factor 1","APOC3 inhibitor",1,-0.0200800953801301,0.0709566600729951,0.777183744853332,27329260,2016,NA,NA,"Growth hormone",NA,NA,30884,"SD","Males and females","European"
"144","Insulin-like growth factor 1","APOC3 inhibitor",1,-0.0200800953801301,0.0709544006364425,0.77717683700282,27329260,2016,NA,NA,"Growth hormone",NA,NA,30884,"SD","Males and females","European"
"145","Insulin-like growth factor binding protein 3","APOC3 inhibitor",1,0.0178886670419957,0.0860046863560011,0.835231761050144,27329260,2016,NA,NA,"Growth hormone",NA,NA,18995,"SD","Males and females","European"
"146","Insulin-like growth factor binding protein 3","APOC3 inhibitor",1,0.0178886670419957,0.0860032069327549,0.835228967353655,27329260,2016,NA,NA,"Growth hormone",NA,NA,18995,"SD","Males and females","European"
"147","Haemoglobin concentration","APOC3 inhibitor",1,0.110629067245119,0.0503253796095445,0.0279294534399883,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,71861,"g/dL","Males and females","Mixed"
"148","Haemoglobin concentration","APOC3 inhibitor",1,0.110629067245119,0.0504219824000841,0.0282307934041181,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,71861,"g/dL","Males and females","Mixed"
"149","Mean cell haemoglobin","APOC3 inhibitor",1,0.0229934924078091,0.0880718012140651,0.794033384087622,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,64731,"pg","Males and females","Mixed"
"150","Mean cell haemoglobin","APOC3 inhibitor",1,0.0229934924078091,0.0880694143167028,0.794027927572297,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,64731,"pg","Males and females","Mixed"
"151","Mean cell haemoglobin concentration","APOC3 inhibitor",1,-0.00130151843817787,0.0290672682906625,0.964285788403795,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,67852,"g/dL","Males and females","Mixed"
"152","Mean cell haemoglobin concentration","APOC3 inhibitor",1,-0.00130151843817787,0.0290672451193059,0.964285759952738,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,67852,"g/dL","Males and females","Mixed"
"153","Mean cell volume","APOC3 inhibitor",1,0.335357917570499,0.224060835281431,0.134464289489008,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,69335,"fl","Males and females","Mixed"
"154","Mean cell volume","APOC3 inhibitor",1,0.335357917570499,0.223861171366594,0.134117138775246,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,69335,"fl","Males and females","Mixed"
"155","Mean platelet volume","APOC3 inhibitor",1,-0.00780911062906724,0.00867678958785249,0.368120250693519,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"log fl","Males and females","European"
"156","Mean platelet volume","APOC3 inhibitor",1,-0.00780911062906724,0.00867958360472843,0.368274449160132,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"log fl","Males and females","European"
"157","Packed cell volume","APOC3 inhibitor",1,0.363557483731019,0.160086767895879,0.0231468138937121,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,63511,"%","Males and females","Mixed"
"158","Packed cell volume","APOC3 inhibitor",1,0.363557483731019,0.160414712878835,0.0234293524543074,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,63511,"%","Males and females","Mixed"
"159","Platelet count","APOC3 inhibitor",1,7.00303687635575,3.38351409978308,0.0384755245639973,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"1x10^9/l","Males and females","European"
"160","Platelet count","APOC3 inhibitor",1,7.00303687635575,3.38927234689288,0.03880619171217,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"1x10^9/l","Males and females","European"
"161","Red blood cell count","APOC3 inhibitor",1,0.0190889370932755,0.0195227765726681,0.32818424412387,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,66214,"10^12/L","Males and females","Mixed"
"162","Red blood cell count","APOC3 inhibitor",1,0.0190889370932755,0.0195301964076464,0.328368043163739,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,66214,"10^12/L","Males and females","Mixed"
"163","Heart rate","APOC3 inhibitor",1,-0.0806941431670282,0.40998462304506,0.8439665486195,23583979,2013,"den Hoed M","HRgene consortium","Hemodynamic",NA,NA,92355,"beats per minute","Males and females","Mixed"
"164","Heart rate","APOC3 inhibitor",1,-0.0806941431670282,0.40997830802603,0.843964176065606,23583979,2013,"den Hoed M","HRgene consortium","Hemodynamic",NA,NA,92355,"beats per minute","Males and females","Mixed"
"165","Leptin","APOC3 inhibitor",1,-0.0121475054229935,0.0399147020595506,0.760871450455587,26833098,2016,"Kilpeläinen",NA,"Hormone",NA,NA,32161,"log ng/ml","Males and females","European"
"166","Leptin","APOC3 inhibitor",1,-0.0121475054229935,0.0399132321041215,0.760862912213715,26833098,2016,"Kilpeläinen",NA,"Hormone",NA,NA,32161,"log ng/ml","Males and females","European"
"167","Plasma cortisol","APOC3 inhibitor",1,0.0399696312364425,0.106925680499748,0.708547470122879,25010111,2014,"Bolton JL","CORNET","Hormone",NA,NA,12597,"SD","Males and females","European"
"168","Plasma cortisol","APOC3 inhibitor",1,0.0399696312364425,0.106919739696312,0.708532016463312,25010111,2014,"Bolton JL","CORNET","Hormone",NA,NA,12597,"SD","Males and females","European"
"169","Chronic kidney disease","APOC3 inhibitor",1,-0.13882863340564,0.130151843817787,0.286122384391018,26831199,2015,"Pattaro","CKDGen","Kidney",12385,104780,117165,"log odds","Males and females","Mixed"
"170","Chronic kidney disease","APOC3 inhibitor",1,-0.13882863340564,0.130210709804572,0.286340272176011,26831199,2015,"Pattaro","CKDGen","Kidney",12385,104780,117165,"log odds","Males and females","Mixed"
"171","Microalbuminuria","APOC3 inhibitor",1,-0.308026030368764,0.178086148588126,0.0836935061479235,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,54116,"log odds","Males and females","European"
"172","Microalbuminuria","APOC3 inhibitor",1,-0.308026030368764,0.177874186550976,0.0833256871946906,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,54116,"log odds","Males and females","European"
"173","Serum creatinine (eGFRcrea)","APOC3 inhibitor",1,0.00650759219088937,0.00737755385746776,0.377733584653733,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,118460,"log ml/min/1.73 m^²","Males and females","Mixed"
"174","Serum creatinine (eGFRcrea)","APOC3 inhibitor",1,0.00650759219088937,0.00737527114967462,0.377585975474249,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,118460,"log ml/min/1.73 m^²","Males and females","Mixed"
"175","Serum cystatin C (eGFRcys)","APOC3 inhibitor",1,0.0156182212581345,0.0160581016910368,0.330748688698679,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,33152,"log ml/min/1.73 m^²","Males and females","Mixed"
"176","Serum cystatin C (eGFRcys)","APOC3 inhibitor",1,0.0156182212581345,0.0160520607375271,0.330566734834094,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,33152,"log ml/min/1.73 m^²","Males and females","Mixed"
"177","Urinary albumin-to-creatinine ratio","APOC3 inhibitor",1,-0.355748373101952,0.247491906651444,0.150600345395964,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,5825,"log mg/g","Males and females","European"
"178","Urinary albumin-to-creatinine ratio","APOC3 inhibitor",1,-0.355748373101952,0.247288503253796,0.150264881073092,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,5825,"log mg/g","Males and females","European"
"179","HDL cholesterol","APOC3 inhibitor",1,0.412581344902386,0.0313092478901317,1.18058012903257e-39,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187167,"SD (mg/dL)","Males and females","Mixed"
"180","HDL cholesterol","APOC3 inhibitor",1,0.412581344902386,0.0290672451193059,9.97574261695541e-46,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187167,"SD (mg/dL)","Males and females","Mixed"
"181","LDL cholesterol","APOC3 inhibitor",1,-0.329718004338395,0.031236442516269,4.78798727998216e-26,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,173082,"SD (mg/dL)","Males and females","Mixed"
"182","LDL cholesterol","APOC3 inhibitor",1,-0.329718004338395,0.0325908940114711,4.65025789418972e-24,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,173082,"SD (mg/dL)","Males and females","Mixed"
"183","Total cholesterol","APOC3 inhibitor",1,-0.45943600867679,0.0299349240780911,3.66255429213758e-53,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187365,"SD (mg/dL)","Males and females","Mixed"
"184","Total cholesterol","APOC3 inhibitor",1,-0.45943600867679,0.0326183219052789,4.6824548180358e-45,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187365,"SD (mg/dL)","Males and females","Mixed"
"185","Triglycerides","APOC3 inhibitor",1,-1,0.0281995661605206,1.92612818234212e-275,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,177861,"SD (mg/dL)","Males and females","Mixed"
"186","Triglycerides","APOC3 inhibitor",1,-1,0.0398802089172456,9.29893434499323e-139,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,177861,"SD (mg/dL)","Males and females","Mixed"
"187","Percent emphysema","APOC3 inhibitor",1,-0.0264642082429501,0.0772234273318872,0.731826698838058,24383474,2014,"Manichaikul A","MESA","Lung disease",NA,NA,7667,"log (% emphysema + 1)","Males and females","Mixed"
"188","Percent emphysema","APOC3 inhibitor",1,-0.0264642082429501,0.0772270332300454,0.731838737915434,24383474,2014,"Manichaikul A","MESA","Lung disease",NA,NA,7667,"log (% emphysema + 1)","Males and females","Mixed"
"189","FEV1/FVC","APOC3 inhibitor",1,-0.0017353579175705,0.0577006507592191,0.97600708890912,21946350,2011,"Soler Artigas M","SpiroMetaplusCHARGE","Lung function",NA,NA,48201,"SD","Males and females","European"
"190","FEV1/FVC","APOC3 inhibitor",1,-0.0017353579175705,0.057700671510848,0.976007097535395,21946350,2011,"Soler Artigas M","SpiroMetaplusCHARGE","Lung function",NA,NA,48201,"SD","Males and females","European"
"191","Copper","APOC3 inhibitor",1,0.017353579175705,0.238611713665944,0.942023145513678,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"192","Copper","APOC3 inhibitor",1,0.017353579175705,0.238612215477623,0.942023267226662,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"193","Ferritin","APOC3 inhibitor",1,0.0563991323210412,0.0802760600615062,0.482327019085134,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"194","Ferritin","APOC3 inhibitor",1,0.0563991323210412,0.0802603036876356,0.482241043015876,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"195","Iron","APOC3 inhibitor",1,0.0832971800433839,0.0854986503535962,0.329931727725356,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"196","Iron","APOC3 inhibitor",1,0.0832971800433839,0.0854663774403471,0.329749141754307,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"197","Selenium","APOC3 inhibitor",1,0.425162689804772,0.260303687635575,0.102398909834216,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"198","Selenium","APOC3 inhibitor",1,0.425162689804772,0.260579653063262,0.102763027635993,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"199","Transferrin","APOC3 inhibitor",1,-0.0885032537960954,0.0876355748373102,0.31254272827524,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"200","Transferrin","APOC3 inhibitor",1,-0.0885032537960954,0.0876711056272473,0.312738878365413,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"201","Transferrin Saturation","APOC3 inhibitor",1,0.112798264642082,0.0859590899831225,0.189441883284477,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"202","Transferrin Saturation","APOC3 inhibitor",1,0.112798264642082,0.0859002169197397,0.189138704042546,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"203","Zinc","APOC3 inhibitor",1,-0.151843817787419,0.229974790430359,0.50908514570286,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"204","Zinc","APOC3 inhibitor",1,-0.151843817787419,0.229934924078091,0.509011698140521,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"205","Urate","APOC3 inhibitor",1,-0.182779497095011,0.175406092834391,0.297394899479066,25811787,2015,"Huffman JE","GUGC","Other",NA,NA,7189,"SD (mg/dL)","Females","European"
"206","Urate","APOC3 inhibitor",1,-0.182779497095011,0.175330346970933,0.297186241122374,25811787,2015,"Huffman JE","GUGC","Other",NA,NA,7189,"SD (mg/dL)","Females","European"
"207","Neo-agreeableness","APOC3 inhibitor",1,-0.0472885032537961,0.55704989154013,0.932348074162409,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"208","Neo-agreeableness","APOC3 inhibitor",1,-0.0472885032537961,0.557051487681222,0.93234826754288,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"209","Neo-conscientiousness","APOC3 inhibitor",1,-0.481995661605206,0.67432354982199,0.474742544035821,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"210","Neo-conscientiousness","APOC3 inhibitor",1,-0.481995661605206,0.674186550976139,0.474652783566231,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"211","Neo-extraversion","APOC3 inhibitor",1,-0.567462039045553,0.698231116850775,0.416382187952988,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"212","Neo-extraversion","APOC3 inhibitor",1,-0.567462039045553,0.698047722342733,0.416259750395915,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"213","Neo-neuroticism","APOC3 inhibitor",1,-0.642516268980477,0.865509761388286,0.457871737602631,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"214","Neo-neuroticism","APOC3 inhibitor",1,-0.642516268980477,0.86569938987195,0.457970239983269,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"215","Neo-openness to experience","APOC3 inhibitor",1,0.265075921908894,0.636920221475964,0.677275462750349,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"216","Neo-openness to experience","APOC3 inhibitor",1,0.265075921908894,0.636876355748373,0.677254488759887,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"217","Neuroticism","APOC3 inhibitor",1,-0.00433839479392625,0.0260303687635575,0.867632334778193,27089181,2016,"Okbay","SSGAC","Personality",NA,NA,170911,"SD","Males and females","European"
"218","Neuroticism","APOC3 inhibitor",1,-0.00433839479392625,0.0260306562585467,0.867633783223738,27089181,2016,"Okbay","SSGAC","Personality",NA,NA,170911,"SD","Males and females","European"
"219","Adiponectin","APOC3 inhibitor",1,-0.066885032537961,0.0363470715835141,0.0657423064452409,22479202,2012,"Dastani Z","ADIPOGen","Protein",NA,NA,39883,"ln(mg/dL)","Males and females","Mixed"
"220","Adiponectin","APOC3 inhibitor",1,-0.066885032537961,0.0363959763562578,0.066106029259922,22479202,2012,"Dastani Z","ADIPOGen","Protein",NA,NA,39883,"ln(mg/dL)","Males and females","Mixed"
"221","2-choice reaction time","APOC3 inhibitor",1,0.402169197396963,0.246681658938571,0.103034606152732,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2602,"SD (milliseconds)","Males and females","European"
"222","2-choice reaction time","APOC3 inhibitor",1,0.402169197396963,0.246420824295011,0.102670585312263,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2602,"SD (milliseconds)","Males and females","European"
"223","4-choice reaction time","APOC3 inhibitor",1,0.149674620390456,0.254698749119423,0.556764869287251,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2829,"SD (milliseconds)","Males and females","European"
"224","4-choice reaction time","APOC3 inhibitor",1,0.149674620390456,0.254663774403471,0.556710688010668,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2829,"SD (milliseconds)","Males and females","European"
"225","8-choice reaction time","APOC3 inhibitor",1,0.524945770065076,0.364425162689805,0.149732721477791,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,1382,"SD (milliseconds)","Males and females","European"
"226","8-choice reaction time","APOC3 inhibitor",1,0.524945770065076,0.36472569857912,0.150068592842864,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,1382,"SD (milliseconds)","Males and females","European"
"227","Alzheimer's disease","APOC3 inhibitor",1,-0.197830802603037,0.131019522776573,0.131060323426818,24162737,2013,"Lambert","IGAP","Psychiatric / neurological",17008,37154,54162,"log odds","Males and females","European"
"228","Alzheimer's disease","APOC3 inhibitor",1,-0.197830802603037,0.131138238969047,0.131409506109723,24162737,2013,"Lambert","IGAP","Psychiatric / neurological",17008,37154,54162,"log odds","Males and females","European"
"229","Amygdala volume","APOC3 inhibitor",1,9.42993492407809,19.5462775038152,0.629492364973312,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"230","Amygdala volume","APOC3 inhibitor",1,9.42993492407809,19.5444685466377,0.629460651524932,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"231","Amyotrophic lateral sclerosis","APOC3 inhibitor",1,-0.277223427331887,0.151178401428925,0.0666910797317559,27455348,2016,"van Rheenen","Project MinE","Psychiatric / neurological",12577,23475,36052,"log odds","Males and females","European"
"232","Amyotrophic lateral sclerosis","APOC3 inhibitor",1,-0.277223427331887,0.150976138828633,0.0663270630893397,27455348,2016,"van Rheenen","Project MinE","Psychiatric / neurological",12577,23475,36052,"log odds","Males and females","European"
"233","Anorexia nervosa","APOC3 inhibitor",1,-0.366120666668113,0.223822125813449,0.101888529965646,24514567,2014,"Boraska V","GCAN","Psychiatric / neurological",2907,14860,17767,"log odds","Males and females","European"
"234","Anorexia nervosa","APOC3 inhibitor",1,-0.366120666668113,0.224060121723579,0.102252827051059,24514567,2014,"Boraska V","GCAN","Psychiatric / neurological",2907,14860,17767,"log odds","Males and females","European"
"235","Autism","APOC3 inhibitor",1,-0.0828481374880694,0.230380609935844,0.719135667072682,NA,2015,NA,"PGC","Psychiatric / neurological",4949,5314,10263,"log odds","Males and females","European"
"236","Autism","APOC3 inhibitor",1,-0.0828481374880694,0.230368763557484,0.719121836012992,NA,2015,NA,"PGC","Psychiatric / neurological",4949,5314,10263,"log odds","Males and females","European"
"237","Bipolar disorder","APOC3 inhibitor",1,0.329793867348807,0.201301518438178,0.101357481147341,21926972,2011,"Sklar P","PGC","Psychiatric / neurological",7481,9250,16731,"log odds","Males and females","European"
"238","Bipolar disorder","APOC3 inhibitor",1,0.329793867348807,0.201516232953022,0.101721960756009,21926972,2011,"Sklar P","PGC","Psychiatric / neurological",7481,9250,16731,"log odds","Males and females","European"
"239","Bulimia nervosa","APOC3 inhibitor",1,0.0563991323210412,0.0650953537762834,0.386266483246393,23568457,2013,"Wade TD",NA,"Psychiatric / neurological",151,2291,2442,"log odds","Females","European"
"240","Bulimia nervosa","APOC3 inhibitor",1,0.0563991323210412,0.0650759219088937,0.386124674283814,23568457,2013,"Wade TD",NA,"Psychiatric / neurological",151,2291,2442,"log odds","Females","European"
"241","Caudate volume","APOC3 inhibitor",1,70.7158351409978,40.6086456720002,0.0816137488905726,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"242","Caudate volume","APOC3 inhibitor",1,70.7158351409978,40.5596529284165,0.0812459689393877,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"243","Depressive symptoms","APOC3 inhibitor",1,0.0260303687635575,0.0303776335850603,0.391504254853084,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,161460,"SD","Males and females","European"
"244","Depressive symptoms","APOC3 inhibitor",1,0.0260303687635575,0.0303687635574837,0.391365938307552,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,161460,"SD","Males and females","European"
"245","Digit symbol","APOC3 inhibitor",1,-0.149240780911063,0.246420824295011,0.544757950630745,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2956,"SD (number correct in 90/120 seconds)","Males and females","European"
"246","Digit symbol","APOC3 inhibitor",1,-0.149240780911063,0.246456759556771,0.544816604129462,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2956,"SD (number correct in 90/120 seconds)","Males and females","European"
"247","G speed factor","APOC3 inhibitor",1,-0.438611713665944,0.268397944001886,0.102220152321516,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2430,"SD","Males and females","European"
"248","G speed factor","APOC3 inhibitor",1,-0.438611713665944,0.268112798264642,0.101855843882841,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2430,"SD","Males and females","European"
"249","Hippocampus volume","APOC3 inhibitor",1,17.2954446854664,39.0290778917414,0.657662637666197,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"250","Hippocampus volume","APOC3 inhibitor",1,17.2954446854664,39.0260303687636,0.657637609419484,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"251","Inspection time","APOC3 inhibitor",1,0.433839479392625,0.254957468672148,0.0888275443815838,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2645,"SD (milliseconds)","Males and females","European"
"252","Inspection time","APOC3 inhibitor",1,0.433839479392625,0.254663774403471,0.0884600455357051,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2645,"SD (milliseconds)","Males and females","European"
"253","Internalizing problems","APOC3 inhibitor",1,-0.184381778741866,0.19175704989154,0.336281496460677,24839885,2014,"Benke","EAGLE","Psychiatric / neurological",NA,NA,4596,NA,"Males and females","European"
"254","Internalizing problems","APOC3 inhibitor",1,-0.184381778741866,0.191827528888641,0.336459064349157,24839885,2014,"Benke","EAGLE","Psychiatric / neurological",NA,NA,4596,NA,"Males and females","European"
"255","Intracranial volume","APOC3 inhibitor",1,1958.11409978308,16025.4643282771,0.902750393529565,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"256","Intracranial volume","APOC3 inhibitor",1,1958.11409978308,16025.369197397,0.902749819097181,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"257","Major depressive disorder","APOC3 inhibitor",1,-0.211670994227332,0.18231032368457,0.245622474523894,22472876,2013,"Sullivan","PGC","Psychiatric / neurological",9240,9519,18759,"log odds","Males and females","European"
"258","Major depressive disorder","APOC3 inhibitor",1,-0.211670994227332,0.182212581344902,0.245369302293686,22472876,2013,"Sullivan","PGC","Psychiatric / neurological",9240,9519,18759,"log odds","Males and females","European"
"259","Migraine in bipolar disorder","APOC3 inhibitor",1,0.707023116173536,0.685032537960954,0.302024567009805,25451450,2015,"Jacobsen KK",NA,"Psychiatric / neurological",460,924,1374,"log odds","Males and females","European"
"260","Migraine in bipolar disorder","APOC3 inhibitor",1,0.707023116173536,0.685322618732635,0.302229245275739,25451450,2015,"Jacobsen KK",NA,"Psychiatric / neurological",460,924,1374,"log odds","Males and females","European"
"261","Nucleus accumbens volume","APOC3 inhibitor",1,3.58394793926247,9.02399330147887,0.691251212546402,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"262","Nucleus accumbens volume","APOC3 inhibitor",1,3.58394793926247,9.0234273318872,0.691232844165837,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"263","Pallidum volume","APOC3 inhibitor",1,10.3748373101952,15.7691973969631,0.51059088488215,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"264","Pallidum volume","APOC3 inhibitor",1,10.3748373101952,15.7719111510541,0.510663632810229,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"265","PGC cross-disorder traits","APOC3 inhibitor",1,-0.136653653186117,0.101084598698482,0.17641558699158,23453885,2013,"Smoller JW","PGC","Psychiatric / neurological",33332,27888,61220,"log odds","Males and females","European"
"266","PGC cross-disorder traits","APOC3 inhibitor",1,-0.136653653186117,0.101158025507407,0.176729759547466,23453885,2013,"Smoller JW","PGC","Psychiatric / neurological",33332,27888,61220,"log odds","Males and females","European"
"267","Putamen volume","APOC3 inhibitor",1,-7.1648590021692,49.5331669553127,0.884989028855161,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"268","Putamen volume","APOC3 inhibitor",1,-7.1648590021692,49.5327548806941,0.884988078706423,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"269","Schizophrenia","APOC3 inhibitor",1,-0.00390279931816052,0.0854663774403471,0.963577473348989,25056061,2014,"Ripke S","PGC","Psychiatric / neurological",35476,46839,82315,"log odds","Males and females","Mixed"
"270","Schizophrenia","APOC3 inhibitor",1,-0.00390279931816052,0.0854664483020888,0.963577503526564,25056061,2014,"Ripke S","PGC","Psychiatric / neurological",35476,46839,82315,"log odds","Males and females","Mixed"
"271","Simple reaction time","APOC3 inhibitor",1,0.480694143167028,0.246793376332461,0.0514437469604969,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2378,"SD (milliseconds)","Males and females","European"
"272","Simple reaction time","APOC3 inhibitor",1,0.480694143167028,0.246420824295011,0.0510922404503593,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2378,"SD (milliseconds)","Males and females","European"
"273","Subjective well being","APOC3 inhibitor",1,-0.017353579175705,0.0303727061117644,0.567759435190682,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,298420,"SD","Males and females","European"
"274","Subjective well being","APOC3 inhibitor",1,-0.017353579175705,0.0303687635574837,0.567709166197353,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,298420,"SD","Males and females","European"
"275","Thalamus volume","APOC3 inhibitor",1,-11.8195227765727,52.0769885377462,0.820452912884783,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"276","Thalamus volume","APOC3 inhibitor",1,-11.8195227765727,52.0759219088937,0.82044929808215,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"277","Age at menarche","APOC3 inhibitor",1,-0.0429501084598699,0.0499642169253796,0.389999999999295,25231870,2014,"Perry JR","ReproGen","Reproductive aging",NA,NA,182416,"years","Females","European"
"278","Age at menarche","APOC3 inhibitor",1,-0.0429501084598698,0.0499788947102119,0.390139221724499,25231870,2014,"Perry JR","ReproGen","Reproductive aging",NA,NA,182416,"years","Females","European"
"279","Age at menopause","APOC3 inhibitor",1,0.0433839479392625,0.173540104152121,0.80259215290399,26414677,2015,"Day","ReproGen","Reproductive aging",NA,NA,69360,"years","Females","European"
"280","Age at menopause","APOC3 inhibitor",1,0.0433839479392625,0.17353579175705,0.802587348634153,26414677,2015,"Day","ReproGen","Reproductive aging",NA,NA,69360,"years","Females","European"
"281","Chronotype","APOC3 inhibitor",1,0.0188899349240781,0.034064989154013,0.579218660931931,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"282","Chronotype","APOC3 inhibitor",1,0.0188899349240781,0.0340691538277082,0.579265039506336,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"283","Sleep duration","APOC3 inhibitor",1,-0.00437752711496746,0.0356254229934924,0.902204898725182,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"284","Sleep duration","APOC3 inhibitor",1,-0.00437752711496746,0.0356256368641549,0.902205482867739,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"285","Father’s age at death","HMGCR inhibitor",1,-0.00139976807639836,0.0636246930422919,0.982447644240431,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"286","Father’s age at death","HMGCR inhibitor",1,-0.00139976807639836,0.0636247344246826,0.982447655654879,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"287","Mother’s age at death","HMGCR inhibitor",1,-0.0116088813096862,0.0707706353657283,0.869703366964365,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"288","Mother’s age at death","HMGCR inhibitor",1,-0.0116088813096862,0.0707680763983629,0.869698697559006,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"289","Parents' age at death","HMGCR inhibitor",1,-0.0988036834924966,0.104574496092529,0.344752693033448,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"290","Parents' age at death","HMGCR inhibitor",1,-0.0988036834924966,0.10444897680764,0.344173240115771,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"291","Top 1 % survival","HMGCR inhibitor",1,0.0234926330150068,0.0118647066848568,0.0476986630792993,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"292","Top 1 % survival","HMGCR inhibitor",1,0.0234926330150068,0.011927050892106,0.0488735237863118,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"293","Birth weight","HMGCR inhibitor",1,0.0613915416098226,0.0492162464173528,0.212256854840856,27680694,2016,"Horikoshi",NA,"Anthropometric",NA,NA,153781,NA,"Males and females","Mixed"
"294","Birth weight","HMGCR inhibitor",1,0.0613915416098226,0.0491132332878581,0.21129954733371,27680694,2016,"Horikoshi",NA,"Anthropometric",NA,NA,153781,NA,"Males and females","Mixed"
"295","Body fat","HMGCR inhibitor",1,0.140518417462483,0.0645325386578748,0.0294446509687447,26833246,2016,"Lu",NA,"Anthropometric",NA,NA,100716,"SD","Males and females","European"
"296","Body fat","HMGCR inhibitor",1,0.140518417462483,0.0641200545702592,0.0284163987470917,26833246,2016,"Lu",NA,"Anthropometric",NA,NA,100716,"SD","Males and females","European"
"297","Body mass index","HMGCR inhibitor",1,0.234652114597544,0.0426972824606016,3.89129547491538e-08,25673413,2015,"Locke AE","GIANT","Anthropometric",NA,NA,339224,"SD (kg/m^2)","Males and females","Mixed"
"298","Body mass index","HMGCR inhibitor",1,0.234652114597544,0.0409276944065484,9.8475829467645e-09,25673413,2015,"Locke AE","GIANT","Anthropometric",NA,NA,339224,"SD (kg/m^2)","Males and females","Mixed"
"299","Child birth length","HMGCR inhibitor",1,0.0177353342428377,0.121422307833389,0.883871474777482,25281659,2015,"van der Valk RJ","EGG","Anthropometric",NA,NA,28459,"SD (cm)","Males and females","European"
"300","Child birth length","HMGCR inhibitor",1,0.0177353342428377,0.121418826739427,0.883868168968033,25281659,2015,"van der Valk RJ","EGG","Anthropometric",NA,NA,28459,"SD (cm)","Males and females","European"
"301","Child birth weight","HMGCR inhibitor",1,0.136425648021828,0.114815582760158,0.234748542775858,23202124,2013,"Horikoshi M","EGG","Anthropometric",NA,NA,26836,"g","Males and females","European"
"302","Child birth weight","HMGCR inhibitor",1,0.136425648021828,0.114597544338336,0.233859282692745,23202124,2013,"Horikoshi M","EGG","Anthropometric",NA,NA,26836,"g","Males and females","European"
"303","Childhood obesity","HMGCR inhibitor",1,0.605729877216917,0.372404078193592,0.103834975232471,22484627,2012,"Bradfield JP","EGG","Anthropometric",5530,8318,13848,"log odds","Males and females","European"
"304","Childhood obesity","HMGCR inhibitor",1,0.605729877216917,0.371077762619372,0.102605156531172,22484627,2012,"Bradfield JP","EGG","Anthropometric",5530,8318,13848,"log odds","Males and females","European"
"305","Difference in height between adolescence and adulthood","HMGCR inhibitor",1,-0.676703790406548,0.304627094878581,0.0263227343923796,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,4282,"SD","Males","European"
"306","Difference in height between adolescence and adulthood","HMGCR inhibitor",1,-0.676703790406548,0.306640471905697,0.0273258476547278,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,4282,"SD","Males","European"
"307","Difference in height between childhood and adulthood","HMGCR inhibitor",1,-0.288888731321965,0.270223226332672,0.285036149714424,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,5043,"SD","Males","European"
"308","Difference in height between childhood and adulthood","HMGCR inhibitor",1,-0.288888731321965,0.269807888335607,0.284295298690205,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,5043,"SD","Males","European"
"309","Extreme body mass index","HMGCR inhibitor",1,1.15961800818554,0.35976497965466,0.0012673807058288,23563607,2013,"Berndt SI","GIANT","Anthropometric",7962,8106,16068,"log odds","Males and females","European"
"310","Extreme body mass index","HMGCR inhibitor",1,1.15961800818554,0.354706684856753,0.00107840310110933,23563607,2013,"Berndt SI","GIANT","Anthropometric",7962,8106,16068,"log odds","Males and females","European"
"311","Extreme height","HMGCR inhibitor",1,0.0572987721691678,0.35471912263737,0.871673781941431,23563607,2013,"Berndt SI","GIANT","Anthropometric",8097,8099,16196,"log odds","Males and females","European"
"312","Extreme height","HMGCR inhibitor",1,0.0572987721691678,0.354706684856753,0.871669321189146,23563607,2013,"Berndt SI","GIANT","Anthropometric",8097,8099,16196,"log odds","Males and females","European"
"313","Extreme waist-to-hip ratio","HMGCR inhibitor",1,0.286493860845839,0.423180225252567,0.498404682432702,23563607,2013,"Berndt SI","GIANT","Anthropometric",4774,5481,10255,"log odds","Males and females","European"
"314","Extreme waist-to-hip ratio","HMGCR inhibitor",1,0.286493860845839,0.422919508867667,0.49813992156856,23563607,2013,"Berndt SI","GIANT","Anthropometric",4774,5481,10255,"log odds","Males and females","European"
"315","Height","HMGCR inhibitor",1,-0.0613915416098226,0.0410512532922179,0.134787860424678,25282103,2014,"Wood AR","GIANT","Anthropometric",NA,NA,253288,"SD (m)","Males and females","European"
"316","Height","HMGCR inhibitor",1,-0.0613915416098226,0.0409276944065484,0.133614402537716,25282103,2014,"Wood AR","GIANT","Anthropometric",NA,NA,253288,"SD (m)","Males and females","European"
"317","Hip circumference","HMGCR inhibitor",1,0.204638472032742,0.0502459615828751,4.64643370956422e-05,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"318","Hip circumference","HMGCR inhibitor",1,0.204638472032742,0.0491132332878581,3.0908593764592e-05,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"319","Infant head circumference","HMGCR inhibitor",1,0.0804911323328786,0.200545702592087,0.688154694098134,22504419,2012,"Taal HR","EGG","Anthropometric",NA,NA,10768,"SD (cm)","Males and females","European"
"320","Infant head circumference","HMGCR inhibitor",1,0.0804911323328786,0.200589110111071,0.688218632180761,22504419,2012,"Taal HR","EGG","Anthropometric",NA,NA,10768,"SD (cm)","Males and females","European"
"321","Obesity class 1","HMGCR inhibitor",1,0.572987721691678,0.179823736826634,0.00144062570511086,23563607,2013,"Berndt SI","GIANT","Anthropometric",32858,65839,98697,"log odds","Males and females","European"
"322","Obesity class 1","HMGCR inhibitor",1,0.572987721691678,0.177353342428377,0.00123457572464113,23563607,2013,"Berndt SI","GIANT","Anthropometric",32858,65839,98697,"log odds","Males and females","European"
"323","Obesity class 2","HMGCR inhibitor",1,0.914051841746248,0.263504465775133,0.000522732725231792,23563607,2013,"Berndt SI","GIANT","Anthropometric",9889,62657,72546,"log odds","Males and females","European"
"324","Obesity class 2","HMGCR inhibitor",1,0.914051841746248,0.259208731241473,0.000421384192820392,23563607,2013,"Berndt SI","GIANT","Anthropometric",9889,62657,72546,"log odds","Males and females","European"
"325","Obesity class 3","HMGCR inhibitor",1,0.982264665757162,0.480197418608964,0.0408013139310125,23563607,2013,"Berndt SI","GIANT","Anthropometric",2896,47468,50364,"log odds","Males and females","European"
"326","Obesity class 3","HMGCR inhibitor",1,0.982264665757162,0.477489768076398,0.0396724862659754,23563607,2013,"Berndt SI","GIANT","Anthropometric",2896,47468,50364,"log odds","Males and females","European"
"327","Overweight","HMGCR inhibitor",1,0.395634379263301,0.125511596180082,0.00162059718770719,23563607,2013,"Berndt SI","GIANT","Anthropometric",93015,65840,158855,"log odds","Males and females","European"
"328","Overweight","HMGCR inhibitor",1,0.395634379263301,0.127176398534979,0.00186511530388868,23563607,2013,"Berndt SI","GIANT","Anthropometric",93015,65840,158855,"log odds","Males and females","European"
"329","Sitting height ratio","HMGCR inhibitor",1,0.150068212824011,0.136425648021828,0.271332121892765,25865494,2015,"Chan",NA,"Anthropometric",NA,NA,21590,"SD","Males and females","European"
"330","Sitting height ratio","HMGCR inhibitor",1,0.150068212824011,0.136647293051677,0.272110279508297,25865494,2015,"Chan",NA,"Anthropometric",NA,NA,21590,"SD","Males and females","European"
"331","Waist circumference","HMGCR inhibitor",1,0.204638472032742,0.0475824468817367,1.70249049002262e-05,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"332","Waist circumference","HMGCR inhibitor",1,0.204638472032742,0.0463847203274216,1.02531502969758e-05,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"333","Waist-to-hip ratio","HMGCR inhibitor",1,0.109140518417462,0.0463847203274216,0.0186255802874029,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD","Males and females","Mixed"
"334","Waist-to-hip ratio","HMGCR inhibitor",1,0.109140518417462,0.0467285313337253,0.0195105796537297,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD","Males and females","Mixed"
"335","Weight","HMGCR inhibitor",1,0.204638472032742,0.0900409276944065,0.0230426200877619,23754948,2013,"Randall JC","GIANT","Anthropometric",NA,NA,60586,"SD (kg)","Males","European"
"336","Weight","HMGCR inhibitor",1,0.204638472032742,0.0906637503717419,0.024000916627419,23754948,2013,"Randall JC","GIANT","Anthropometric",NA,NA,60586,"SD (kg)","Males","European"
"337","Crohn's disease","HMGCR inhibitor",1,-0.120035393674625,0.317932665086153,0.705765110557958,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",5956,14927,20883,"log odds","Males and females","European"
"338","Crohn's disease","HMGCR inhibitor",1,-0.120035393674625,0.317871759890859,0.705711363128149,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",5956,14927,20883,"log odds","Males and females","European"
"339","Eczema","HMGCR inhibitor",1,-0.162951992046385,0.23263240861528,0.483633917811691,26482879,2014,"Paternoster","EAGLE","Autoimmune / inflammatory",10788,30047,40835,"log odds","Males and females","European"
"340","Eczema","HMGCR inhibitor",1,-0.162951992046385,0.232785741489381,0.483922011369593,26482879,2014,"Paternoster","EAGLE","Autoimmune / inflammatory",10788,30047,40835,"log odds","Males and females","European"
"341","Gout","HMGCR inhibitor",1,0.422919508867667,0.450204638472033,0.347528523523374,23263486,2013,"Köttgen","GUGC","Autoimmune / inflammatory",2115,67259,69374,"log odds","Males and females","European"
"342","Gout","HMGCR inhibitor",1,0.422919508867667,0.450738191328184,0.348099533508468,23263486,2013,"Köttgen","GUGC","Autoimmune / inflammatory",2115,67259,69374,"log odds","Males and females","European"
"343","Inflammatory bowel disease","HMGCR inhibitor",1,0.0395061816102319,0.234652114597544,0.866299566030784,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",12882,21770,34652,"log odds","Males and females","European"
"344","Inflammatory bowel disease","HMGCR inhibitor",1,0.0395061816102319,0.234661052314907,0.86630461045239,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",12882,21770,34652,"log odds","Males and females","European"
"345","Juvenile idiopathic arthritis","HMGCR inhibitor",1,-0.469323693278308,0.742024702186903,0.527066309987163,23603761,2013,"Hinks",NA,"Autoimmune / inflammatory",2816,13056,15872,"log odds","Males and females","European"
"346","Juvenile idiopathic arthritis","HMGCR inhibitor",1,-0.469323693278308,0.742423487503248,0.52728826233408,23603761,2013,"Hinks",NA,"Autoimmune / inflammatory",2816,13056,15872,"log odds","Males and females","European"
"347","Multiple sclerosis","HMGCR inhibitor",1,0.40325787505457,0.229624231497954,0.0790603605315042,24076602,2013,"Beecham","IMSGC","Autoimmune / inflammatory",14498,24091,38589,"log odds","Males and females","European"
"348","Multiple sclerosis","HMGCR inhibitor",1,0.40325787505457,0.230573917618462,0.0803029451933494,24076602,2013,"Beecham","IMSGC","Autoimmune / inflammatory",14498,24091,38589,"log odds","Males and females","European"
"349","Narcolepsy","HMGCR inhibitor",1,-0.040866425372442,0.491071225968563,0.933677455489718,23459209,2013,"Faraco",NA,"Autoimmune / inflammatory",1886,10421,12307,"log odds","Males and females","European"
"350","Narcolepsy","HMGCR inhibitor",1,-0.040866425372442,0.491066655927694,0.933676839692079,23459209,2013,"Faraco",NA,"Autoimmune / inflammatory",1886,10421,12307,"log odds","Males and females","European"
"351","Primary biliary cirrhosis","HMGCR inhibitor",1,-0.0340638499125512,0.454492280637108,0.940255100781476,26394269,2015,"Cordell",NA,"Autoimmune / inflammatory",2764,10475,13239,"log odds","Males and females","European"
"352","Primary biliary cirrhosis","HMGCR inhibitor",1,-0.0340638499125512,0.454495711383055,0.940255550920079,26394269,2015,"Cordell",NA,"Autoimmune / inflammatory",2764,10475,13239,"log odds","Males and females","European"
"353","Psoriasis","HMGCR inhibitor",1,0.0546796916444748,0.430215635226466,0.89886256793588,23143594,2012,"Tsoi",NA,"Autoimmune / inflammatory",10588,22806,33394,"log odds","Males and females","European"
"354","Psoriasis","HMGCR inhibitor",1,0.0546796916444748,0.430224974013216,0.898864751505545,23143594,2012,"Tsoi",NA,"Autoimmune / inflammatory",10588,22806,33394,"log odds","Males and females","European"
"355","Rheumatoid arthritis","HMGCR inhibitor",1,0.135748033467531,0.171619725630529,0.428954768608163,24390342,2014,"Okada Y",NA,"Autoimmune / inflammatory",19234,61565,80799,"log odds","Males and females","Mixed"
"356","Rheumatoid arthritis","HMGCR inhibitor",1,0.135748033467531,0.171475377282401,0.428566311113805,24390342,2014,"Okada Y",NA,"Autoimmune / inflammatory",19234,61565,80799,"log odds","Males and females","Mixed"
"357","Systemic lupus erythematosus","HMGCR inhibitor",1,-0.270158626141883,0.410153145685835,0.510102919547236,26502338,2015,"Bentham",NA,"Autoimmune / inflammatory",7219,15991,23210,"log odds","Males and females","European"
"358","Systemic lupus erythematosus","HMGCR inhibitor",1,-0.270158626141883,0.409913953199181,0.509856087199277,26502338,2015,"Bentham",NA,"Autoimmune / inflammatory",7219,15991,23210,"log odds","Males and females","European"
"359","Type 1 diabetes","HMGCR inhibitor",1,-0.166779940281037,0.30473072443835,0.584170807196003,25751624,2015,"Onengut-Gumuscu",NA,"Autoimmune / inflammatory",9563,9369,18932,"log odds","Males and females","European"
"360","Type 1 diabetes","HMGCR inhibitor",1,-0.166779940281037,0.304608040399727,0.584019400946897,25751624,2015,"Onengut-Gumuscu",NA,"Autoimmune / inflammatory",9563,9369,18932,"log odds","Males and females","European"
"361","Ulcerative colitis","HMGCR inhibitor",1,0.113171855717735,0.297465777074646,0.703608908149451,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",6968,20464,27432,"log odds","Males and females","European"
"362","Ulcerative colitis","HMGCR inhibitor",1,0.113171855717735,0.297407912687585,0.703553971358486,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",6968,20464,27432,"log odds","Males and females","European"
"363","Age of smoking initiation","HMGCR inhibitor",1,-0.0109140518417462,0.0313778990450205,0.727970796961297,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,47961,"log years","Males and females","European"
"364","Age of smoking initiation","HMGCR inhibitor",1,-0.0109140518417462,0.0313829998898613,0.728013257257391,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,47961,"log years","Males and females","European"
"365","Alcohol dependence","HMGCR inhibitor",1,1.33519444363029,0.74027816735905,0.0712879455229772,22978509,2012,"Olfson",NA,"Behavioural",1897,1932,3829,"log odds","Males and females","Mixed"
"366","Alcohol dependence","HMGCR inhibitor",1,1.33519444363029,0.737034952493861,0.0700518173773362,22978509,2012,"Olfson",NA,"Behavioural",1897,1932,3829,"log odds","Males and females","Mixed"
"367","Cigarettes smoked per day","HMGCR inhibitor",1,2.36289222373806,1.15250383917956,0.0403424760761076,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,68028,"Cigarettes per day","Males and females","European"
"368","Cigarettes smoked per day","HMGCR inhibitor",1,2.36289222373806,1.14597544338336,0.039216804093476,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,68028,"Cigarettes per day","Males and females","European"
"369","Ever vs never smoked","HMGCR inhibitor",1,0.136425648021828,0.162346521145975,0.400719946701513,20418890,2010,"Furberg","TAG","Behavioural",41969,32066,74035,"log odds","Males and females","European"
"370","Ever vs never smoked","HMGCR inhibitor",1,0.136425648021828,0.162500504012691,0.401166439350125,20418890,2010,"Furberg","TAG","Behavioural",41969,32066,74035,"log odds","Males and females","European"
"371","Former vs current smoker","HMGCR inhibitor",1,0.0654843110504775,0.225127916827978,0.771146146693907,20418890,2010,"Furberg","TAG","Behavioural",23554,18415,41969,"log odds","Males and females","European"
"372","Former vs current smoker","HMGCR inhibitor",1,0.0654843110504775,0.225102319236016,0.771120848329444,20418890,2010,"Furberg","TAG","Behavioural",23554,18415,41969,"log odds","Males and females","European"
"373","Paget's disease","HMGCR inhibitor",1,-0.698547066848567,0.84199727148704,0.406747424982512,21623375,2011,"Albagha OM",NA,"Bone",741,2699,3440,"log odds","Males and females","European"
"374","Paget's disease","HMGCR inhibitor",1,-0.698547066848567,0.842775682924611,0.407180936368535,21623375,2011,"Albagha OM",NA,"Bone",741,2699,3440,"log odds","Males and females","European"
"375","Lung adenocarcinoma","HMGCR inhibitor",1,0.162105265143247,0.376151187889613,0.666499099937859,24880342,2014,"Wang Y","ILCCO","Cancer",3442,14894,18336,"log odds","Males and females","European"
"376","Lung adenocarcinoma","HMGCR inhibitor",1,0.162105265143247,0.376057298772169,0.666420865794585,24880342,2014,"Wang Y","ILCCO","Cancer",3442,14894,18336,"log odds","Males and females","European"
"377","Lung cancer","HMGCR inhibitor",1,0.235749667931787,0.242660300136426,0.331288715312239,24880342,2014,"Wang Y","ILCCO","Cancer",11348,15861,27209,"log odds","Males and females","European"
"378","Lung cancer","HMGCR inhibitor",1,0.235749667931787,0.242967879747469,0.331901214096844,24880342,2014,"Wang Y","ILCCO","Cancer",11348,15861,27209,"log odds","Males and females","European"
"379","Melanoma","HMGCR inhibitor",1,-1.23812228197135,0.775306957708049,0.110278050402725,21926416,2011,"Amos CI","MDACC","Cancer",1804,1026,2830,"log odds","Males and females","European"
"380","Melanoma","HMGCR inhibitor",1,-1.23812228197135,0.777959366119241,0.111497109648259,21926416,2011,"Amos CI","MDACC","Cancer",1804,1026,2830,"log odds","Males and females","European"
"381","Small cell lung carcinoma","HMGCR inhibitor",1,0.685376014564802,0.403232864291397,0.089186848910552,NA,NA,NA,"TRICL","Cancer",2791,20580,23371,NA,"Males and females","European"
"382","Small cell lung carcinoma","HMGCR inhibitor",1,0.685376014564802,0.401664392905866,0.0879447973310574,NA,NA,NA,"TRICL","Cancer",2791,20580,23371,NA,"Males and females","European"
"383","Squamous cell lung cancer","HMGCR inhibitor",1,0.230254151115962,0.372810519393956,0.536827771108444,24880342,2014,"Wang Y","ILCCO","Cancer",3275,15038,18313,"log odds","Males and females","European"
"384","Squamous cell lung cancer","HMGCR inhibitor",1,0.230254151115962,0.372619372442019,0.53661889545792,24880342,2014,"Wang Y","ILCCO","Cancer",3275,15038,18313,"log odds","Males and females","European"
"385","Thyroid cancer","HMGCR inhibitor",1,0.185429106678035,1.16306837651961,0.873329349073997,23894154,2013,"Kohler A",NA,"Cancer",649,431,1080,"log odds","Males and females","European"
"386","Thyroid cancer","HMGCR inhibitor",1,0.185429106678035,1.16302864938608,0.873325058752378,23894154,2013,"Kohler A",NA,"Cancer",649,431,1080,"log odds","Males and females","European"
"387","Coronary heart disease","HMGCR inhibitor",1,-0.488772169167803,0.129405184174625,0.000158685471628216,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",60801,123504,184305,"log odds","Males and females","Mixed"
"388","Coronary heart disease","HMGCR inhibitor",1,-0.488772169167803,0.131862642992414,0.000209996845422566,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",60801,123504,184305,"log odds","Males and females","Mixed"
"389","Myocardial infarction","HMGCR inhibitor",1,-0.472230559345157,0.141894212230559,0.000874572165354962,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",43676,128199,171875,"log odds","Males and females","Mixed"
"390","Myocardial infarction","HMGCR inhibitor",1,-0.472230559345157,0.143990622612802,0.00103957141574809,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",43676,128199,171875,"log odds","Males and females","Mixed"
"391","Type 2 diabetes","HMGCR inhibitor",1,0.270158626141883,0.169801779691678,0.11160428147463,24509480,2014,"Mahajan A","DIAGRAM","Diabetes",26488,83964,110452,"log odds","Males and females","Mixed"
"392","Type 2 diabetes","HMGCR inhibitor",1,0.270158626141883,0.17037839732509,0.11282123117745,24509480,2014,"Mahajan A","DIAGRAM","Diabetes",26488,83964,110452,"log odds","Males and females","Mixed"
"393","College completion","HMGCR inhibitor",1,-0.164700971818554,0.136692580169713,0.22824167709362,23722424,2013,"Rietveld CA","SSGAC","Education",20044,75383,95427,"log odds","Males and females","European"
"394","College completion","HMGCR inhibitor",1,-0.164700971818554,0.136425648021828,0.227332752507352,23722424,2013,"Rietveld CA","SSGAC","Education",20044,75383,95427,"log odds","Males and females","European"
"395","Years of schooling","HMGCR inhibitor",1,-0.0954979536152797,0.0409276944065484,0.0196306572572907,27225129,2016,"Okbay","SSGAC","Education",NA,NA,293723,"SD (years)","Males and females","European"
"396","Years of schooling","HMGCR inhibitor",1,-0.0954979536152797,0.041226040299342,0.0205338535823479,27225129,2016,"Okbay","SSGAC","Education",NA,NA,293723,"SD (years)","Males and females","European"
"397","2hr glucose","HMGCR inhibitor",1,0.409276944065484,0.260075670214296,0.115560502120245,20081857,2010,"Saxena R","MAGIC","Glycemic",NA,NA,15234,"mmol/L","Males and females","European"
"398","2hr glucose","HMGCR inhibitor",1,0.409276944065484,0.259208731241473,0.114348129742201,20081857,2010,"Saxena R","MAGIC","Glycemic",NA,NA,15234,"mmol/L","Males and females","European"
"399","AUCins","HMGCR inhibitor",1,-0.409276944065484,0.300885463069207,0.173753460825538,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4324,"SD (mU*min/l)","Males and females","European"
"400","AUCins","HMGCR inhibitor",1,-0.409276944065484,0.300136425648022,0.172682041418748,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4324,"SD (mU*min/l)","Males and females","European"
"401","AUCins/AUCglu","HMGCR inhibitor",1,-0.313778990450205,0.300576919333058,0.296521276023925,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4213,"SD","Males and females","European"
"402","AUCins/AUCglu","HMGCR inhibitor",1,-0.313778990450205,0.300136425648022,0.295812938228253,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4213,"SD","Males and females","European"
"403","Corrected insulin response","HMGCR inhibitor",1,-0.0504774897680764,0.272863844454797,0.853235708602267,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5318,"SD","Males and females","European"
"404","Corrected insulin response","HMGCR inhibitor",1,-0.0504774897680764,0.272851296043656,0.853229035573251,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5318,"SD","Males and females","European"
"405","Fasting glucose","HMGCR inhibitor",1,0.00818553888130969,0.00954979536152797,0.391365938307552,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,58074,"mmol/L","Males and females","European"
"406","Fasting glucose","HMGCR inhibitor",1,0.00818553888130969,0.00955921893259598,0.391833035068765,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,58074,"mmol/L","Males and females","European"
"407","Fasting insulin","HMGCR inhibitor",1,-0.00954979536152797,0.00956261960658964,0.317959947607355,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,51750,"log pmol/L","Males and females","European"
"408","Fasting insulin","HMGCR inhibitor",1,-0.00954979536152797,0.00954979536152797,0.317310507862914,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,51750,"log pmol/L","Males and females","European"
"409","Fasting proinsulin","HMGCR inhibitor",1,0.107776261937244,0.099747331531357,0.279922843051286,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,10701,"log pmol/L","Males and females","European"
"410","Fasting proinsulin","HMGCR inhibitor",1,0.107776261937244,0.0995907230559345,0.27916731988398,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,10701,"log pmol/L","Males and females","European"
"411","HbA1C","HMGCR inhibitor",1,0.00136425648021828,0.0477489768076398,0.977206399475098,20858683,2010,"Soranzo N","MAGIC","Glycemic",NA,NA,46368,"%","Males and females","European"
"412","HbA1C","HMGCR inhibitor",1,0.00136425648021828,0.0477490291866143,0.977206424472059,20858683,2010,"Soranzo N","MAGIC","Glycemic",NA,NA,46368,"%","Males and females","European"
"413","HOMA-B","HMGCR inhibitor",1,0.0313778990450205,0.0464132350111789,0.499005733441924,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"414","HOMA-B","HMGCR inhibitor",1,0.0313778990450205,0.0463847203274216,0.498741913600147,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"415","HOMA-IR","HMGCR inhibitor",1,0.0654843110504775,0.0559345156889495,0.241706636032056,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"416","HOMA-IR","HMGCR inhibitor",1,0.0654843110504775,0.0560374415478501,0.242572331826023,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"417","Incremental insulin at 30 minutes","HMGCR inhibitor",1,-0.327421555252387,0.286493860845839,0.253097908947116,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4447,"SD","Males and females","European"
"418","Incremental insulin at 30 minutes","HMGCR inhibitor",1,-0.327421555252387,0.286996258772026,0.253929632536045,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4447,"SD","Males and females","European"
"419","Insulin at 30 minutes","HMGCR inhibitor",1,-0.117326057298772,0.300136425648022,0.695864434022019,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4409,"SD","Males and females","European"
"420","Insulin at 30 minutes","HMGCR inhibitor",1,-0.117326057298772,0.30019805036141,0.695923752149935,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4409,"SD","Males and females","European"
"421","Insulin disposition index","HMGCR inhibitor",1,0.0927694406548431,0.272893677841477,0.733896293437943,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5130,"SD","Males and females","European"
"422","Insulin disposition index","HMGCR inhibitor",1,0.0927694406548431,0.272851296043656,0.733856527927944,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5130,"SD","Males and females","European"
"423","Insulin sensitivity index","HMGCR inhibitor",1,0.177353342428377,0.286493860845839,0.535884989067038,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4769,"SD","Males and females","European"
"424","Insulin sensitivity index","HMGCR inhibitor",1,0.177353342428377,0.286641357070287,0.536094851077302,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4769,"SD","Males and females","European"
"425","Insulin-like growth factor 1","HMGCR inhibitor",1,-0.163959364772169,0.119200733499575,0.168979719393859,27329260,2016,NA,NA,"Growth hormone",NA,NA,30884,"SD","Males and females","European"
"426","Insulin-like growth factor 1","HMGCR inhibitor",1,-0.163959364772169,0.118897291350614,0.167894753899429,27329260,2016,NA,NA,"Growth hormone",NA,NA,30884,"SD","Males and females","European"
"427","Insulin-like growth factor binding protein 3","HMGCR inhibitor",1,-0.0401503666623465,0.142899027224778,0.778733265021006,27329260,2016,NA,NA,"Growth hormone",NA,NA,18995,"SD","Males and females","European"
"428","Insulin-like growth factor binding protein 3","HMGCR inhibitor",1,-0.0401503666623465,0.142883867125512,0.778710399831261,27329260,2016,NA,NA,"Growth hormone",NA,NA,18995,"SD","Males and females","European"
"429","Haemoglobin concentration","HMGCR inhibitor",1,-0.0914051841746248,0.0818553888130969,0.264136875256031,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,71861,"g/dL","Males and females","Mixed"
"430","Haemoglobin concentration","HMGCR inhibitor",1,-0.0914051841746248,0.081992432876818,0.264936031913518,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,71861,"g/dL","Males and females","Mixed"
"431","Mean cell haemoglobin","HMGCR inhibitor",1,0.18281036834925,0.144611186903138,0.206175854627279,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,64731,"pg","Males and females","Mixed"
"432","Mean cell haemoglobin","HMGCR inhibitor",1,0.18281036834925,0.144921402362795,0.207148588996587,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,64731,"pg","Males and females","Mixed"
"433","Mean cell haemoglobin concentration","HMGCR inhibitor",1,-0.0286493860845839,0.0491356856533723,0.559848344912651,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,67852,"g/dL","Males and females","Mixed"
"434","Mean cell haemoglobin concentration","HMGCR inhibitor",1,-0.0286493860845839,0.0491132332878581,0.559668927199412,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,67852,"g/dL","Males and females","Mixed"
"435","Mean cell volume","HMGCR inhibitor",1,0.657571623465211,0.372640323789997,0.0776262729831585,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,69335,"fl","Males and females","Mixed"
"436","Mean cell volume","HMGCR inhibitor",1,0.657571623465211,0.371077762619372,0.0763847931814509,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,69335,"fl","Males and females","Mixed"
"437","Mean platelet volume","HMGCR inhibitor",1,0.00818553888130969,0.0150068212824011,0.585440934568927,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"log fl","Males and females","European"
"438","Mean platelet volume","HMGCR inhibitor",1,0.00818553888130969,0.015012819860245,0.585590801106087,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"log fl","Males and females","European"
"439","Packed cell volume","HMGCR inhibitor",1,-0.0709413369713506,0.242837653478854,0.770183536019218,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,63511,"%","Males and females","Mixed"
"440","Packed cell volume","HMGCR inhibitor",1,-0.0709413369713506,0.24286550103305,0.770209146327889,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,63511,"%","Males and females","Mixed"
"441","Platelet count","HMGCR inhibitor",1,-11.9058663028649,5.88511633086959,0.0430683131706495,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"1x10^9/l","Males and females","European"
"442","Platelet count","HMGCR inhibitor",1,-11.9058663028649,5.85266030013643,0.0419248100459031,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"1x10^9/l","Males and females","European"
"443","Red blood cell count","HMGCR inhibitor",1,-0.0477489768076398,0.0314753888905488,0.129260171896764,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,66214,"10^12/L","Males and females","Mixed"
"444","Red blood cell count","HMGCR inhibitor",1,-0.0477489768076398,0.0313778990450205,0.128074458684967,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,66214,"10^12/L","Males and females","Mixed"
"445","Heart rate","HMGCR inhibitor",1,-0.439290586630286,0.703956343792633,0.532607221484386,23583979,2013,"den Hoed M","HRgene consortium","Hemodynamic",NA,NA,92355,"beats per minute","Males and females","Mixed"
"446","Heart rate","HMGCR inhibitor",1,-0.439290586630286,0.704324620057012,0.532821525826987,23583979,2013,"den Hoed M","HRgene consortium","Hemodynamic",NA,NA,92355,"beats per minute","Males and females","Mixed"
"447","Leptin","HMGCR inhibitor",1,0.034106412005457,0.0723272089129995,0.637242923090607,26833098,2016,"Kilpeläinen",NA,"Hormone",NA,NA,32161,"log ng/ml","Males and females","European"
"448","Leptin","HMGCR inhibitor",1,0.034106412005457,0.0723055934515689,0.637142284076075,26833098,2016,"Kilpeläinen",NA,"Hormone",NA,NA,32161,"log ng/ml","Males and females","European"
"449","Plasma cortisol","HMGCR inhibitor",1,-0.211541609822647,0.174614844462564,0.225713210512021,25010111,2014,"Bolton JL","CORNET","Hormone",NA,NA,12597,"SD","Males and females","European"
"450","Plasma cortisol","HMGCR inhibitor",1,-0.211541609822647,0.174270122783083,0.224796634359789,25010111,2014,"Bolton JL","CORNET","Hormone",NA,NA,12597,"SD","Males and females","European"
"451","Chronic kidney disease","HMGCR inhibitor",1,-0.0136425648021828,0.218281036834925,0.950164661941506,26831199,2015,"Pattaro","CKDGen","Kidney",12385,104780,117165,"log odds","Males and females","Mixed"
"452","Chronic kidney disease","HMGCR inhibitor",1,-0.0136425648021828,0.218282182622613,0.950164923192357,26831199,2015,"Pattaro","CKDGen","Kidney",12385,104780,117165,"log odds","Males and females","Mixed"
"453","Microalbuminuria","HMGCR inhibitor",1,0.259208731241473,0.286493860845839,0.365591537564832,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,54116,"log odds","Males and females","European"
"454","Microalbuminuria","HMGCR inhibitor",1,0.259208731241473,0.286808834705901,0.366118277272982,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,54116,"log odds","Males and females","European"
"455","Serum creatinine (eGFRcrea)","HMGCR inhibitor",1,0.00545702592087312,0.0125511596180082,0.663720229645602,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,118460,"log ml/min/1.73 m^²","Males and females","Mixed"
"456","Serum creatinine (eGFRcrea)","HMGCR inhibitor",1,0.00545702592087312,0.0125543475003125,0.663800375701244,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,118460,"log ml/min/1.73 m^²","Males and females","Mixed"
"457","Serum cystatin C (eGFRcys)","HMGCR inhibitor",1,-0.00818553888130969,0.0259208731241473,0.752162308378054,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,33152,"log ml/min/1.73 m^²","Males and females","Mixed"
"458","Serum cystatin C (eGFRcys)","HMGCR inhibitor",1,-0.00818553888130969,0.0259243464463887,0.752194424514936,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,33152,"log ml/min/1.73 m^²","Males and females","Mixed"
"459","Urinary albumin-to-creatinine ratio","HMGCR inhibitor",1,-0.190995907230559,0.395634379263301,0.629267134854082,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,5825,"log mg/g","Males and females","European"
"460","Urinary albumin-to-creatinine ratio","HMGCR inhibitor",1,-0.190995907230559,0.395758263302697,0.629374450702364,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,5825,"log mg/g","Males and females","European"
"461","HDL cholesterol","HMGCR inhibitor",1,-0.0518417462482947,0.0477489768076398,0.277605418363564,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187167,"SD (mg/dL)","Males and females","Mixed"
"462","HDL cholesterol","HMGCR inhibitor",1,-0.0518417462482947,0.0478245522791025,0.278365433186895,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187167,"SD (mg/dL)","Males and females","Mixed"
"463","LDL cholesterol","HMGCR inhibitor",1,-1,0.0518417462482947,6.58401388802333e-83,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,173082,"SD (mg/dL)","Males and females","Mixed"
"464","LDL cholesterol","HMGCR inhibitor",1,-1,0.0733153006414429,2.32458865187338e-42,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,173082,"SD (mg/dL)","Males and females","Mixed"
"465","Total cholesterol","HMGCR inhibitor",1,-0.933151432469304,0.0689374092093286,9.55918146521176e-42,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187365,"SD (mg/dL)","Males and females","Mixed"
"466","Total cholesterol","HMGCR inhibitor",1,-0.933151432469304,0.0491132332878581,1.70544479052608e-80,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187365,"SD (mg/dL)","Males and females","Mixed"
"467","Triglycerides","HMGCR inhibitor",1,-0.034106412005457,0.0464184078207582,0.462485374304322,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,177861,"SD (mg/dL)","Males and females","Mixed"
"468","Triglycerides","HMGCR inhibitor",1,-0.034106412005457,0.0463847203274216,0.462160389897216,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,177861,"SD (mg/dL)","Males and females","Mixed"
"469","Percent emphysema","HMGCR inhibitor",1,0.137789904502046,0.142062378766934,0.332083695952913,24383474,2014,"Manichaikul A","MESA","Lung disease",NA,NA,7667,"log (% emphysema + 1)","Males and females","Mixed"
"470","Percent emphysema","HMGCR inhibitor",1,0.137789904502046,0.141882673942701,0.331471673255633,24383474,2014,"Manichaikul A","MESA","Lung disease",NA,NA,7667,"log (% emphysema + 1)","Males and females","Mixed"
"471","FEV1","HMGCR inhibitor",1,-0.103683492496589,0.0995907230559345,0.297831046676008,21946350,2011,"Soler Artigas M","SpiroMetaplusCHARGE","Lung function",NA,NA,48201,"SD","Males and females","European"
"472","FEV1","HMGCR inhibitor",1,-0.103683492496589,0.0997356715367384,0.29853375352834,21946350,2011,"Soler Artigas M","SpiroMetaplusCHARGE","Lung function",NA,NA,48201,"SD","Males and females","European"
"473","FEV1/FVC","HMGCR inhibitor",1,0.0136425648021828,0.0982264665757162,0.889537951249028,21946350,2011,"Soler Artigas M","SpiroMetaplusCHARGE","Lung function",NA,NA,48201,"SD","Males and females","European"
"474","FEV1/FVC","HMGCR inhibitor",1,0.0136425648021828,0.0982290127442604,0.889540796144054,21946350,2011,"Soler Artigas M","SpiroMetaplusCHARGE","Lung function",NA,NA,48201,"SD","Males and females","European"
"475","Copper","HMGCR inhibitor",1,0.0409276944065484,0.381997707053529,0.914676958909711,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"476","Copper","HMGCR inhibitor",1,0.0409276944065484,0.381991814461119,0.914675647748153,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"477","Ferritin","HMGCR inhibitor",1,0.207366984993179,0.132332878581173,0.117112281919277,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"478","Ferritin","HMGCR inhibitor",1,0.207366984993179,0.132768817822186,0.118319768004102,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"479","Iron","HMGCR inhibitor",1,0.0586630286493861,0.139154160982265,0.673339909453361,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"480","Iron","HMGCR inhibitor",1,0.0586630286493861,0.139187389438423,0.673413383913033,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"481","Selenium","HMGCR inhibitor",1,-0.163710777626194,0.422919508867667,0.698684565645401,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"482","Selenium","HMGCR inhibitor",1,-0.163710777626194,0.423004658417097,0.698742250947981,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"483","Transferrin","HMGCR inhibitor",1,-0.271487039563438,0.143936690066642,0.05927394706638,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"484","Transferrin","HMGCR inhibitor",1,-0.271487039563438,0.143246930422919,0.0580608653062308,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"485","Transferrin Saturation","HMGCR inhibitor",1,0.17462482946794,0.140809729243722,0.214920853747839,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"486","Transferrin Saturation","HMGCR inhibitor",1,0.17462482946794,0.140518417462483,0.213971603916108,25352340,2014,"Benyamin","GIS","Metal",NA,NA,23986,"SD","Males and females","European"
"487","Zinc","HMGCR inhibitor",1,-0.750341064120055,0.368349249658936,0.0416463306220433,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"488","Zinc","HMGCR inhibitor",1,-0.750341064120055,0.370397490850952,0.0427880996224409,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"489","Urate","HMGCR inhibitor",1,0.311581245986357,0.293263653944066,0.288026375153323,25811787,2015,"Huffman JE","GUGC","Other",NA,NA,7189,"SD (mg/dL)","Females","European"
"490","Urate","HMGCR inhibitor",1,0.311581245986357,0.293708167091722,0.288756625211216,25811787,2015,"Huffman JE","GUGC","Other",NA,NA,7189,"SD (mg/dL)","Females","European"
"491","Neo-agreeableness","HMGCR inhibitor",1,0.279672578444748,0.870395634379263,0.74797046695195,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"492","Neo-agreeableness","HMGCR inhibitor",1,0.279672578444748,0.870516383004144,0.748004239386503,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"493","Neo-conscientiousness","HMGCR inhibitor",1,-0.197817189631651,1.05320600272851,0.8510147512847,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"494","Neo-conscientiousness","HMGCR inhibitor",1,-0.197817189631651,1.05325592952308,0.851021730882909,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"495","Neo-extraversion","HMGCR inhibitor",1,-0.628922237380628,1.08458390177353,0.561999446034331,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"496","Neo-extraversion","HMGCR inhibitor",1,-0.628922237380627,1.08507386322265,0.562176046880897,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"497","Neo-neuroticism","HMGCR inhibitor",1,0.660300136425648,1.3506139154161,0.624920362458645,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"498","Neo-neuroticism","HMGCR inhibitor",1,0.660300136425648,1.35104763704045,0.625031486091355,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"499","Neo-openness to experience","HMGCR inhibitor",1,0.305593451568895,1.00148957004279,0.760260345529964,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"500","Neo-openness to experience","HMGCR inhibitor",1,0.305593451568895,1.00136425648022,0.760231263641308,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"501","Neuroticism","HMGCR inhibitor",1,-0.0682128240109141,0.0545702592087312,0.21129954733371,27089181,2016,"Okbay","SSGAC","Personality",NA,NA,170911,"SD","Males and females","European"
"502","Neuroticism","HMGCR inhibitor",1,-0.0682128240109141,0.0546847182415031,0.212256854840856,27089181,2016,"Okbay","SSGAC","Personality",NA,NA,170911,"SD","Males and females","European"
"503","Adiponectin","HMGCR inhibitor",1,0.0193042291950887,0.0619781718963165,0.755444719586999,22479202,2012,"Dastani Z","ADIPOGen","Protein",NA,NA,39883,"ln(mg/dL)","Males and females","Mixed"
"504","Adiponectin","HMGCR inhibitor",1,0.0193042291950887,0.0619862510731001,0.755475577195709,22479202,2012,"Dastani Z","ADIPOGen","Protein",NA,NA,39883,"ln(mg/dL)","Males and females","Mixed"
"505","2-choice reaction time","HMGCR inhibitor",1,0.562073669849932,0.380381027689067,0.139498918220749,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2602,"SD (milliseconds)","Males and females","European"
"506","2-choice reaction time","HMGCR inhibitor",1,0.562073669849932,0.379263301500682,0.138336466496878,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2602,"SD (milliseconds)","Males and females","European"
"507","4-choice reaction time","HMGCR inhibitor",1,-0.00409276944065484,0.388813154754788,0.991601371499552,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2829,"SD (milliseconds)","Males and females","European"
"508","4-choice reaction time","HMGCR inhibitor",1,-0.00409276944065484,0.38881309686221,0.991601370249079,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2829,"SD (milliseconds)","Males and females","European"
"509","8-choice reaction time","HMGCR inhibitor",1,0,0.559345156889495,1,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,1382,"SD (milliseconds)","Males and females","European"
"510","8-choice reaction time","HMGCR inhibitor",1,0,0.559345156889495,1,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,1382,"SD (milliseconds)","Males and females","European"
"511","Alzheimer's disease","HMGCR inhibitor",1,-0.0641200545702592,0.223738062755798,0.774429820982408,24162737,2013,"Lambert","IGAP","Psychiatric / neurological",17008,37154,54162,"log odds","Males and females","European"
"512","Alzheimer's disease","HMGCR inhibitor",1,-0.0641200545702592,0.22376275458008,0.774454038345874,24162737,2013,"Lambert","IGAP","Psychiatric / neurological",17008,37154,54162,"log odds","Males and females","European"
"513","Amygdala volume","HMGCR inhibitor",1,12.4324693042292,31.7091430390264,0.695000304508178,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"514","Amygdala volume","HMGCR inhibitor",1,12.4324693042292,31.7025920873124,0.694940444796395,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"515","Amyotrophic lateral sclerosis","HMGCR inhibitor",1,0.163710777626194,0.245712783878628,0.50523926270108,27455348,2016,"van Rheenen","Project MinE","Psychiatric / neurological",12577,23475,36052,"log odds","Males and females","European"
"516","Amyotrophic lateral sclerosis","HMGCR inhibitor",1,0.163710777626194,0.245566166439291,0.504985075093846,27455348,2016,"van Rheenen","Project MinE","Psychiatric / neurological",12577,23475,36052,"log odds","Males and females","European"
"517","Anorexia nervosa","HMGCR inhibitor",1,-0.806490031234652,0.436590461837439,0.0647114797184056,24514567,2014,"Boraska V","GCAN","Psychiatric / neurological",2907,14860,17767,"log odds","Males and females","European"
"518","Anorexia nervosa","HMGCR inhibitor",1,-0.806490031234652,0.434583901773533,0.0634856055630121,24514567,2014,"Boraska V","GCAN","Psychiatric / neurological",2907,14860,17767,"log odds","Males and females","European"
"519","Autism","HMGCR inhibitor",1,-0.391512591371078,0.381991814461119,0.305399033346543,NA,2015,NA,"PGC","Psychiatric / neurological",4949,5314,10263,"log odds","Males and females","European"
"520","Autism","HMGCR inhibitor",1,-0.391512591371078,0.382530655243021,0.306080807686361,NA,2015,NA,"PGC","Psychiatric / neurological",4949,5314,10263,"log odds","Males and females","European"
"521","Bipolar disorder","HMGCR inhibitor",1,-0.318224083267394,0.334649720113064,0.341646548637107,21926972,2011,"Sklar P","PGC","Psychiatric / neurological",7481,9250,16731,"log odds","Males and females","European"
"522","Bipolar disorder","HMGCR inhibitor",1,-0.318224083267394,0.334242837653479,0.34105919924535,21926972,2011,"Sklar P","PGC","Psychiatric / neurological",7481,9250,16731,"log odds","Males and females","European"
"523","Bulimia nervosa","HMGCR inhibitor",1,0.0136425648021828,0.0954979536152797,0.886403006367064,23568457,2013,"Wade TD",NA,"Psychiatric / neurological",151,2291,2442,"log odds","Females","European"
"524","Bulimia nervosa","HMGCR inhibitor",1,0.0136425648021828,0.0955005725295293,0.88640610040668,23568457,2013,"Wade TD",NA,"Psychiatric / neurological",151,2291,2442,"log odds","Females","European"
"525","Caudate volume","HMGCR inhibitor",1,-23.6111869031378,65.5707711099543,0.718782021147249,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"526","Caudate volume","HMGCR inhibitor",1,-23.6111869031378,65.5593451568895,0.718735091789181,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"527","Depressive symptoms","HMGCR inhibitor",1,0.122783083219645,0.0414197184821418,0.00303310210113333,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,161460,"SD","Males and females","European"
"528","Depressive symptoms","HMGCR inhibitor",1,0.122783083219645,0.0409276944065484,0.00269979606326019,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,161460,"SD","Males and females","European"
"529","Digit symbol","HMGCR inhibitor",1,-0.156889495225102,0.367075111969102,0.669084848326116,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2956,"SD (number correct in 90/120 seconds)","Males and females","European"
"530","Digit symbol","HMGCR inhibitor",1,-0.156889495225102,0.366984993178718,0.669008417414906,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2956,"SD (number correct in 90/120 seconds)","Males and females","European"
"531","G speed factor","HMGCR inhibitor",1,0.488403819918145,0.414733969986357,0.238943514749654,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2430,"SD","Males and females","European"
"532","G speed factor","HMGCR inhibitor",1,0.488403819918145,0.415506141251956,0.239817495385442,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2430,"SD","Males and females","European"
"533","Hippocampus volume","HMGCR inhibitor",1,18.6425648021828,63.0477489768076,0.767467126586895,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"534","Hippocampus volume","HMGCR inhibitor",1,18.6425648021828,63.0551560302016,0.767493655383171,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"535","Inspection time","HMGCR inhibitor",1,-0.0954979536152797,0.390208761165904,0.806661204286511,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2645,"SD (milliseconds)","Males and females","European"
"536","Inspection time","HMGCR inhibitor",1,-0.0954979536152797,0.390177353342428,0.806645949515006,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2645,"SD (milliseconds)","Males and females","European"
"537","Internalizing problems","HMGCR inhibitor",1,-0.652114597544338,0.322377778296811,0.0430909474597475,24839885,2014,"Benke","EAGLE","Psychiatric / neurological",NA,NA,4596,NA,"Males and females","European"
"538","Internalizing problems","HMGCR inhibitor",1,-0.652114597544338,0.320600272851296,0.041947305214289,24839885,2014,"Benke","EAGLE","Psychiatric / neurological",NA,NA,4596,NA,"Males and females","European"
"539","Intracranial volume","HMGCR inhibitor",1,-21415.6889495225,25824.1410346156,0.406940612200237,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"540","Intracranial volume","HMGCR inhibitor",1,-21415.6889495225,25800.2646657572,0.406506586570278,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"541","Major depressive disorder","HMGCR inhibitor",1,0.40325787505457,0.296043656207367,0.173148410617409,22472876,2013,"Sullivan","PGC","Psychiatric / neurological",9240,9519,18759,"log odds","Males and females","European"
"542","Major depressive disorder","HMGCR inhibitor",1,0.40325787505457,0.29678087905983,0.174218499889726,22472876,2013,"Sullivan","PGC","Psychiatric / neurological",9240,9519,18759,"log odds","Males and females","European"
"543","Nucleus accumbens volume","HMGCR inhibitor",1,-3.59481582537517,14.5825375170532,0.805283509973887,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"544","Nucleus accumbens volume","HMGCR inhibitor",1,-3.59481582537517,14.5837282975261,0.805299089414088,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"545","Pallidum volume","HMGCR inhibitor",1,-19.3465211459754,25.9225475404966,0.455474005315359,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"546","Pallidum volume","HMGCR inhibitor",1,-19.3465211459754,25.9031377899045,0.455136335286811,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"547","PGC cross-disorder traits","HMGCR inhibitor",1,-0.0177468722107776,0.169167803547067,0.916449672701533,23453885,2013,"Smoller JW","PGC","Psychiatric / neurological",33332,27888,61220,"log odds","Males and females","European"
"548","PGC cross-disorder traits","HMGCR inhibitor",1,-0.0177468722107776,0.169170305343509,0.916450903770094,23453885,2013,"Smoller JW","PGC","Psychiatric / neurological",33332,27888,61220,"log odds","Males and females","European"
"549","Putamen volume","HMGCR inhibitor",1,1.07776261937244,80.227850288054,0.989281723402829,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"550","Putamen volume","HMGCR inhibitor",1,1.07776261937244,80.2278308321964,0.989281720803722,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"551","Schizophrenia","HMGCR inhibitor",1,-0.0737323118534789,0.146025480320891,0.613609608502576,25056061,2014,"Ripke S","PGC","Psychiatric / neurological",35476,46839,82315,"log odds","Males and females","Mixed"
"552","Schizophrenia","HMGCR inhibitor",1,-0.0737323118534789,0.145975443383356,0.613488046152819,25056061,2014,"Ripke S","PGC","Psychiatric / neurological",35476,46839,82315,"log odds","Males and females","Mixed"
"553","Simple reaction time","HMGCR inhibitor",1,0.251023192360164,0.379486498499729,0.508303753791547,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2378,"SD (milliseconds)","Males and females","European"
"554","Simple reaction time","HMGCR inhibitor",1,0.251023192360164,0.379263301500682,0.508054216876709,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2378,"SD (milliseconds)","Males and females","European"
"555","Subjective well being","HMGCR inhibitor",1,0.0682128240109141,0.0410801824299781,0.0968179149233078,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,298420,"SD","Males and females","European"
"556","Subjective well being","HMGCR inhibitor",1,0.0682128240109141,0.0409276944065484,0.0955807045456294,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,298420,"SD","Males and females","European"
"557","Thalamus volume","HMGCR inhibitor",1,47.4338335607094,84.2991750866298,0.573649786143574,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"558","Thalamus volume","HMGCR inhibitor",1,47.4338335607094,84.2633015006821,0.573486646239908,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"559","Age at menarche","HMGCR inhibitor",1,-0.177353342428377,0.0841581563645169,0.0350845232523988,25231870,2014,"Perry JR","ReproGen","Reproductive aging",NA,NA,182416,"years","Females","European"
"560","Age at menarche","HMGCR inhibitor",1,-0.177353342428377,0.0836544081440655,0.0339999999999919,25231870,2014,"Perry JR","ReproGen","Reproductive aging",NA,NA,182416,"years","Females","European"
"561","Age at menopause","HMGCR inhibitor",1,0.409276944065484,0.273675021948119,0.134787860424678,26414677,2015,"Day","ReproGen","Reproductive aging",NA,NA,69360,"years","Females","European"
"562","Age at menopause","HMGCR inhibitor",1,0.409276944065484,0.272851296043656,0.133614402537716,26414677,2015,"Day","ReproGen","Reproductive aging",NA,NA,69360,"years","Females","European"
"563","Chronotype","HMGCR inhibitor",1,-0.0441907230559345,0.054606058398809,0.418363247628897,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"564","Chronotype","HMGCR inhibitor",1,-0.0441907230559345,0.0545579809004093,0.417953254091144,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"565","Sleep duration","HMGCR inhibitor",1,0.0275180081855389,0.0549600272851296,0.616588387426372,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"566","Sleep duration","HMGCR inhibitor",1,0.0275180081855389,0.0549785388514176,0.616707057547883,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"567","Father’s age at death","Lp(a) inhibitor",1,0.0187997727272727,0.00631643181818182,0.00291722693704832,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"568","Father’s age at death","Lp(a) inhibitor",1,0.0187997727272727,0.00795277375169363,0.0180823989879167,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"569","Mother’s age at death","Lp(a) inhibitor",1,0.00488106060606061,0.00705193939393939,0.488837724872208,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"570","Mother’s age at death","Lp(a) inhibitor",1,0.00488106060606061,0.00716266859580737,0.495581487402779,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"571","Parents' age at death","Lp(a) inhibitor",1,0.0505987878787879,0.0104358333333333,1.24359487663793e-06,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"572","Parents' age at death","Lp(a) inhibitor",1,0.0505987878787879,0.0166747597606247,0.00240971671526471,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"573","Top 1 % survival","Lp(a) inhibitor",1,0.00209118939393939,0.00130758143986914,0.109758308211641,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"574","Top 1 % survival","Lp(a) inhibitor",1,0.00209118939393939,0.001192,0.0793699506856872,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"575","Birth weight","Lp(a) inhibitor",1,-0.00378787878787879,0.00576462957144818,0.511123233319003,27680694,2016,"Horikoshi",NA,"Anthropometric",NA,NA,153781,NA,"Males and females","Mixed"
"576","Birth weight","Lp(a) inhibitor",1,-0.00378787878787879,0.00568181818181818,0.504985075093846,27680694,2016,"Horikoshi",NA,"Anthropometric",NA,NA,153781,NA,"Males and females","Mixed"
"577","Body fat","Lp(a) inhibitor",1,0.026969696969697,0.0116666666666667,0.0207948659716683,26833246,2016,"Lu",NA,"Anthropometric",NA,NA,100716,"SD","Males and females","European"
"578","Body fat","Lp(a) inhibitor",1,0.026969696969697,0.0135707089904043,0.0468840450084408,26833246,2016,"Lu",NA,"Anthropometric",NA,NA,100716,"SD","Males and females","European"
"579","Body mass index","Lp(a) inhibitor",1,0.0137121212121212,0.00808171847650626,0.0897564477565933,25673413,2015,"Locke AE","GIANT","Anthropometric",NA,NA,339224,"SD (kg/m^2)","Males and females","Mixed"
"580","Body mass index","Lp(a) inhibitor",1,0.0137121212121212,0.00727272727272727,0.0593736055923928,25673413,2015,"Locke AE","GIANT","Anthropometric",NA,NA,339224,"SD (kg/m^2)","Males and females","Mixed"
"581","Child birth length","Lp(a) inhibitor",1,-0.0300757575757576,0.0190909090909091,0.115164876721782,25281659,2015,"van der Valk RJ","EGG","Anthropometric",NA,NA,28459,"SD (cm)","Males and females","European"
"582","Child birth length","Lp(a) inhibitor",1,-0.0300757575757576,0.020596640541954,0.144227871275369,25281659,2015,"van der Valk RJ","EGG","Anthropometric",NA,NA,28459,"SD (cm)","Males and females","European"
"583","Child birth weight","Lp(a) inhibitor",1,-0.0143939393939394,0.0178126877767877,0.419048968571412,23202124,2013,"Horikoshi M","EGG","Anthropometric",NA,NA,26836,"g","Males and females","European"
"584","Child birth weight","Lp(a) inhibitor",1,-0.0143939393939394,0.0174242424242424,0.408754766219334,23202124,2013,"Horikoshi M","EGG","Anthropometric",NA,NA,26836,"g","Males and females","European"
"585","Childhood obesity","Lp(a) inhibitor",1,-0.0348484848484848,0.0534079768003619,0.514081329497316,22484627,2012,"Bradfield JP","EGG","Anthropometric",5530,8318,13848,"log odds","Males and females","European"
"586","Childhood obesity","Lp(a) inhibitor",1,-0.0348484848484848,0.0526515151515152,0.508054216876709,22484627,2012,"Bradfield JP","EGG","Anthropometric",5530,8318,13848,"log odds","Males and females","European"
"587","Difference in height between adolescence and adulthood","Lp(a) inhibitor",1,0.000705368885609848,0.0464996341898485,0.987897079843403,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,4282,"SD","Males","European"
"588","Difference in height between adolescence and adulthood","Lp(a) inhibitor",1,0.000705368885609848,0.0464999876334072,0.987897171829902,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,4282,"SD","Males","European"
"589","Difference in height between childhood and adulthood","Lp(a) inhibitor",1,-0.0282888024118182,0.041114984631335,0.491426851419128,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,5043,"SD","Males","European"
"590","Difference in height between childhood and adulthood","Lp(a) inhibitor",1,-0.0282888024118182,0.0404669416286364,0.484514809859888,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,5043,"SD","Males","European"
"591","Height","Lp(a) inhibitor",1,-0.0106060606060606,0.00650760032046668,0.103144631365312,25282103,2014,"Wood AR","GIANT","Anthropometric",NA,NA,253288,"SD (m)","Males and females","European"
"592","Height","Lp(a) inhibitor",1,-0.0106060606060606,0.00590909090909091,0.0726741286768933,25282103,2014,"Wood AR","GIANT","Anthropometric",NA,NA,253288,"SD (m)","Males and females","European"
"593","Hip circumference","Lp(a) inhibitor",1,-0.00325757575757576,0.00909090909090909,0.720093875656711,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"594","Hip circumference","Lp(a) inhibitor",1,-0.00325757575757576,0.00912938618757084,0.721224251926686,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"595","Infant head circumference","Lp(a) inhibitor",1,0.0154545454545455,0.0275,0.574127280760313,22504419,2012,"Taal HR","EGG","Anthropometric",NA,NA,10768,"SD (cm)","Males and females","European"
"596","Infant head circumference","Lp(a) inhibitor",1,0.0154545454545455,0.0277854109210036,0.578066761508414,22504419,2012,"Taal HR","EGG","Anthropometric",NA,NA,10768,"SD (cm)","Males and females","European"
"597","Obesity class 1","Lp(a) inhibitor",1,0.0189393939393939,0.0257575757575758,0.462160389897216,23563607,2013,"Berndt SI","GIANT","Anthropometric",32858,65839,98697,"log odds","Males and females","European"
"598","Obesity class 1","Lp(a) inhibitor",1,0.0189393939393939,0.0262135483104946,0.469984656885496,23563607,2013,"Berndt SI","GIANT","Anthropometric",32858,65839,98697,"log odds","Males and females","European"
"599","Obesity class 2","Lp(a) inhibitor",1,0.0568181818181818,0.0484647996178484,0.241052640074298,23563607,2013,"Berndt SI","GIANT","Anthropometric",9889,62657,72546,"log odds","Males and females","European"
"600","Obesity class 2","Lp(a) inhibitor",1,0.0568181818181818,0.0462121212121212,0.218881326542939,23563607,2013,"Berndt SI","GIANT","Anthropometric",9889,62657,72546,"log odds","Males and females","European"
"601","Obesity class 3","Lp(a) inhibitor",1,0.0621212121212121,0.0833333333333333,0.455996980015239,23563607,2013,"Berndt SI","GIANT","Anthropometric",2896,47468,50364,"log odds","Males and females","European"
"602","Obesity class 3","Lp(a) inhibitor",1,0.0621212121212121,0.0848492228511209,0.464085264199222,23563607,2013,"Berndt SI","GIANT","Anthropometric",2896,47468,50364,"log odds","Males and females","European"
"603","Overweight","Lp(a) inhibitor",1,0.0113636363636364,0.0174242424242424,0.514288986716092,23563607,2013,"Berndt SI","GIANT","Anthropometric",93015,65840,158855,"log odds","Males and females","European"
"604","Overweight","Lp(a) inhibitor",1,0.0113636363636364,0.0176673509689978,0.520094472112775,23563607,2013,"Berndt SI","GIANT","Anthropometric",93015,65840,158855,"log odds","Males and females","European"
"605","Sitting height ratio","Lp(a) inhibitor",1,-0.0272727272727273,0.0180808384514359,0.131457975424305,25865494,2015,"Chan",NA,"Anthropometric",NA,NA,21590,"SD","Males and females","European"
"606","Sitting height ratio","Lp(a) inhibitor",1,-0.0272727272727273,0.0166666666666667,0.101763504951258,25865494,2015,"Chan",NA,"Anthropometric",NA,NA,21590,"SD","Males and females","European"
"607","Waist circumference","Lp(a) inhibitor",1,0.00833333333333333,0.00909090909090909,0.359317338329571,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"608","Waist circumference","Lp(a) inhibitor",1,0.00833333333333333,0.00933983115071602,0.372266464523179,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"609","Waist-to-hip ratio","Lp(a) inhibitor",1,0.0113636363636364,0.00909090909090909,0.21129954733371,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD","Males and females","Mixed"
"610","Waist-to-hip ratio","Lp(a) inhibitor",1,0.0113636363636364,0.00954859645718416,0.234013193144805,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD","Males and females","Mixed"
"611","Weight","Lp(a) inhibitor",1,-0.00984848484848485,0.0121212121212121,0.416504786576218,23754948,2013,"Randall JC","GIANT","Anthropometric",NA,NA,60586,"SD (kg)","Males","European"
"612","Weight","Lp(a) inhibitor",1,-0.00984848484848485,0.0123827122191424,0.42641488215899,23754948,2013,"Randall JC","GIANT","Anthropometric",NA,NA,60586,"SD (kg)","Males","European"
"613","Crohn's disease","Lp(a) inhibitor",1,-0.0460617518641667,0.0407719299041668,0.258585055069181,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",5956,14927,20883,"log odds","Males and females","European"
"614","Crohn's disease","Lp(a) inhibitor",1,-0.0460617518641667,0.0390151515151515,0.237756937084468,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",5956,14927,20883,"log odds","Males and females","European"
"615","Eczema","Lp(a) inhibitor",1,-0.0479443088414394,0.0337208174391667,0.155083883815093,26482879,2014,"Paternoster","EAGLE","Autoimmune / inflammatory",10788,30047,40835,"log odds","Males and females","European"
"616","Eczema","Lp(a) inhibitor",1,-0.0479443088414394,0.0359019959597814,0.181738326686485,26482879,2014,"Paternoster","EAGLE","Autoimmune / inflammatory",10788,30047,40835,"log odds","Males and females","European"
"617","Gout","Lp(a) inhibitor",1,0.00833333333333333,0.0682154538825567,0.902770754779935,23263486,2013,"Köttgen","GUGC","Autoimmune / inflammatory",2115,67259,69374,"log odds","Males and females","European"
"618","Gout","Lp(a) inhibitor",1,0.00833333333333333,0.0681818181818182,0.902723027603871,23263486,2013,"Köttgen","GUGC","Autoimmune / inflammatory",2115,67259,69374,"log odds","Males and females","European"
"619","Inflammatory bowel disease","Lp(a) inhibitor",1,-0.0126504921387121,0.0288203741063234,0.660703073012018,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",12882,21770,34652,"log odds","Males and females","European"
"620","Inflammatory bowel disease","Lp(a) inhibitor",1,-0.0126504921387121,0.0286363636363636,0.658660558075562,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",12882,21770,34652,"log odds","Males and females","European"
"621","Juvenile idiopathic arthritis","Lp(a) inhibitor",1,0.00623773100537879,0.0758870713707004,0.934489625212711,23603761,2013,"Hinks",NA,"Autoimmune / inflammatory",2816,13056,15872,"log odds","Males and females","European"
"622","Juvenile idiopathic arthritis","Lp(a) inhibitor",1,0.00623773100537879,0.0758701329613636,0.934475032594482,23603761,2013,"Hinks",NA,"Autoimmune / inflammatory",2816,13056,15872,"log odds","Males and females","European"
"623","Multiple sclerosis","Lp(a) inhibitor",1,0.00528455586093182,0.0245494772605303,0.82956349020697,24076602,2013,"Beecham","IMSGC","Autoimmune / inflammatory",14498,24091,38589,"log odds","Males and females","European"
"624","Multiple sclerosis","Lp(a) inhibitor",1,0.00528455586093182,0.0245870247933851,0.829819782196806,24076602,2013,"Beecham","IMSGC","Autoimmune / inflammatory",14498,24091,38589,"log odds","Males and females","European"
"625","Narcolepsy","Lp(a) inhibitor",1,0.133530276829545,0.0569346233952273,0.0190104278024994,23459209,2013,"Faraco",NA,"Autoimmune / inflammatory",1886,10421,12307,"log odds","Males and females","European"
"626","Narcolepsy","Lp(a) inhibitor",1,0.133530276829545,0.0664793566733353,0.0445798251491602,23459209,2013,"Faraco",NA,"Autoimmune / inflammatory",1886,10421,12307,"log odds","Males and females","European"
"627","Psoriasis","Lp(a) inhibitor",1,0.0434177020553788,0.0503470334911512,0.388484699999861,23143594,2012,"Tsoi",NA,"Autoimmune / inflammatory",10588,22806,33394,"log odds","Males and females","European"
"628","Psoriasis","Lp(a) inhibitor",1,0.0434177020553788,0.0490946601562121,0.37649807893022,23143594,2012,"Tsoi",NA,"Autoimmune / inflammatory",10588,22806,33394,"log odds","Males and females","European"
"629","Rheumatoid arthritis","Lp(a) inhibitor",1,0.0223930320011364,0.0306271103483723,0.464687132484751,24390342,2014,"Okada Y",NA,"Autoimmune / inflammatory",19234,61565,80799,"log odds","Males and females","Mixed"
"630","Rheumatoid arthritis","Lp(a) inhibitor",1,0.0223930320011364,0.0300814219449242,0.456626044482373,24390342,2014,"Okada Y",NA,"Autoimmune / inflammatory",19234,61565,80799,"log odds","Males and females","Mixed"
"631","Systemic lupus erythematosus","Lp(a) inhibitor",1,-0.0223930320011364,0.0526645191874803,0.670689798477359,26502338,2015,"Bentham",NA,"Autoimmune / inflammatory",7219,15991,23210,"log odds","Males and females","European"
"632","Systemic lupus erythematosus","Lp(a) inhibitor",1,-0.0223930320011364,0.0523490557621212,0.668823081210287,26502338,2015,"Bentham",NA,"Autoimmune / inflammatory",7219,15991,23210,"log odds","Males and females","European"
"633","Type 1 diabetes","Lp(a) inhibitor",1,-0.0112046102065152,0.0307858481134839,0.715892901986994,25751624,2015,"Onengut-Gumuscu",NA,"Autoimmune / inflammatory",9563,9369,18932,"log odds","Males and females","European"
"634","Type 1 diabetes","Lp(a) inhibitor",1,-0.0112046102065152,0.030650847945303,0.714696197596015,25751624,2015,"Onengut-Gumuscu",NA,"Autoimmune / inflammatory",9563,9369,18932,"log odds","Males and females","European"
"635","Ulcerative colitis","Lp(a) inhibitor",1,0.00780061021015152,0.0359650220029685,0.828290677814618,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",6968,20464,27432,"log odds","Males and females","European"
"636","Ulcerative colitis","Lp(a) inhibitor",1,0.00780061021015152,0.0359090909090909,0.828027405010483,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",6968,20464,27432,"log odds","Males and females","European"
"637","Age of smoking initiation","Lp(a) inhibitor",1,-0.00143939393939394,0.0125054738501884,0.908364978949091,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,47961,"log years","Males and females","European"
"638","Age of smoking initiation","Lp(a) inhibitor",1,-0.00143939393939394,0.0125,0.908325028249512,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,47961,"log years","Males and females","European"
"639","Cigarettes smoked per day","Lp(a) inhibitor",1,-0.468787878787879,0.46160941251544,0.309843271087113,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,68028,"Cigarettes per day","Males and females","European"
"640","Cigarettes smoked per day","Lp(a) inhibitor",1,-0.468787878787879,0.445606060606061,0.292788941693213,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,68028,"Cigarettes per day","Males and females","European"
"641","Ever vs never smoked","Lp(a) inhibitor",1,-0.065,0.075,0.386124674283814,20418890,2010,"Furberg","TAG","Behavioural",41969,32066,74035,"log odds","Males and females","European"
"642","Ever vs never smoked","Lp(a) inhibitor",1,-0.065,0.0768382901713427,0.397590450918179,20418890,2010,"Furberg","TAG","Behavioural",41969,32066,74035,"log odds","Males and females","European"
"643","Former vs current smoker","Lp(a) inhibitor",1,0.155909090909091,0.0987260603698132,0.114288108089104,20418890,2010,"Furberg","TAG","Behavioural",23554,18415,41969,"log odds","Males and females","European"
"644","Former vs current smoker","Lp(a) inhibitor",1,0.155909090909091,0.0902272727272727,0.0839954501865626,20418890,2010,"Furberg","TAG","Behavioural",23554,18415,41969,"log odds","Males and females","European"
"645","Paget's disease","Lp(a) inhibitor",1,0.0605,0.113115151515152,0.592751376904605,21623375,2011,"Albagha OM",NA,"Bone",741,2699,3440,"log odds","Males and females","European"
"646","Paget's disease","Lp(a) inhibitor",1,0.0605,0.114179027711193,0.596202318995958,21623375,2011,"Albagha OM",NA,"Bone",741,2699,3440,"log odds","Males and females","European"
"647","Lung adenocarcinoma","Lp(a) inhibitor",1,0.0610036544491667,0.0488416666666667,0.211661982710186,24880342,2014,"Wang Y","ILCCO","Cancer",3442,14894,18336,"log odds","Males and females","European"
"648","Lung adenocarcinoma","Lp(a) inhibitor",1,0.0610036544491667,0.0512968239551597,0.234349689970952,24880342,2014,"Wang Y","ILCCO","Cancer",3442,14894,18336,"log odds","Males and females","European"
"649","Lung cancer","Lp(a) inhibitor",1,0.0208463241189394,0.0335530303030303,0.534405657458104,24880342,2014,"Wang Y","ILCCO","Cancer",11348,15861,27209,"log odds","Males and females","European"
"650","Lung cancer","Lp(a) inhibitor",1,0.0208463241189394,0.0339781617319752,0.539531739062237,24880342,2014,"Wang Y","ILCCO","Cancer",11348,15861,27209,"log odds","Males and females","European"
"651","Melanoma","Lp(a) inhibitor",1,-0.0304407497218182,0.0898111613621091,0.734653632871736,21926416,2011,"Amos CI","MDACC","Cancer",1804,1026,2830,"log odds","Males and females","European"
"652","Melanoma","Lp(a) inhibitor",1,-0.0304407497218182,0.089469696969697,0.733679332148041,21926416,2011,"Amos CI","MDACC","Cancer",1804,1026,2830,"log odds","Males and females","European"
"653","Small cell lung carcinoma","Lp(a) inhibitor",1,0.0762260937431818,0.0510659090909091,0.135515675724118,NA,NA,NA,"TRICL","Cancer",2791,20580,23371,NA,"Males and females","European"
"654","Small cell lung carcinoma","Lp(a) inhibitor",1,0.0762260937431818,0.0546954279164593,0.163424367905336,NA,NA,NA,"TRICL","Cancer",2791,20580,23371,NA,"Males and females","European"
"655","Squamous cell lung cancer","Lp(a) inhibitor",1,-0.0281908834864394,0.0553220310114366,0.610347221423155,24880342,2014,"Wang Y","ILCCO","Cancer",3275,15038,18313,"log odds","Males and females","European"
"656","Squamous cell lung cancer","Lp(a) inhibitor",1,-0.0281908834864394,0.0548454545454545,0.60724791333742,24880342,2014,"Wang Y","ILCCO","Cancer",3275,15038,18313,"log odds","Males and females","European"
"657","Coronary heart disease","Lp(a) inhibitor",1,-0.241362121212121,0.0647324897448416,0.000192539892480913,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",60801,123504,184305,"log odds","Males and females","Mixed"
"658","Coronary heart disease","Lp(a) inhibitor",1,-0.241362121212121,0.0184840151515152,5.72985303585879e-39,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",60801,123504,184305,"log odds","Males and females","Mixed"
"659","Myocardial infarction","Lp(a) inhibitor",1,-0.215737878787879,0.0589971787457292,0.000255434203743975,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",43676,128199,171875,"log odds","Males and females","Mixed"
"660","Myocardial infarction","Lp(a) inhibitor",1,-0.215737878787879,0.0201453365288636,9.22812359362815e-27,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",43676,128199,171875,"log odds","Males and females","Mixed"
"661","Type 2 diabetes","Lp(a) inhibitor",1,0.0150019903759091,0.036133085686523,0.678004955392883,24509480,2014,"Mahajan A","DIAGRAM","Diabetes",26488,83964,110452,"log odds","Males and females","Mixed"
"662","Type 2 diabetes","Lp(a) inhibitor",1,0.0150019903759091,0.0359267505685606,0.676260371644962,24509480,2014,"Mahajan A","DIAGRAM","Diabetes",26488,83964,110452,"log odds","Males and females","Mixed"
"663","College completion","Lp(a) inhibitor",1,0.0282543823815909,0.0174882587451212,0.106176474939373,23722424,2013,"Rietveld CA","SSGAC","Education",20044,75383,95427,"log odds","Males and females","European"
"664","College completion","Lp(a) inhibitor",1,0.0282543823815909,0.0159090909090909,0.0757346066527534,23722424,2013,"Rietveld CA","SSGAC","Education",20044,75383,95427,"log odds","Males and females","European"
"665","Years of schooling","Lp(a) inhibitor",1,0.00303030303030303,0.00386712804395176,0.433271593281862,27225129,2016,"Okbay","SSGAC","Education",NA,NA,293723,"SD (years)","Males and females","European"
"666","Years of schooling","Lp(a) inhibitor",1,0.00303030303030303,0.00378787878787879,0.423710797166793,27225129,2016,"Okbay","SSGAC","Education",NA,NA,293723,"SD (years)","Males and females","European"
"667","2hr glucose","Lp(a) inhibitor",1,0.0477272727272727,0.0356060606060606,0.180107039640696,20081857,2010,"Saxena R","MAGIC","Glycemic",NA,NA,15234,"mmol/L","Males and females","European"
"668","2hr glucose","Lp(a) inhibitor",1,0.0477272727272727,0.0376600525716968,0.205041509852882,20081857,2010,"Saxena R","MAGIC","Glycemic",NA,NA,15234,"mmol/L","Males and females","European"
"669","AUCins","Lp(a) inhibitor",1,-0.0386363636363636,0.0462121212121212,0.403118014218166,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4324,"SD (mU*min/l)","Males and females","European"
"670","AUCins","Lp(a) inhibitor",1,-0.0386363636363636,0.0472671056045342,0.413697077528415,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4324,"SD (mU*min/l)","Males and females","European"
"671","AUCins/AUCglu","Lp(a) inhibitor",1,-0.0522727272727273,0.0488535545715984,0.284624616906859,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4213,"SD","Males and females","European"
"672","AUCins/AUCglu","Lp(a) inhibitor",1,-0.0522727272727273,0.046969696969697,0.265749994484718,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4213,"SD","Males and females","European"
"673","Corrected insulin response","Lp(a) inhibitor",1,-0.0393939393939394,0.0436158320235413,0.366418299037254,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5318,"SD","Males and females","European"
"674","Corrected insulin response","Lp(a) inhibitor",1,-0.0393939393939394,0.0424242424242424,0.353111234506006,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5318,"SD","Males and females","European"
"675","Fasting glucose","Lp(a) inhibitor",1,0.000303030303030303,0.00136363636363636,0.824140895741885,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,58074,"mmol/L","Males and females","European"
"676","Fasting glucose","Lp(a) inhibitor",1,0.000303030303030303,0.00136585894886623,0.824422393045213,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,58074,"mmol/L","Males and females","European"
"677","Fasting insulin","Lp(a) inhibitor",1,-0.00053030303030303,0.00137043164682847,0.698785388584274,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,51750,"log pmol/L","Males and females","European"
"678","Fasting insulin","Lp(a) inhibitor",1,-0.00053030303030303,0.00136363636363636,0.697358341877476,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,51750,"log pmol/L","Males and females","European"
"679","Fasting proinsulin","Lp(a) inhibitor",1,0.00909090909090909,0.0130890434943398,0.487341478139593,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,10701,"log pmol/L","Males and females","European"
"680","Fasting proinsulin","Lp(a) inhibitor",1,0.00909090909090909,0.0128787878787879,0.480261302753423,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,10701,"log pmol/L","Males and females","European"
"681","HbA1C","Lp(a) inhibitor",1,-0.000151515151515152,0.00666678041324567,0.981868130273477,20858683,2010,"Soranzo N","MAGIC","Glycemic",NA,NA,46368,"%","Males and females","European"
"682","HbA1C","Lp(a) inhibitor",1,-0.000151515151515152,0.00666666666666667,0.981867820961016,20858683,2010,"Soranzo N","MAGIC","Glycemic",NA,NA,46368,"%","Males and females","European"
"683","HOMA-B","Lp(a) inhibitor",1,-0.000909090909090909,0.00651934031088117,0.889098333097557,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"684","HOMA-B","Lp(a) inhibitor",1,-0.000909090909090909,0.00651515151515151,0.889027492331461,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"685","HOMA-IR","Lp(a) inhibitor",1,-0.00757575757575758,0.00757575757575758,0.317310507862914,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"686","HOMA-IR","Lp(a) inhibitor",1,-0.00757575757575758,0.00782200024455055,0.332785124842519,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"687","Incremental insulin at 30 minutes","Lp(a) inhibitor",1,-0.0310606060606061,0.0461503222738262,0.500927451880818,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4447,"SD","Males and females","European"
"688","Incremental insulin at 30 minutes","Lp(a) inhibitor",1,-0.0310606060606061,0.0454545454545454,0.494396235653322,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4447,"SD","Males and females","European"
"689","Insulin at 30 minutes","Lp(a) inhibitor",1,-0.0310606060606061,0.0468966596936548,0.507766019614907,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4409,"SD","Males and females","European"
"690","Insulin at 30 minutes","Lp(a) inhibitor",1,-0.0310606060606061,0.0462121212121212,0.501500208935513,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4409,"SD","Males and females","European"
"691","Insulin disposition index","Lp(a) inhibitor",1,-0.0181818181818182,0.0424242424242424,0.668235141795249,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5130,"SD","Males and females","European"
"692","Insulin disposition index","Lp(a) inhibitor",1,-0.0181818181818182,0.0426808607545643,0.670111747098644,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5130,"SD","Males and females","European"
"693","Insulin sensitivity index","Lp(a) inhibitor",1,0.0234848484848485,0.0458536021935954,0.608531899054282,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4769,"SD","Males and females","European"
"694","Insulin sensitivity index","Lp(a) inhibitor",1,0.0234848484848485,0.0454545454545454,0.605388868880522,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4769,"SD","Males and females","European"
"695","Insulin-like growth factor 1","Lp(a) inhibitor",1,-0.0269119353986364,0.0151059061580329,0.0748225548162308,27329260,2016,NA,NA,"Growth hormone",NA,NA,30884,"SD","Males and females","European"
"696","Insulin-like growth factor 1","Lp(a) inhibitor",1,-0.0269119353986364,0.0134291094803788,0.0450700604224085,27329260,2016,NA,NA,"Growth hormone",NA,NA,30884,"SD","Males and females","European"
"697","Insulin-like growth factor binding protein 3","Lp(a) inhibitor",1,-0.0140427194575,0.0164627426231061,0.393659304203932,27329260,2016,NA,NA,"Growth hormone",NA,NA,18995,"SD","Males and females","European"
"698","Insulin-like growth factor binding protein 3","Lp(a) inhibitor",1,-0.0140427194575,0.0168537739117475,0.404726755554309,27329260,2016,NA,NA,"Growth hormone",NA,NA,18995,"SD","Males and females","European"
"699","Haemoglobin concentration","Lp(a) inhibitor",1,0.00916666666666667,0.0118181818181818,0.437960969881749,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,71861,"g/dL","Males and females","Mixed"
"700","Haemoglobin concentration","Lp(a) inhibitor",1,0.00916666666666667,0.0120507543770299,0.446853239272989,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,71861,"g/dL","Males and females","Mixed"
"701","Mean cell haemoglobin","Lp(a) inhibitor",1,0.00984848484848485,0.0206105848623164,0.63276674886191,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,64731,"pg","Males and females","Mixed"
"702","Mean cell haemoglobin","Lp(a) inhibitor",1,0.00984848484848485,0.0204545454545455,0.63017433816751,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,64731,"pg","Males and females","Mixed"
"703","Mean cell haemoglobin concentration","Lp(a) inhibitor",1,0.00598484848484849,0.00669429066076741,0.371309691972831,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,67852,"g/dL","Males and females","Mixed"
"704","Mean cell haemoglobin concentration","Lp(a) inhibitor",1,0.00598484848484849,0.00651515151515151,0.358302398291574,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,67852,"g/dL","Males and females","Mixed"
"705","Mean cell volume","Lp(a) inhibitor",1,0.0107575757575758,0.0516649518801509,0.835058712199594,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,69335,"fl","Males and females","Mixed"
"706","Mean cell volume","Lp(a) inhibitor",1,0.0107575757575758,0.0515909090909091,0.834825398547739,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,69335,"fl","Males and females","Mixed"
"707","Mean platelet volume","Lp(a) inhibitor",1,-0.00106060606060606,0.00243952175581345,0.663736766301917,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"log fl","Males and females","European"
"708","Mean platelet volume","Lp(a) inhibitor",1,-0.00106060606060606,0.00242424242424242,0.661748776081758,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"log fl","Males and females","European"
"709","Packed cell volume","Lp(a) inhibitor",1,0.0670454545454545,0.0409090909090909,0.101236402173935,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,63511,"%","Males and females","Mixed"
"710","Packed cell volume","Lp(a) inhibitor",1,0.0670454545454545,0.044390541036733,0.130952985563535,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,63511,"%","Males and females","Mixed"
"711","Platelet count","Lp(a) inhibitor",1,-0.503181818181818,0.800454545454545,0.529597796626244,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"1x10^9/l","Males and females","European"
"712","Platelet count","Lp(a) inhibitor",1,-0.503181818181818,0.810835678676412,0.53488134893489,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"1x10^9/l","Males and females","European"
"713","Red blood cell count","Lp(a) inhibitor",1,0.00257575757575758,0.00466839465906878,0.581123930819883,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,66214,"10^12/L","Males and females","Mixed"
"714","Red blood cell count","Lp(a) inhibitor",1,0.00257575757575758,0.00462121212121212,0.577269842906158,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,66214,"10^12/L","Males and females","Mixed"
"715","Heart rate","Lp(a) inhibitor",1,0.0612878787878788,0.110606060606061,0.579503848017921,23583979,2013,"den Hoed M","HRgene consortium","Hemodynamic",NA,NA,92355,"beats per minute","Males and females","Mixed"
"716","Heart rate","Lp(a) inhibitor",1,0.0612878787878788,0.111722212096173,0.583297967883096,23583979,2013,"den Hoed M","HRgene consortium","Hemodynamic",NA,NA,92355,"beats per minute","Males and females","Mixed"
"717","Leptin","Lp(a) inhibitor",1,0.00871212121212121,0.0111363636363636,0.434030692671656,26833098,2016,"Kilpeläinen",NA,"Hormone",NA,NA,32161,"log ng/ml","Males and females","European"
"718","Leptin","Lp(a) inhibitor",1,0.00871212121212121,0.0113592678538796,0.443104401139198,26833098,2016,"Kilpeläinen",NA,"Hormone",NA,NA,32161,"log ng/ml","Males and females","European"
"719","Plasma cortisol","Lp(a) inhibitor",1,-0.0336128787878788,0.0324785034667692,0.300703023934067,25010111,2014,"Bolton JL","CORNET","Hormone",NA,NA,12597,"SD","Males and females","European"
"720","Plasma cortisol","Lp(a) inhibitor",1,-0.0336128787878788,0.0313083333333333,0.282998386843853,25010111,2014,"Bolton JL","CORNET","Hormone",NA,NA,12597,"SD","Males and females","European"
"721","Chronic kidney disease","Lp(a) inhibitor",1,-0.0643939393939394,0.0318181818181818,0.0429897539234366,26831199,2015,"Pattaro","CKDGen","Kidney",12385,104780,117165,"log odds","Males and females","Mixed"
"722","Chronic kidney disease","Lp(a) inhibitor",1,-0.0643939393939394,0.0358655643891867,0.0725859747664717,26831199,2015,"Pattaro","CKDGen","Kidney",12385,104780,117165,"log odds","Males and females","Mixed"
"723","Microalbuminuria","Lp(a) inhibitor",1,0.0159090909090909,0.0494119138976495,0.747476387905374,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,54116,"log odds","Males and females","European"
"724","Microalbuminuria","Lp(a) inhibitor",1,0.0159090909090909,0.0492424242424242,0.746636986614261,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,54116,"log odds","Males and females","European"
"725","Serum creatinine (eGFRcrea)","Lp(a) inhibitor",1,0.00833333333333333,0.00285916495722567,0.00356140239745657,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,118460,"log ml/min/1.73 m^²","Males and females","Mixed"
"726","Serum creatinine (eGFRcrea)","Lp(a) inhibitor",1,0.00833333333333333,0.00189393939393939,1.08250878154077e-05,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,118460,"log ml/min/1.73 m^²","Males and females","Mixed"
"727","Serum cystatin C (eGFRcys)","Lp(a) inhibitor",1,0.00265151515151515,0.00422203508643059,0.529991974571902,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,33152,"log ml/min/1.73 m^²","Males and females","Mixed"
"728","Serum cystatin C (eGFRcys)","Lp(a) inhibitor",1,0.00265151515151515,0.00416666666666667,0.524539436435313,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,33152,"log ml/min/1.73 m^²","Males and females","Mixed"
"729","Urinary albumin-to-creatinine ratio","Lp(a) inhibitor",1,-0.00424242424242424,0.0742504316380824,0.954436306026764,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,5825,"log mg/g","Males and females","European"
"730","Urinary albumin-to-creatinine ratio","Lp(a) inhibitor",1,-0.00424242424242424,0.0742424242424242,0.954431397113681,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,5825,"log mg/g","Males and females","European"
"731","HDL cholesterol","Lp(a) inhibitor",1,-0.0134090909090909,0.00954545454545454,0.160092090674302,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187167,"SD (mg/dL)","Males and females","Mixed"
"732","HDL cholesterol","Lp(a) inhibitor",1,-0.0134090909090909,0.0101486136521381,0.186410297353171,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187167,"SD (mg/dL)","Males and females","Mixed"
"733","LDL cholesterol","Lp(a) inhibitor",1,-0.0889393939393939,0.0108333333333333,2.21575294807547e-16,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,173082,"SD (mg/dL)","Males and females","Mixed"
"734","LDL cholesterol","Lp(a) inhibitor",1,-0.0889393939393939,0.0252971573299571,0.000438454084515705,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,173082,"SD (mg/dL)","Males and females","Mixed"
"735","Total cholesterol","Lp(a) inhibitor",1,-0.0937878787878788,0.0263363535526523,0.000369224803012583,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187365,"SD (mg/dL)","Males and females","Mixed"
"736","Total cholesterol","Lp(a) inhibitor",1,-0.0937878787878788,0.0106060606060606,9.3301489352378e-19,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187365,"SD (mg/dL)","Males and females","Mixed"
"737","Triglycerides","Lp(a) inhibitor",1,-0.0132575757575758,0.0102068335775526,0.193980952534561,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,177861,"SD (mg/dL)","Males and females","Mixed"
"738","Triglycerides","Lp(a) inhibitor",1,-0.0132575757575758,0.00962121212121212,0.168217875086273,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,177861,"SD (mg/dL)","Males and females","Mixed"
"739","FEV1/FVC","Lp(a) inhibitor",1,-0.0121212121212121,0.0146532176713857,0.40812098654337,21946350,2011,"Soler Artigas M","SpiroMetaplusCHARGE","Lung function",NA,NA,48201,"SD","Males and females","European"
"740","FEV1/FVC","Lp(a) inhibitor",1,-0.0121212121212121,0.0143181818181818,0.397239945299093,21946350,2011,"Soler Artigas M","SpiroMetaplusCHARGE","Lung function",NA,NA,48201,"SD","Males and females","European"
"741","Copper","Lp(a) inhibitor",1,0.0189393939393939,0.0477272727272727,0.691496221175875,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"742","Copper","Lp(a) inhibitor",1,0.0189393939393939,0.0479748889326786,0.693007297991602,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"743","Selenium","Lp(a) inhibitor",1,-0.00909090909090909,0.0515681172624997,0.86006664038782,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"744","Selenium","Lp(a) inhibitor",1,-0.00909090909090909,0.0515151515151515,0.859924253238214,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"745","Zinc","Lp(a) inhibitor",1,-0.00606060606060606,0.0462121212121212,0.895658593641375,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"746","Zinc","Lp(a) inhibitor",1,-0.00606060606060606,0.0462383689300391,0.895717485670056,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"747","Urate","Lp(a) inhibitor",1,0.0307586214112879,0.0461048513208333,0.504679513348238,25811787,2015,"Huffman JE","GUGC","Other",NA,NA,7189,"SD (mg/dL)","Females","European"
"748","Urate","Lp(a) inhibitor",1,0.0307586214112879,0.0467777782184849,0.510828797785759,25811787,2015,"Huffman JE","GUGC","Other",NA,NA,7189,"SD (mg/dL)","Females","European"
"749","Neo-agreeableness","Lp(a) inhibitor",1,-0.162878787878788,0.101515151515152,0.108608815475462,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"750","Neo-agreeableness","Lp(a) inhibitor",1,-0.162878787878788,0.109808861863392,0.137996407852331,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"751","Neo-conscientiousness","Lp(a) inhibitor",1,-0.155681818181818,0.129662280277449,0.22987861285047,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"752","Neo-conscientiousness","Lp(a) inhibitor",1,-0.155681818181818,0.123333333333333,0.206846247801082,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"753","Neo-extraversion","Lp(a) inhibitor",1,-0.17030303030303,0.126136363636364,0.176967824594693,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"754","Neo-extraversion","Lp(a) inhibitor",1,-0.17030303030303,0.133515771417565,0.202122617664406,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"755","Neo-neuroticism","Lp(a) inhibitor",1,0.107878787878788,0.161489212821259,0.504117806435344,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"756","Neo-neuroticism","Lp(a) inhibitor",1,0.107878787878788,0.159090909090909,0.497711309807077,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"757","Neo-openness to experience","Lp(a) inhibitor",1,-0.109242424242424,0.116060606060606,0.3465750870279,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"758","Neo-openness to experience","Lp(a) inhibitor",1,-0.109242424242424,0.119408847285297,0.360264928183921,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"759","Neuroticism","Lp(a) inhibitor",1,0.00378787878787879,0.0061383093817948,0.537176497638691,27089181,2016,"Okbay","SSGAC","Personality",NA,NA,170911,"SD","Males and females","European"
"760","Neuroticism","Lp(a) inhibitor",1,0.00378787878787879,0.00606060606060606,0.531971058097401,27089181,2016,"Okbay","SSGAC","Personality",NA,NA,170911,"SD","Males and females","European"
"761","Adiponectin","Lp(a) inhibitor",1,-0.0118643939393939,0.00994355350844834,0.232801060741323,22479202,2012,"Dastani Z","ADIPOGen","Protein",NA,NA,39883,"ln(mg/dL)","Males and females","Mixed"
"762","Adiponectin","Lp(a) inhibitor",1,-0.0118643939393939,0.00946439393939394,0.209993974953429,22479202,2012,"Dastani Z","ADIPOGen","Protein",NA,NA,39883,"ln(mg/dL)","Males and females","Mixed"
"763","2-choice reaction time","Lp(a) inhibitor",1,-0.0322727272727273,0.0482934868949632,0.503966033100398,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2602,"SD (milliseconds)","Males and females","European"
"764","2-choice reaction time","Lp(a) inhibitor",1,-0.0322727272727273,0.0475757575757576,0.497553639038854,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2602,"SD (milliseconds)","Males and females","European"
"765","4-choice reaction time","Lp(a) inhibitor",1,0.0203030303030303,0.0431818181818182,0.638229680513853,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2829,"SD (milliseconds)","Males and females","European"
"766","4-choice reaction time","Lp(a) inhibitor",1,0.0203030303030303,0.0434960009821765,0.640657829817932,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2829,"SD (milliseconds)","Males and females","European"
"767","8-choice reaction time","Lp(a) inhibitor",1,-0.053030303030303,0.0643939393939394,0.410206998692259,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,1382,"SD (milliseconds)","Males and females","European"
"768","8-choice reaction time","Lp(a) inhibitor",1,-0.053030303030303,0.0658207193416045,0.420428559656806,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,1382,"SD (milliseconds)","Males and females","European"
"769","Alzheimer's disease","Lp(a) inhibitor",1,0.0390909090909091,0.0282575757575758,0.166548987710252,24162737,2013,"Lambert","IGAP","Psychiatric / neurological",17008,37154,54162,"log odds","Males and females","European"
"770","Alzheimer's disease","Lp(a) inhibitor",1,0.0390909090909091,0.029990728779319,0.192426936494511,24162737,2013,"Lambert","IGAP","Psychiatric / neurological",17008,37154,54162,"log odds","Males and females","European"
"771","Amygdala volume","Lp(a) inhibitor",1,12.9673484848485,6.40784457348103,0.0430043477778475,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"772","Amygdala volume","Lp(a) inhibitor",1,12.9673484848485,5.47280303030303,0.0178161891224822,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"773","Amyotrophic lateral sclerosis","Lp(a) inhibitor",1,-0.0286363636363636,0.0288340509884725,0.320639802682132,27455348,2016,"van Rheenen","Project MinE","Psychiatric / neurological",12577,23475,36052,"log odds","Males and females","European"
"774","Amyotrophic lateral sclerosis","Lp(a) inhibitor",1,-0.0286363636363636,0.0278787878787879,0.304338579537456,27455348,2016,"van Rheenen","Project MinE","Psychiatric / neurological",12577,23475,36052,"log odds","Males and females","European"
"775","Autism","Lp(a) inhibitor",1,-0.0841660397871212,0.05171217224507,0.103612567485125,NA,2015,NA,"PGC","Psychiatric / neurological",4949,5314,10263,"log odds","Males and females","European"
"776","Autism","Lp(a) inhibitor",1,-0.0841660397871212,0.046969696969697,0.0731454393321807,NA,2015,NA,"PGC","Psychiatric / neurological",4949,5314,10263,"log odds","Males and females","European"
"777","Bipolar disorder","Lp(a) inhibitor",1,-0.0665515837675758,0.0403787878787879,0.0993153679746087,21926972,2011,"Sklar P","PGC","Psychiatric / neurological",7481,9250,16731,"log odds","Males and females","European"
"778","Bipolar disorder","Lp(a) inhibitor",1,-0.0665515837675758,0.0438526396686031,0.129110562790773,21926972,2011,"Sklar P","PGC","Psychiatric / neurological",7481,9250,16731,"log odds","Males and females","European"
"779","Bulimia nervosa","Lp(a) inhibitor",1,0.0257575757575758,0.0165347855669493,0.11928515769184,23568457,2013,"Wade TD",NA,"Psychiatric / neurological",151,2291,2442,"log odds","Females","European"
"780","Bulimia nervosa","Lp(a) inhibitor",1,0.0257575757575758,0.0151515151515152,0.0891309255170861,23568457,2013,"Wade TD",NA,"Psychiatric / neurological",151,2291,2442,"log odds","Females","European"
"781","Caudate volume","Lp(a) inhibitor",1,0.950757575757576,10.8153787878788,0.929949852725036,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"782","Caudate volume","Lp(a) inhibitor",1,0.950757575757576,10.8181392455734,0.929967681397524,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"783","Depressive symptoms","Lp(a) inhibitor",1,-0.0053030303030303,0.00547540017118539,0.332785124842519,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,161460,"SD","Males and females","European"
"784","Depressive symptoms","Lp(a) inhibitor",1,-0.0053030303030303,0.0053030303030303,0.317310507862914,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,161460,"SD","Males and females","European"
"785","Digit symbol","Lp(a) inhibitor",1,-0.0078030303030303,0.041714908649252,0.851616606719574,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2956,"SD (number correct in 90/120 seconds)","Males and females","European"
"786","Digit symbol","Lp(a) inhibitor",1,-0.0078030303030303,0.0416666666666667,0.851446805164149,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2956,"SD (number correct in 90/120 seconds)","Males and females","European"
"787","G speed factor","Lp(a) inhibitor",1,-0.045530303030303,0.0484791421334169,0.347641911335211,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2430,"SD","Males and females","European"
"788","G speed factor","Lp(a) inhibitor",1,-0.045530303030303,0.0470454545454545,0.333147320465376,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2430,"SD","Males and females","European"
"789","Hippocampus volume","Lp(a) inhibitor",1,13.4527272727273,10.5491666666667,0.202224039926182,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"790","Hippocampus volume","Lp(a) inhibitor",1,13.4527272727273,11.1013968342809,0.225587065570415,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"791","Inspection time","Lp(a) inhibitor",1,-0.0153787878787879,0.0444186542500673,0.729174654676258,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2645,"SD (milliseconds)","Males and females","European"
"792","Inspection time","Lp(a) inhibitor",1,-0.0153787878787879,0.0442424242424242,0.728138548447724,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2645,"SD (milliseconds)","Males and females","European"
"793","Internalizing problems","Lp(a) inhibitor",1,0.0343181818181818,0.0447727272727273,0.443380361480081,24839885,2014,"Benke","EAGLE","Psychiatric / neurological",NA,NA,4596,NA,"Males and females","European"
"794","Internalizing problems","Lp(a) inhibitor",1,0.0343181818181818,0.0456333632733293,0.452026117411402,24839885,2014,"Benke","EAGLE","Psychiatric / neurological",NA,NA,4596,NA,"Males and females","European"
"795","Intracranial volume","Lp(a) inhibitor",1,704.383333333333,4901.48190287896,0.885730864862491,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"796","Intracranial volume","Lp(a) inhibitor",1,704.383333333333,4898.13704545454,0.885653368591153,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"797","Nucleus accumbens volume","Lp(a) inhibitor",1,3.24583333333333,2.71939262843892,0.232639325075233,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"798","Nucleus accumbens volume","Lp(a) inhibitor",1,3.24583333333333,2.58825757575758,0.209819771272131,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"799","Pallidum volume","Lp(a) inhibitor",1,1.79151515151515,4.35810606060606,0.681016413177372,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"800","Pallidum volume","Lp(a) inhibitor",1,1.79151515151515,4.38236516593053,0.68268572451912,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"801","Putamen volume","Lp(a) inhibitor",1,1.82590909090909,13.6236162978962,0.893382578309046,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"802","Putamen volume","Lp(a) inhibitor",1,1.82590909090909,13.6155303030303,0.893319638876279,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"803","Schizophrenia","Lp(a) inhibitor",1,0.0109059699118939,0.0187710902709433,0.56124165762868,25056061,2014,"Ripke S","PGC","Psychiatric / neurological",35476,46839,82315,"log odds","Males and females","Mixed"
"804","Schizophrenia","Lp(a) inhibitor",1,0.0109059699118939,0.0185606060606061,0.556809572276498,25056061,2014,"Ripke S","PGC","Psychiatric / neurological",35476,46839,82315,"log odds","Males and females","Mixed"
"805","Simple reaction time","Lp(a) inhibitor",1,0.116439393939394,0.0547394439686205,0.0334070367343879,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2378,"SD (milliseconds)","Males and females","European"
"806","Simple reaction time","Lp(a) inhibitor",1,0.116439393939394,0.0458333333333333,0.0110695401729227,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2378,"SD (milliseconds)","Males and females","European"
"807","Subjective well being","Lp(a) inhibitor",1,-0.00833333333333333,0.00571926116028718,0.145098531685254,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,298420,"SD","Males and females","European"
"808","Subjective well being","Lp(a) inhibitor",1,-0.00833333333333333,0.0053030303030303,0.116083133738655,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,298420,"SD","Males and females","European"
"809","Thalamus volume","Lp(a) inhibitor",1,6.59469696969697,14.1376629751437,0.640884111401568,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"810","Thalamus volume","Lp(a) inhibitor",1,6.59469696969697,14.0356818181818,0.638460566696441,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"811","Age at menarche","Lp(a) inhibitor",1,0.00431818181818182,0.0116654287681196,0.711256463373632,25231870,2014,"Perry JR","ReproGen","Reproductive aging",NA,NA,182416,"years","Females","European"
"812","Age at menarche","Lp(a) inhibitor",1,0.00431818181818182,0.0116125080143939,0.710000000000228,25231870,2014,"Perry JR","ReproGen","Reproductive aging",NA,NA,182416,"years","Females","European"
"813","Age at menopause","Lp(a) inhibitor",1,0.00757575757575758,0.0378787878787879,0.841480581121794,26414677,2015,"Day","ReproGen","Reproductive aging",NA,NA,69360,"years","Females","European"
"814","Age at menopause","Lp(a) inhibitor",1,0.00757575757575758,0.0379288037795197,0.841686850407621,26414677,2015,"Day","ReproGen","Reproductive aging",NA,NA,69360,"years","Females","European"
"815","Chronotype","Lp(a) inhibitor",1,-0.00594400757575758,0.00564336761517676,0.292215821723079,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"816","Chronotype","Lp(a) inhibitor",1,-0.00594400757575758,0.00543262878787879,0.273897527534669,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"817","Sleep duration","Lp(a) inhibitor",1,0.00170543181818182,0.00547235606060606,0.755310412553902,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"818","Sleep duration","Lp(a) inhibitor",1,0.00170543181818182,0.00548988429044465,0.756066813945036,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"819","Father’s age at death","NPC1L1 inhibitor",1,0.146257525773196,0.121379175257732,0.228217234012732,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"820","Father’s age at death","NPC1L1 inhibitor",1,0.146257525773196,0.122275304659041,0.23164466546578,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"821","Mother’s age at death","NPC1L1 inhibitor",1,-0.199634639175258,0.13495175257732,0.139059140154212,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"822","Mother’s age at death","NPC1L1 inhibitor",1,-0.199634639175258,0.136450632427756,0.143452612298253,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"823","Parents' age at death","NPC1L1 inhibitor",1,-0.00744657731958763,0.199491521722963,0.970223648952335,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"824","Parents' age at death","NPC1L1 inhibitor",1,-0.00744657731958763,0.199490103092784,0.970223437302666,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"825","Top 1 % survival","NPC1L1 inhibitor",1,-0.0456818556701031,0.0224987628865979,0.0423142376816523,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"826","Top 1 % survival","NPC1L1 inhibitor",1,-0.0456818556701031,0.0229672624258688,0.0467013437538061,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"827","Birth weight","NPC1L1 inhibitor",1,0.103092783505155,0.0913175862929164,0.258919876199271,27680694,2016,"Horikoshi",NA,"Anthropometric",NA,NA,153781,NA,"Males and females","Mixed"
"828","Birth weight","NPC1L1 inhibitor",1,0.103092783505155,0.0907216494845361,0.255804407976616,27680694,2016,"Horikoshi",NA,"Anthropometric",NA,NA,153781,NA,"Males and females","Mixed"
"829","Body fat","NPC1L1 inhibitor",1,0.0185567010309278,0.138157051070206,0.893152709959199,26833246,2016,"Lu",NA,"Anthropometric",NA,NA,100716,"SD","Males and females","European"
"830","Body fat","NPC1L1 inhibitor",1,0.0185567010309278,0.138144329896907,0.893142929842994,26833246,2016,"Lu",NA,"Anthropometric",NA,NA,100716,"SD","Males and females","European"
"831","Body mass index","NPC1L1 inhibitor",1,0.0432989690721649,0.0804123711340206,0.590258451314772,25673413,2015,"Locke AE","GIANT","Anthropometric",NA,NA,339224,"SD (kg/m^2)","Males and females","Mixed"
"832","Body mass index","NPC1L1 inhibitor",1,0.0432989690721649,0.0805312733541059,0.590807300737527,25673413,2015,"Locke AE","GIANT","Anthropometric",NA,NA,339224,"SD (kg/m^2)","Males and females","Mixed"
"833","Child birth length","NPC1L1 inhibitor",1,0.249484536082474,0.281542932581663,0.375545761648844,25281659,2015,"van der Valk RJ","EGG","Anthropometric",NA,NA,28459,"SD (cm)","Males and females","European"
"834","Child birth length","NPC1L1 inhibitor",1,0.249484536082474,0.280412371134021,0.373623834627255,25281659,2015,"van der Valk RJ","EGG","Anthropometric",NA,NA,28459,"SD (cm)","Males and females","European"
"835","Child birth weight","NPC1L1 inhibitor",1,0.371134020618557,0.229882712774193,0.106429971724769,23202124,2013,"Horikoshi M","EGG","Anthropometric",NA,NA,26836,"g","Males and females","European"
"836","Child birth weight","NPC1L1 inhibitor",1,0.371134020618557,0.22680412371134,0.101763504951258,23202124,2013,"Horikoshi M","EGG","Anthropometric",NA,NA,26836,"g","Males and females","European"
"837","Childhood obesity","NPC1L1 inhibitor",1,0.554639175257732,0.742324186593551,0.454963541868657,22484627,2012,"Bradfield JP","EGG","Anthropometric",5530,8318,13848,"log odds","Males and females","European"
"838","Childhood obesity","NPC1L1 inhibitor",1,0.554639175257732,0.74020618556701,0.453674225730266,22484627,2012,"Bradfield JP","EGG","Anthropometric",5530,8318,13848,"log odds","Males and females","European"
"839","Difference in height between adolescence and adulthood","NPC1L1 inhibitor",1,-0.493882931758763,0.614646697795876,0.421672345603134,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,4282,"SD","Males","European"
"840","Difference in height between adolescence and adulthood","NPC1L1 inhibitor",1,-0.493882931758763,0.61666872687972,0.42319616061503,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,4282,"SD","Males","European"
"841","Difference in height between childhood and adulthood","NPC1L1 inhibitor",1,0.412015106742268,0.52894426942268,0.436015886638505,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,5043,"SD","Males","European"
"842","Difference in height between childhood and adulthood","NPC1L1 inhibitor",1,0.412015106742268,0.530579670158665,0.437431581122168,23449627,2013,"Cousminer","EGG","Anthropometric",NA,NA,5043,"SD","Males","European"
"843","Extreme body mass index","NPC1L1 inhibitor",1,-0.148453608247423,0.783648696497449,0.849748777406044,23563607,2013,"Berndt SI","GIANT","Anthropometric",7962,8106,16068,"log odds","Males and females","European"
"844","Extreme body mass index","NPC1L1 inhibitor",1,-0.148453608247423,0.783505154639175,0.849721578471507,23563607,2013,"Berndt SI","GIANT","Anthropometric",7962,8106,16068,"log odds","Males and females","European"
"845","Extreme height","NPC1L1 inhibitor",1,0.845360824742268,0.783505154639175,0.280611190843872,23563607,2013,"Berndt SI","GIANT","Anthropometric",8097,8099,16196,"log odds","Males and females","European"
"846","Extreme height","NPC1L1 inhibitor",1,0.845360824742268,0.788146422637301,0.283453488434465,23563607,2013,"Berndt SI","GIANT","Anthropometric",8097,8099,16196,"log odds","Males and females","European"
"847","Extreme waist-to-hip ratio","NPC1L1 inhibitor",1,1.21649484536082,0.956383575042753,0.203382430171778,23563607,2013,"Berndt SI","GIANT","Anthropometric",4774,5481,10255,"log odds","Males and females","European"
"848","Extreme waist-to-hip ratio","NPC1L1 inhibitor",1,1.21649484536082,0.948453608247423,0.199629202157063,23563607,2013,"Berndt SI","GIANT","Anthropometric",4774,5481,10255,"log odds","Males and females","European"
"849","Height","NPC1L1 inhibitor",1,-0.00824742268041237,0.0866019467892533,0.924129213343849,25282103,2014,"Wood AR","GIANT","Anthropometric",NA,NA,253288,"SD (m)","Males and females","European"
"850","Height","NPC1L1 inhibitor",1,-0.00824742268041237,0.0865979381443299,0.924125711867492,25282103,2014,"Wood AR","GIANT","Anthropometric",NA,NA,253288,"SD (m)","Males and females","European"
"851","Hip circumference","NPC1L1 inhibitor",1,0.0742268041237113,0.0948453608247423,0.433856933557041,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"852","Hip circumference","NPC1L1 inhibitor",1,0.0742268041237113,0.0951413712008276,0.435288587759672,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"853","Infant head circumference","NPC1L1 inhibitor",1,-0.430927835051546,0.392115202848649,0.271775600030528,22504419,2012,"Taal HR","EGG","Anthropometric",NA,NA,10768,"SD (cm)","Males and females","European"
"854","Infant head circumference","NPC1L1 inhibitor",1,-0.430927835051546,0.389690721649485,0.268804390787302,22504419,2012,"Taal HR","EGG","Anthropometric",NA,NA,10768,"SD (cm)","Males and females","European"
"855","Obesity class 1","NPC1L1 inhibitor",1,0.204123711340206,0.371134020618557,0.582319373576693,23563607,2013,"Berndt SI","GIANT","Anthropometric",32858,65839,98697,"log odds","Males and females","European"
"856","Obesity class 1","NPC1L1 inhibitor",1,0.204123711340206,0.371706552899234,0.582900561524657,23563607,2013,"Berndt SI","GIANT","Anthropometric",32858,65839,98697,"log odds","Males and females","European"
"857","Obesity class 2","NPC1L1 inhibitor",1,-0.412371134020619,0.558257807768796,0.460104317898612,23563607,2013,"Berndt SI","GIANT","Anthropometric",9889,62657,72546,"log odds","Males and females","European"
"858","Obesity class 2","NPC1L1 inhibitor",1,-0.412371134020619,0.556701030927835,0.458850651929467,23563607,2013,"Berndt SI","GIANT","Anthropometric",9889,62657,72546,"log odds","Males and females","European"
"859","Obesity class 3","NPC1L1 inhibitor",1,0.783505154639175,1.11621242616305,0.482721608420598,23563607,2013,"Berndt SI","GIANT","Anthropometric",2896,47468,50364,"log odds","Males and females","European"
"860","Obesity class 3","NPC1L1 inhibitor",1,0.783505154639175,1.11340206185567,0.481617313358525,23563607,2013,"Berndt SI","GIANT","Anthropometric",2896,47468,50364,"log odds","Males and females","European"
"861","Overweight","NPC1L1 inhibitor",1,-0.0824742268041237,0.268170718903521,0.758429532657873,23563607,2013,"Berndt SI","GIANT","Anthropometric",93015,65840,158855,"log odds","Males and females","European"
"862","Overweight","NPC1L1 inhibitor",1,-0.0824742268041237,0.268041237113402,0.75831647352629,23563607,2013,"Berndt SI","GIANT","Anthropometric",93015,65840,158855,"log odds","Males and females","European"
"863","Sitting height ratio","NPC1L1 inhibitor",1,-0.0969072164948454,0.268041237113402,0.71769695838687,25865494,2015,"Chan",NA,"Anthropometric",NA,NA,21590,"SD","Males and females","European"
"864","Sitting height ratio","NPC1L1 inhibitor",1,-0.0969072164948454,0.26821998648625,0.717877045874862,25865494,2015,"Chan",NA,"Anthropometric",NA,NA,21590,"SD","Males and females","European"
"865","Waist circumference","NPC1L1 inhibitor",1,0.0288659793814433,0.0887077458596567,0.744874270334821,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"866","Waist circumference","NPC1L1 inhibitor",1,0.0288659793814433,0.088659793814433,0.744741090227158,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"867","Waist-to-hip ratio","NPC1L1 inhibitor",1,-0.022680412371134,0.0886893999250551,0.798160441957776,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD","Males and females","Mixed"
"868","Waist-to-hip ratio","NPC1L1 inhibitor",1,-0.022680412371134,0.088659793814433,0.798094499004888,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD","Males and females","Mixed"
"869","Weight","NPC1L1 inhibitor",1,-0.0577319587628866,0.191752577319588,0.763357099203955,23754948,2013,"Randall JC","GIANT","Anthropometric",NA,NA,60586,"SD (kg)","Males","European"
"870","Weight","NPC1L1 inhibitor",1,-0.0577319587628866,0.191841266295443,0.763463236556957,23754948,2013,"Randall JC","GIANT","Anthropometric",NA,NA,60586,"SD (kg)","Males","European"
"871","Crohn's disease","NPC1L1 inhibitor",1,-0.81443200282268,0.640359999680205,0.203431893305979,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",5956,14927,20883,"log odds","Males and females","European"
"872","Crohn's disease","NPC1L1 inhibitor",1,-0.81443200282268,0.635051546391753,0.199679232143623,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",5956,14927,20883,"log odds","Males and females","European"
"873","Eczema","NPC1L1 inhibitor",1,0.43698999643299,0.477202595026236,0.359807136364805,26482879,2014,"Paternoster","EAGLE","Autoimmune / inflammatory",10788,30047,40835,"log odds","Males and females","European"
"874","Eczema","NPC1L1 inhibitor",1,0.43698999643299,0.475155909072165,0.357741536263903,26482879,2014,"Paternoster","EAGLE","Autoimmune / inflammatory",10788,30047,40835,"log odds","Males and females","European"
"875","Gout","NPC1L1 inhibitor",1,-0.989690721649485,1.03092783505155,0.337055214933676,23263486,2013,"Köttgen","GUGC","Autoimmune / inflammatory",2115,67259,69374,"log odds","Males and females","European"
"876","Gout","NPC1L1 inhibitor",1,-0.989690721649485,1.03576545393859,0.339316692031075,23263486,2013,"Köttgen","GUGC","Autoimmune / inflammatory",2115,67259,69374,"log odds","Males and females","European"
"877","Inflammatory bowel disease","NPC1L1 inhibitor",1,-0.325860444226804,0.470103092783505,0.48820409603651,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",12882,21770,34652,"log odds","Males and females","European"
"878","Inflammatory bowel disease","NPC1L1 inhibitor",1,-0.325860444226804,0.471254469274206,0.489267405982209,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",12882,21770,34652,"log odds","Males and females","European"
"879","Rheumatoid arthritis","NPC1L1 inhibitor",1,0.609459840030928,0.413348429389699,0.14036161084261,24390342,2014,"Okada Y",NA,"Autoimmune / inflammatory",19234,61565,80799,"log odds","Males and females","Mixed"
"880","Rheumatoid arthritis","NPC1L1 inhibitor",1,0.609459840030928,0.408736504983505,0.135939842462586,24390342,2014,"Okada Y",NA,"Autoimmune / inflammatory",19234,61565,80799,"log odds","Males and females","Mixed"
"881","Systemic lupus erythematosus","NPC1L1 inhibitor",1,-0.205161460890103,0.835247704969742,0.805969065152222,26502338,2015,"Bentham",NA,"Autoimmune / inflammatory",7219,15991,23210,"log odds","Males and females","European"
"882","Systemic lupus erythematosus","NPC1L1 inhibitor",1,-0.205161460890103,0.834990474837113,0.805910484323676,26502338,2015,"Bentham",NA,"Autoimmune / inflammatory",7219,15991,23210,"log odds","Males and females","European"
"883","Ulcerative colitis","NPC1L1 inhibitor",1,-0.0824326038618557,0.595876288659794,0.889972936674686,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",6968,20464,27432,"log odds","Males and females","European"
"884","Ulcerative colitis","NPC1L1 inhibitor",1,-0.0824326038618557,0.595934485500973,0.889983613167571,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",6968,20464,27432,"log odds","Males and females","European"
"885","Age of smoking initiation","NPC1L1 inhibitor",1,0.0536082474226804,0.10529402728335,0.610661775061147,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,47961,"log years","Males and females","European"
"886","Age of smoking initiation","NPC1L1 inhibitor",1,0.0536082474226804,0.105154639175258,0.610188838027009,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,47961,"log years","Males and females","European"
"887","Cigarettes smoked per day","NPC1L1 inhibitor",1,8.62474226804124,4.76083376845261,0.0700475113597576,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,68028,"Cigarettes per day","Males and females","European"
"888","Cigarettes smoked per day","NPC1L1 inhibitor",1,8.62474226804124,4.68041237113402,0.06536825496792,20418890,2010,"Furberg","TAG","Behavioural",NA,NA,68028,"Cigarettes per day","Males and females","European"
"889","Ever vs never smoked","NPC1L1 inhibitor",1,-0.276288659793814,0.691285448779842,0.689396815764396,20418890,2010,"Furberg","TAG","Behavioural",41969,32066,74035,"log odds","Males and females","European"
"890","Ever vs never smoked","NPC1L1 inhibitor",1,-0.276288659793814,0.690721649484536,0.689156516779352,20418890,2010,"Furberg","TAG","Behavioural",41969,32066,74035,"log odds","Males and females","European"
"891","Former vs current smoker","NPC1L1 inhibitor",1,-1.08865979381443,0.962886597938144,0.258214651143096,20418890,2010,"Furberg","TAG","Behavioural",23554,18415,41969,"log odds","Males and females","European"
"892","Former vs current smoker","NPC1L1 inhibitor",1,-1.08865979381443,0.969148094266323,0.261303208725201,20418890,2010,"Furberg","TAG","Behavioural",23554,18415,41969,"log odds","Males and females","European"
"893","Paget's disease","NPC1L1 inhibitor",1,3.26919587628866,2.06371134020619,0.113163165112157,21623375,2011,"Albagha OM",NA,"Bone",741,2699,3440,"log odds","Males and females","European"
"894","Paget's disease","NPC1L1 inhibitor",1,3.26919587628866,2.08997509767133,0.117764223750175,21623375,2011,"Albagha OM",NA,"Bone",741,2699,3440,"log odds","Males and females","European"
"895","Lung adenocarcinoma","NPC1L1 inhibitor",1,-0.268186401880412,0.771670103092783,0.728185503689853,24880342,2014,"Wang Y","ILCCO","Cancer",3442,14894,18336,"log odds","Males and females","European"
"896","Lung adenocarcinoma","NPC1L1 inhibitor",1,-0.268186401880412,0.77214564273201,0.728346279546204,24880342,2014,"Wang Y","ILCCO","Cancer",3442,14894,18336,"log odds","Males and females","European"
"897","Lung cancer","NPC1L1 inhibitor",1,0.0762645825492783,0.490699672487217,0.876490154644097,24880342,2014,"Wang Y","ILCCO","Cancer",11348,15861,27209,"log odds","Males and females","European"
"898","Lung cancer","NPC1L1 inhibitor",1,0.0762645825492783,0.490639175257732,0.876475047772779,24880342,2014,"Wang Y","ILCCO","Cancer",11348,15861,27209,"log odds","Males and females","European"
"899","Small cell lung carcinoma","NPC1L1 inhibitor",1,-1.16214979905361,0.7764952961253,0.134481632295033,NA,NA,NA,"TRICL","Cancer",2791,20580,23371,NA,"Males and females","European"
"900","Small cell lung carcinoma","NPC1L1 inhibitor",1,-1.16214979905361,0.767567010309278,0.13000821347182,NA,NA,NA,"TRICL","Cancer",2791,20580,23371,NA,"Males and females","European"
"901","Squamous cell lung cancer","NPC1L1 inhibitor",1,0.00668149483175258,0.752948453608247,0.992919845203376,24880342,2014,"Wang Y","ILCCO","Cancer",3275,15038,18313,"log odds","Males and females","European"
"902","Squamous cell lung cancer","NPC1L1 inhibitor",1,0.00668149483175258,0.752948756202467,0.992919848048666,24880342,2014,"Wang Y","ILCCO","Cancer",3275,15038,18313,"log odds","Males and females","European"
"903","Coronary heart disease","NPC1L1 inhibitor",1,-0.425814432989691,0.250651450064211,0.0893510463155624,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",60801,123504,184305,"log odds","Males and females","Mixed"
"904","Coronary heart disease","NPC1L1 inhibitor",1,-0.425814432989691,0.246931958762887,0.0846320315890559,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",60801,123504,184305,"log odds","Males and females","Mixed"
"905","Myocardial infarction","NPC1L1 inhibitor",1,-0.0847410309278351,0.281317649470535,0.763239886362229,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",43676,128199,171875,"log odds","Males and females","Mixed"
"906","Myocardial infarction","NPC1L1 inhibitor",1,-0.0847410309278351,0.281187341857732,0.763133448041991,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",43676,128199,171875,"log odds","Males and females","Mixed"
"907","Type 2 diabetes","NPC1L1 inhibitor",1,1.00598276637938,0.460338689838155,0.028866120843825,24509480,2014,"Mahajan A","DIAGRAM","Diabetes",26488,83964,110452,"log odds","Males and females","Mixed"
"908","Type 2 diabetes","NPC1L1 inhibitor",1,1.00598276637938,0.44897879734433,0.0250518706500625,24509480,2014,"Mahajan A","DIAGRAM","Diabetes",26488,83964,110452,"log odds","Males and females","Mixed"
"909","College completion","NPC1L1 inhibitor",1,-0.500880259154639,0.252544625383761,0.0473301706268396,23722424,2013,"Rietveld CA","SSGAC","Education",20044,75383,95427,"log odds","Males and females","European"
"910","College completion","NPC1L1 inhibitor",1,-0.500880259154639,0.247422680412371,0.0429299321753035,23722424,2013,"Rietveld CA","SSGAC","Education",20044,75383,95427,"log odds","Males and females","European"
"911","Years of schooling","NPC1L1 inhibitor",1,-0.0412371134020619,0.0619958171563995,0.505948412718485,27225129,2016,"Okbay","SSGAC","Education",NA,NA,293723,"SD (years)","Males and females","European"
"912","Years of schooling","NPC1L1 inhibitor",1,-0.0412371134020619,0.0618556701030928,0.504985075093846,27225129,2016,"Okbay","SSGAC","Education",NA,NA,293723,"SD (years)","Males and females","European"
"913","2hr glucose","NPC1L1 inhibitor",1,0.177319587628866,0.536381727771541,0.740958211599202,20081857,2010,"Saxena R","MAGIC","Glycemic",NA,NA,15234,"mmol/L","Males and females","European"
"914","2hr glucose","NPC1L1 inhibitor",1,0.177319587628866,0.536082474226804,0.740818804131443,20081857,2010,"Saxena R","MAGIC","Glycemic",NA,NA,15234,"mmol/L","Males and females","European"
"915","AUCins","NPC1L1 inhibitor",1,-0.179381443298969,0.577319587628866,0.756017836028758,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4324,"SD (mU*min/l)","Males and females","European"
"916","AUCins","NPC1L1 inhibitor",1,-0.179381443298969,0.577603975106294,0.756134148898935,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4324,"SD (mU*min/l)","Males and females","European"
"917","AUCins/AUCglu","NPC1L1 inhibitor",1,-0.197938144329897,0.577319587628866,0.731705934672859,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4213,"SD","Males and females","European"
"918","AUCins/AUCglu","NPC1L1 inhibitor",1,-0.197938144329897,0.577665838733351,0.731860551644362,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4213,"SD","Males and females","European"
"919","Corrected insulin response","NPC1L1 inhibitor",1,-0.989690721649485,0.565609328357188,0.0801566398063246,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5318,"SD","Males and females","European"
"920","Corrected insulin response","NPC1L1 inhibitor",1,-0.989690721649485,0.556701030927835,0.0754403596268005,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5318,"SD","Males and females","European"
"921","Fasting glucose","NPC1L1 inhibitor",1,-0.00206185567010309,0.0206185567010309,0.920344325445942,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,58074,"mmol/L","Males and females","European"
"922","Fasting glucose","NPC1L1 inhibitor",1,-0.00206185567010309,0.0206196089678271,0.920348376930067,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,58074,"mmol/L","Males and females","European"
"923","Fasting insulin","NPC1L1 inhibitor",1,-0.0206185567010309,0.0185567010309278,0.266520525805011,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,51750,"log pmol/L","Males and females","European"
"924","Fasting insulin","NPC1L1 inhibitor",1,-0.0206185567010309,0.0186732565022282,0.269516913865745,22581228,2012,"Manning AK","MAGIC","Glycemic",NA,NA,51750,"log pmol/L","Males and females","European"
"925","Fasting proinsulin","NPC1L1 inhibitor",1,0.088659793814433,0.22680412371134,0.695864434022019,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,10701,"log pmol/L","Males and females","European"
"926","Fasting proinsulin","NPC1L1 inhibitor",1,0.088659793814433,0.226980935787527,0.696089537374607,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,10701,"log pmol/L","Males and females","European"
"927","HbA1C","NPC1L1 inhibitor",1,0.222680412371134,0.101030927835052,0.027518603622956,20858683,2010,"Soranzo N","MAGIC","Glycemic",NA,NA,46368,"%","Males and females","European"
"928","HbA1C","NPC1L1 inhibitor",1,0.222680412371134,0.103505510844566,0.031445664965837,20858683,2010,"Soranzo N","MAGIC","Glycemic",NA,NA,46368,"%","Males and females","European"
"929","HOMA-B","NPC1L1 inhibitor",1,-0.179381443298969,0.0969072164948454,0.0641603708840794,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"930","HOMA-B","NPC1L1 inhibitor",1,-0.179381443298969,0.0985872933364475,0.0688323023820236,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"931","HOMA-IR","NPC1L1 inhibitor",1,-0.14020618556701,0.122471420643778,0.252288959669986,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"932","HOMA-IR","NPC1L1 inhibitor",1,-0.14020618556701,0.121649484536082,0.249098268106654,20081858,2011,"Dupuis J","MAGIC","Glycemic",NA,NA,46186,"log HOMA","Males and females","European"
"933","Incremental insulin at 30 minutes","NPC1L1 inhibitor",1,-0.350515463917526,0.577319587628866,0.543756110575491,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4447,"SD","Males and females","European"
"934","Incremental insulin at 30 minutes","NPC1L1 inhibitor",1,-0.350515463917526,0.578404685256162,0.544512199187069,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4447,"SD","Males and females","European"
"935","Insulin at 30 minutes","NPC1L1 inhibitor",1,-0.288659793814433,0.577319587628866,0.617075077451974,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4409,"SD","Males and females","European"
"936","Insulin at 30 minutes","NPC1L1 inhibitor",1,-0.288659793814433,0.578055723860884,0.6175234931921,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4409,"SD","Males and females","European"
"937","Insulin disposition index","NPC1L1 inhibitor",1,-0.783505154639175,0.536082474226804,0.143867728481615,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5130,"SD","Males and females","European"
"938","Insulin disposition index","NPC1L1 inhibitor",1,-0.783505154639175,0.541895237245601,0.148216210699402,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,5130,"SD","Males and females","European"
"939","Insulin sensitivity index","NPC1L1 inhibitor",1,0.618556701030928,0.58069210945393,0.286782733156217,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4769,"SD","Males and females","European"
"940","Insulin sensitivity index","NPC1L1 inhibitor",1,0.618556701030928,0.577319587628866,0.283976771750912,24699409,2014,"Prokopenko","MAGIC","Glycemic",NA,NA,4769,"SD","Males and females","European"
"941","Insulin-like growth factor 1","NPC1L1 inhibitor",1,-0.108334548041649,0.225962210669806,0.631628080031496,27329260,2016,NA,NA,"Growth hormone",NA,NA,30884,"SD","Males and females","European"
"942","Insulin-like growth factor 1","NPC1L1 inhibitor",1,-0.108334548041649,0.225696975086598,0.631227393032185,27329260,2016,NA,NA,"Growth hormone",NA,NA,30884,"SD","Males and females","European"
"943","Insulin-like growth factor binding protein 3","NPC1L1 inhibitor",1,0.256504038090722,0.274335869616495,0.349788299427761,27329260,2016,NA,NA,"Growth hormone",NA,NA,18995,"SD","Males and females","European"
"944","Insulin-like growth factor binding protein 3","NPC1L1 inhibitor",1,0.256504038090722,0.27555715984222,0.351928052704653,27329260,2016,NA,NA,"Growth hormone",NA,NA,18995,"SD","Males and females","European"
"945","Haemoglobin concentration","NPC1L1 inhibitor",1,-0.354639175257732,0.215372359929048,0.0996335604212278,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,71861,"g/dL","Males and females","Mixed"
"946","Haemoglobin concentration","NPC1L1 inhibitor",1,-0.354639175257732,0.212371134020619,0.0949385739924384,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,71861,"g/dL","Males and females","Mixed"
"947","Mean cell haemoglobin","NPC1L1 inhibitor",1,-0.670103092783505,0.360824742268041,0.0632908322333453,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,64731,"pg","Males and females","Mixed"
"948","Mean cell haemoglobin","NPC1L1 inhibitor",1,-0.670103092783505,0.367121149775109,0.0679570609706628,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,64731,"pg","Males and females","Mixed"
"949","Mean cell haemoglobin concentration","NPC1L1 inhibitor",1,-0.022680412371134,0.119587628865979,0.849579350391596,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,67852,"g/dL","Males and females","Mixed"
"950","Mean cell haemoglobin concentration","NPC1L1 inhibitor",1,-0.022680412371134,0.119609579874004,0.84960662660644,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,67852,"g/dL","Males and females","Mixed"
"951","Mean cell volume","NPC1L1 inhibitor",1,-2.30515463917526,0.954617542724633,0.015746378590009,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,69335,"fl","Males and females","Mixed"
"952","Mean cell volume","NPC1L1 inhibitor",1,-2.30515463917526,0.925773195876289,0.012775110047983,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,69335,"fl","Males and females","Mixed"
"953","Mean platelet volume","NPC1L1 inhibitor",1,-0.0247422680412371,0.0350515463917526,0.480261302753423,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"log fl","Males and females","European"
"954","Mean platelet volume","NPC1L1 inhibitor",1,-0.0247422680412371,0.0351405688059902,0.481374158650605,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"log fl","Males and females","European"
"955","Packed cell volume","NPC1L1 inhibitor",1,-0.550515463917526,0.62680412371134,0.379786646773077,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,63511,"%","Males and females","Mixed"
"956","Packed cell volume","NPC1L1 inhibitor",1,-0.550515463917526,0.629266948491187,0.381654425797876,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,63511,"%","Males and females","Mixed"
"957","Platelet count","NPC1L1 inhibitor",1,-1.0020618556701,14.6518961589685,0.945474167317717,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"1x10^9/l","Males and females","European"
"958","Platelet count","NPC1L1 inhibitor",1,-1.0020618556701,14.6515463917526,0.945472867684825,22139419,2011,"Gieger C","HaemGen","Haemotological",NA,NA,66867,"1x10^9/l","Males and females","European"
"959","Red blood cell count","NPC1L1 inhibitor",1,0.0144329896907216,0.0783640833388134,0.853873321678994,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,66214,"10^12/L","Males and females","Mixed"
"960","Red blood cell count","NPC1L1 inhibitor",1,0.0144329896907216,0.0783505154639175,0.853848301985592,23222517,2012,"van der Harst P","HaemGen","Haemotological",NA,NA,66214,"10^12/L","Males and females","Mixed"
"961","Heart rate","NPC1L1 inhibitor",1,1.23711340206186,1.49278350515464,0.40725761253401,23583979,2013,"den Hoed M","HRgene consortium","Hemodynamic",NA,NA,92355,"beats per minute","Males and females","Mixed"
"962","Heart rate","NPC1L1 inhibitor",1,1.23711340206186,1.49800676638997,0.408895051743827,23583979,2013,"den Hoed M","HRgene consortium","Hemodynamic",NA,NA,92355,"beats per minute","Males and females","Mixed"
"963","Leptin","NPC1L1 inhibitor",1,-0.185567010309278,0.145542457435059,0.202308324963018,26833098,2016,"Kilpeläinen",NA,"Hormone",NA,NA,32161,"log ng/ml","Males and females","European"
"964","Leptin","NPC1L1 inhibitor",1,-0.185567010309278,0.144329896907216,0.198542793686662,26833098,2016,"Kilpeläinen",NA,"Hormone",NA,NA,32161,"log ng/ml","Males and females","European"
"965","Plasma cortisol","NPC1L1 inhibitor",1,0.563546391752577,0.38391542222127,0.142133551126252,25010111,2014,"Bolton JL","CORNET","Hormone",NA,NA,12597,"SD","Males and females","European"
"966","Plasma cortisol","NPC1L1 inhibitor",1,0.563546391752577,0.379670103092783,0.137727913134415,25010111,2014,"Bolton JL","CORNET","Hormone",NA,NA,12597,"SD","Males and females","European"
"967","Chronic kidney disease","NPC1L1 inhibitor",1,-0.597938144329897,0.45360824742268,0.187442790475691,26831199,2015,"Pattaro","CKDGen","Kidney",12385,104780,117165,"log odds","Males and females","Mixed"
"968","Chronic kidney disease","NPC1L1 inhibitor",1,-0.597938144329897,0.457613198992783,0.191333197657564,26831199,2015,"Pattaro","CKDGen","Kidney",12385,104780,117165,"log odds","Males and females","Mixed"
"969","Microalbuminuria","NPC1L1 inhibitor",1,0.45360824742268,0.723103192131406,0.530457514348011,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,54116,"log odds","Males and females","European"
"970","Microalbuminuria","NPC1L1 inhibitor",1,0.45360824742268,0.721649484536083,0.529629670287596,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,54116,"log odds","Males and females","European"
"971","Serum creatinine (eGFRcrea)","NPC1L1 inhibitor",1,0,0.0268041237113402,1,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,118460,"log ml/min/1.73 m^²","Males and females","Mixed"
"972","Serum creatinine (eGFRcrea)","NPC1L1 inhibitor",1,0,0.0268041237113402,1,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,118460,"log ml/min/1.73 m^²","Males and females","Mixed"
"973","Serum cystatin C (eGFRcys)","NPC1L1 inhibitor",1,0.00206185567010309,0.0659797102842443,0.975070289340373,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,33152,"log ml/min/1.73 m^²","Males and females","Mixed"
"974","Serum cystatin C (eGFRcys)","NPC1L1 inhibitor",1,0.00206185567010309,0.065979381443299,0.975070165131246,26831199,2015,"Pattaro","CKDGen","Kidney",NA,NA,33152,"log ml/min/1.73 m^²","Males and females","Mixed"
"975","Urinary albumin-to-creatinine ratio","NPC1L1 inhibitor",1,-0.309278350515464,0.969072164948454,0.749613576677174,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,5825,"log mg/g","Males and females","European"
"976","Urinary albumin-to-creatinine ratio","NPC1L1 inhibitor",1,-0.309278350515464,0.969575791678199,0.749739282153778,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,5825,"log mg/g","Males and females","European"
"977","HDL cholesterol","NPC1L1 inhibitor",1,0.101030927835052,0.0927835051546392,0.276202886617978,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187167,"SD (mg/dL)","Males and females","Mixed"
"978","HDL cholesterol","NPC1L1 inhibitor",1,0.101030927835052,0.0933432737172629,0.279093060680211,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187167,"SD (mg/dL)","Males and females","Mixed"
"979","LDL cholesterol","NPC1L1 inhibitor",1,-1,0.101030927835052,4.24856030820427e-23,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,173082,"SD (mg/dL)","Males and females","Mixed"
"980","LDL cholesterol","NPC1L1 inhibitor",1,-1,0.142879308363467,2.5795402219194e-12,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,173082,"SD (mg/dL)","Males and females","Mixed"
"981","Total cholesterol","NPC1L1 inhibitor",1,-0.94020618556701,0.135698527385891,4.24906855385126e-12,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187365,"SD (mg/dL)","Males and females","Mixed"
"982","Total cholesterol","NPC1L1 inhibitor",1,-0.94020618556701,0.0969072164948454,2.95275858241544e-22,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187365,"SD (mg/dL)","Males and females","Mixed"
"983","Triglycerides","NPC1L1 inhibitor",1,-0.305154639175258,0.0958170655908811,0.00144872633806647,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,177861,"SD (mg/dL)","Males and females","Mixed"
"984","Triglycerides","NPC1L1 inhibitor",1,-0.305154639175258,0.0907216494845361,0.000769228240299476,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,177861,"SD (mg/dL)","Males and females","Mixed"
"985","FEV1/FVC","NPC1L1 inhibitor",1,-0.177319587628866,0.216494845360825,0.412759245541654,21946350,2011,"Soler Artigas M","SpiroMetaplusCHARGE","Lung function",NA,NA,48201,"SD","Males and females","European"
"986","FEV1/FVC","NPC1L1 inhibitor",1,-0.177319587628866,0.217234796434315,0.414352729541987,21946350,2011,"Soler Artigas M","SpiroMetaplusCHARGE","Lung function",NA,NA,48201,"SD","Males and females","European"
"987","Copper","NPC1L1 inhibitor",1,-1.17525773195876,0.894513537694387,0.188896266017306,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"988","Copper","NPC1L1 inhibitor",1,-1.17525773195876,0.88659793814433,0.184978392077357,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"989","Selenium","NPC1L1 inhibitor",1,0.515463917525773,0.970470482759323,0.595315894426079,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"990","Selenium","NPC1L1 inhibitor",1,0.515463917525773,0.969072164948454,0.594784941477696,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"991","Zinc","NPC1L1 inhibitor",1,-0.45360824742268,0.865979381443299,0.600411028614905,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"992","Zinc","NPC1L1 inhibitor",1,-0.45360824742268,0.867191176744987,0.600920278575017,23720494,2013,"Evans",NA,"Metal",NA,NA,2603,"SD","Males and females","European"
"993","Urate","NPC1L1 inhibitor",1,0.403362950509278,0.691845665004351,0.559876829123838,25811787,2015,"Huffman JE","GUGC","Other",NA,NA,7189,"SD (mg/dL)","Females","European"
"994","Urate","NPC1L1 inhibitor",1,0.403362950509278,0.690644400418557,0.559194379788291,25811787,2015,"Huffman JE","GUGC","Other",NA,NA,7189,"SD (mg/dL)","Females","European"
"995","Neo-agreeableness","NPC1L1 inhibitor",1,1.62474226804124,1.74587819666673,0.352052210069151,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"996","Neo-agreeableness","NPC1L1 inhibitor",1,1.62474226804124,1.73814432989691,0.349913636679174,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"997","Neo-conscientiousness","NPC1L1 inhibitor",1,-3.25154639175258,2.12577319587629,0.126119997562784,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"998","Neo-conscientiousness","NPC1L1 inhibitor",1,-3.25154639175258,2.15100636083462,0.13062557219688,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"999","Neo-extraversion","NPC1L1 inhibitor",1,-0.0969072164948454,2.19175257731959,0.964733434151334,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"1000","Neo-extraversion","NPC1L1 inhibitor",1,-0.0969072164948454,2.19177444472383,0.964733785777777,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"1001","Neo-neuroticism","NPC1L1 inhibitor",1,-0.85360824742268,2.69896907216495,0.751796089788706,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"1002","Neo-neuroticism","NPC1L1 inhibitor",1,-0.85360824742268,2.70034655809614,0.751918539765583,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"1003","Neo-openness to experience","NPC1L1 inhibitor",1,-2.31546391752577,2.00749118569124,0.2487414217651,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"1004","Neo-openness to experience","NPC1L1 inhibitor",1,-2.31546391752577,1.99381443298969,0.245510292444934,21173776,2012,"de Moor MH","GPC","Personality",NA,NA,17375,"arbitrary score","Males and females","European"
"1005","Neuroticism","NPC1L1 inhibitor",1,0,0.103092783505155,1,27089181,2016,"Okbay","SSGAC","Personality",NA,NA,170911,"SD","Males and females","European"
"1006","Neuroticism","NPC1L1 inhibitor",1,0,0.103092783505155,1,27089181,2016,"Okbay","SSGAC","Personality",NA,NA,170911,"SD","Males and females","European"
"1007","Adiponectin","NPC1L1 inhibitor",1,0.115958762886598,0.138742268041237,0.403275637821385,22479202,2012,"Dastani Z","ADIPOGen","Protein",NA,NA,39883,"ln(mg/dL)","Males and females","Mixed"
"1008","Adiponectin","NPC1L1 inhibitor",1,0.115958762886598,0.139236015599141,0.404945344378822,22479202,2012,"Dastani Z","ADIPOGen","Protein",NA,NA,39883,"ln(mg/dL)","Males and females","Mixed"
"1009","2-choice reaction time","NPC1L1 inhibitor",1,-0.91340206185567,0.678470087187249,0.178216342115919,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2602,"SD (milliseconds)","Males and females","European"
"1010","2-choice reaction time","NPC1L1 inhibitor",1,-0.91340206185567,0.672164948453608,0.174179639890953,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2602,"SD (milliseconds)","Males and females","European"
"1011","4-choice reaction time","NPC1L1 inhibitor",1,0.0474226804123711,0.723727199386819,0.947755500696852,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2829,"SD (milliseconds)","Males and females","European"
"1012","4-choice reaction time","NPC1L1 inhibitor",1,0.0474226804123711,0.723711340206186,0.947754357465131,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2829,"SD (milliseconds)","Males and females","European"
"1013","8-choice reaction time","NPC1L1 inhibitor",1,-1.1340206185567,1.05776952292517,0.283681099972425,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,1382,"SD (milliseconds)","Males and females","European"
"1014","8-choice reaction time","NPC1L1 inhibitor",1,-1.1340206185567,1.05154639175258,0.280841292693571,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,1382,"SD (milliseconds)","Males and females","European"
"1015","Alzheimer's disease","NPC1L1 inhibitor",1,0.509278350515464,0.435051546391753,0.241753117342364,24162737,2013,"Lambert","IGAP","Psychiatric / neurological",17008,37154,54162,"log odds","Males and females","European"
"1016","Alzheimer's disease","NPC1L1 inhibitor",1,0.509278350515464,0.438083605331626,0.245026717027855,24162737,2013,"Lambert","IGAP","Psychiatric / neurological",17008,37154,54162,"log odds","Males and females","European"
"1017","Amygdala volume","NPC1L1 inhibitor",1,22.7567010309278,63.6824742268041,0.720832519817509,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1018","Amygdala volume","NPC1L1 inhibitor",1,22.7567010309278,63.7239635086648,0.72100668113329,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1019","Amyotrophic lateral sclerosis","NPC1L1 inhibitor",1,-0.991752577319588,0.476288659793814,0.0373195415622813,27455348,2016,"van Rheenen","Project MinE","Psychiatric / neurological",12577,23475,36052,"log odds","Males and females","European"
"1020","Amyotrophic lateral sclerosis","NPC1L1 inhibitor",1,-0.991752577319588,0.486713943852715,0.0415849664510651,27455348,2016,"van Rheenen","Project MinE","Psychiatric / neurological",12577,23475,36052,"log odds","Males and females","European"
"1021","Autism","NPC1L1 inhibitor",1,0.228828591051546,0.738144329896907,0.756556991256779,NA,2015,NA,"PGC","Psychiatric / neurological",4949,5314,10263,"log odds","Males and females","European"
"1022","Autism","NPC1L1 inhibitor",1,0.228828591051546,0.738506282334841,0.756672535429258,NA,2015,NA,"PGC","Psychiatric / neurological",4949,5314,10263,"log odds","Males and females","European"
"1023","Bipolar disorder","NPC1L1 inhibitor",1,0.135635368249897,0.703226311003041,0.84705620350962,21926972,2011,"Sklar P","PGC","Psychiatric / neurological",7481,9250,16731,"log odds","Males and females","European"
"1024","Bipolar disorder","NPC1L1 inhibitor",1,0.135635368249897,0.703092783505155,0.847027515770489,21926972,2011,"Sklar P","PGC","Psychiatric / neurological",7481,9250,16731,"log odds","Males and females","European"
"1025","Bulimia nervosa","NPC1L1 inhibitor",1,0.494845360824742,0.272663846916715,0.0695461871324673,23568457,2013,"Wade TD",NA,"Psychiatric / neurological",151,2291,2442,"log odds","Females","European"
"1026","Bulimia nervosa","NPC1L1 inhibitor",1,0.494845360824742,0.268041237113402,0.0648698702799591,23568457,2013,"Wade TD",NA,"Psychiatric / neurological",151,2291,2442,"log odds","Females","European"
"1027","Caudate volume","NPC1L1 inhibitor",1,112.878350515464,132.612918459899,0.394665657778108,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1028","Caudate volume","NPC1L1 inhibitor",1,112.878350515464,132.121649484536,0.392910171668637,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1029","Depressive symptoms","NPC1L1 inhibitor",1,0.0412371134020619,0.123781473236497,0.739025231918941,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,161460,"SD","Males and females","European"
"1030","Depressive symptoms","NPC1L1 inhibitor",1,0.0412371134020619,0.123711340206186,0.738882680363527,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,161460,"SD","Males and females","European"
"1031","Digit symbol","NPC1L1 inhibitor",1,0.181443298969072,0.696907216494845,0.794589928227816,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2956,"SD (number correct in 90/120 seconds)","Males and females","European"
"1032","Digit symbol","NPC1L1 inhibitor",1,0.181443298969072,0.697148268356813,0.794659363028019,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2956,"SD (number correct in 90/120 seconds)","Males and females","European"
"1033","G speed factor","NPC1L1 inhibitor",1,-1.35051546391753,0.777319587628866,0.0823164976858937,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2430,"SD","Males and females","European"
"1034","G speed factor","NPC1L1 inhibitor",1,-1.35051546391753,0.789203814080342,0.0870372080636512,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2430,"SD","Males and females","European"
"1035","Hippocampus volume","NPC1L1 inhibitor",1,87.3443298969072,127.139603185034,0.492085590747179,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1036","Hippocampus volume","NPC1L1 inhibitor",1,87.3443298969072,126.832989690722,0.491039619802299,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1037","Inspection time","NPC1L1 inhibitor",1,-0.878350515463918,0.731958762886598,0.230139340443417,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2645,"SD (milliseconds)","Males and females","European"
"1038","Inspection time","NPC1L1 inhibitor",1,-0.878350515463918,0.737318465043501,0.233544867244713,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2645,"SD (milliseconds)","Males and females","European"
"1039","Internalizing problems","NPC1L1 inhibitor",1,-0.519587628865979,1.14845360824742,0.650963777738144,24839885,2014,"Benke","EAGLE","Psychiatric / neurological",NA,NA,4596,NA,"Males and females","European"
"1040","Internalizing problems","NPC1L1 inhibitor",1,-0.519587628865979,1.14965271036624,0.651303695604727,24839885,2014,"Benke","EAGLE","Psychiatric / neurological",NA,NA,4596,NA,"Males and females","European"
"1041","Intracranial volume","NPC1L1 inhibitor",1,-8542.24742268041,51349.5395882718,0.86787766546685,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1042","Intracranial volume","NPC1L1 inhibitor",1,-8542.24742268041,51342.2865979381,0.867859172466638,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1043","Nucleus accumbens volume","NPC1L1 inhibitor",1,25.2268041237113,29.9539875535672,0.399684313044719,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1044","Nucleus accumbens volume","NPC1L1 inhibitor",1,25.2268041237113,29.8453608247423,0.397971030089455,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1045","Pallidum volume","NPC1L1 inhibitor",1,-28.4845360824742,51.4413856834377,0.5797650034783,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1046","Pallidum volume","NPC1L1 inhibitor",1,-28.4845360824742,51.360824742268,0.579170651005435,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1047","Putamen volume","NPC1L1 inhibitor",1,91.6721649484536,161.360864930389,0.569954201999356,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1048","Putamen volume","NPC1L1 inhibitor",1,91.6721649484536,161.094845360825,0.569317392947452,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1049","Schizophrenia","NPC1L1 inhibitor",1,0.191683544434845,0.276288659793814,0.487820191400834,25056061,2014,"Ripke S","PGC","Psychiatric / neurological",35476,46839,82315,"log odds","Males and females","Mixed"
"1050","Schizophrenia","NPC1L1 inhibitor",1,0.191683544434845,0.276966539825908,0.488885862946839,25056061,2014,"Ripke S","PGC","Psychiatric / neurological",35476,46839,82315,"log odds","Males and females","Mixed"
"1051","Simple reaction time","NPC1L1 inhibitor",1,0.606185567010309,0.670842648901441,0.366197934602528,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2378,"SD (milliseconds)","Males and females","European"
"1052","Simple reaction time","NPC1L1 inhibitor",1,0.606185567010309,0.668041237113402,0.364191393721584,21130836,2011,"Luciano",NA,"Psychiatric / neurological",NA,NA,2378,"SD (milliseconds)","Males and females","European"
"1053","Subjective well being","NPC1L1 inhibitor",1,-0.0618556701030928,0.0827106539942646,0.454546937768359,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,298420,"SD","Males and females","European"
"1054","Subjective well being","NPC1L1 inhibitor",1,-0.0618556701030928,0.0824742268041237,0.453254704753736,27089181,2016,"Okbay","SSGAC","Psychiatric / neurological",NA,NA,298420,"SD","Males and females","European"
"1055","Thalamus volume","NPC1L1 inhibitor",1,-22.2969072164948,168.164948453608,0.89451803320007,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1056","Thalamus volume","NPC1L1 inhibitor",1,-22.2969072164948,168.180035804134,0.894527440622554,25607358,2015,"Hibar","ENIGMA","Psychiatric / neurological",NA,NA,30717,"mm3","Males and females","European"
"1057","Age at menarche","NPC1L1 inhibitor",1,-0.152577319587629,0.170197270453814,0.370000000000144,25231870,2014,"Perry JR","ReproGen","Reproductive aging",NA,NA,182416,"years","Females","European"
"1058","Age at menarche","NPC1L1 inhibitor",1,-0.152577319587629,0.170893926057195,0.371954186774962,25231870,2014,"Perry JR","ReproGen","Reproductive aging",NA,NA,182416,"years","Females","European"
"1059","Age at menopause","NPC1L1 inhibitor",1,0,0.618556701030928,1,26414677,2015,"Day","ReproGen","Reproductive aging",NA,NA,69360,"years","Females","European"
"1060","Age at menopause","NPC1L1 inhibitor",1,0,0.618556701030928,1,26414677,2015,"Day","ReproGen","Reproductive aging",NA,NA,69360,"years","Females","European"
"1061","Chronotype","NPC1L1 inhibitor",1,0.144656701030928,0.103818762886598,0.163511567801294,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"1062","Chronotype","NPC1L1 inhibitor",1,0.144656701030928,0.104842395658761,0.167662440635026,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"1063","Sleep duration","NPC1L1 inhibitor",1,0.0494521649484536,0.104618350515464,0.636433565105777,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"1064","Sleep duration","NPC1L1 inhibitor",1,0.0494521649484536,0.10473758284452,0.636817577721012,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"1065","Father’s age at death","PCSK9 inhibitor",1,0.0813975855130785,0.034692152917505,0.0189617379450734,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"1066","Father’s age at death","PCSK9 inhibitor",1,0.0813975855130785,0.0348171823163305,0.019394679298649,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"1067","Mother’s age at death","PCSK9 inhibitor",1,0.0266903420523139,0.0384006997753054,0.487025017378541,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"1068","Mother’s age at death","PCSK9 inhibitor",1,0.0266903420523139,0.0383885311871227,0.486886960397446,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"1069","Parents' age at death","PCSK9 inhibitor",1,0.103724346076459,0.0562244316439242,0.0650627174804733,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"1070","Parents' age at death","PCSK9 inhibitor",1,0.103724346076459,0.0560987927565392,0.0644637890092098,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"1071","Top 1 % survival","PCSK9 inhibitor",1,-0.00112823138832998,0.0066366398390342,0.865009826691669,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"1072","Top 1 % survival","PCSK9 inhibitor",1,-0.00112823138832998,0.00663676562906619,0.865012360678017,27015805,2016,"Pilling","UK Biobank","Aging",NA,NA,75244,NA,"Males and females","European"
"1073","Birth weight","PCSK9 inhibitor",1,-0.000804828973843058,0.0295774791518392,0.978291545001896,27680694,2016,"Horikoshi",NA,"Anthropometric",NA,NA,153781,NA,"Males and females","Mixed"
"1074","Birth weight","PCSK9 inhibitor",1,-0.000804828973843058,0.0295774647887324,0.978291534462659,27680694,2016,"Horikoshi",NA,"Anthropometric",NA,NA,153781,NA,"Males and females","Mixed"
"1075","Body fat","PCSK9 inhibitor",1,0.0366197183098592,0.058953722334004,0.534494085438626,26833246,2016,"Lu",NA,"Anthropometric",NA,NA,100716,"SD","Males and females","European"
"1076","Body fat","PCSK9 inhibitor",1,0.0366197183098592,0.0589686388042046,0.534597462893666,26833246,2016,"Lu",NA,"Anthropometric",NA,NA,100716,"SD","Males and females","European"
"1077","Body mass index","PCSK9 inhibitor",1,0.0183098591549296,0.0362173038229376,0.613168688648307,25673413,2015,"Locke AE","GIANT","Anthropometric",NA,NA,339224,"SD (kg/m^2)","Males and females","Mixed"
"1078","Body mass index","PCSK9 inhibitor",1,0.0183098591549296,0.0362233742568172,0.613228179363945,25673413,2015,"Locke AE","GIANT","Anthropometric",NA,NA,339224,"SD (kg/m^2)","Males and females","Mixed"
"1079","Childhood obesity","PCSK9 inhibitor",1,-0.031817655844668,0.169488826898444,0.851090539475804,22484627,2012,"Bradfield JP","EGG","Anthropometric",5530,8318,13848,"log odds","Males and females","European"
"1080","Childhood obesity","PCSK9 inhibitor",1,-0.031817655844668,0.16948490945674,0.851087137854945,22484627,2012,"Bradfield JP","EGG","Anthropometric",5530,8318,13848,"log odds","Males and females","European"
"1081","Hip circumference","PCSK9 inhibitor",1,0.0156941649899396,0.0402414486921529,0.696536546928035,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"1082","Hip circumference","PCSK9 inhibitor",1,0.0156941649899396,0.0402454627478876,0.696565310733326,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"1083","Waist circumference","PCSK9 inhibitor",1,0.0422535211267606,0.0362173038229376,0.243345009148762,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"1084","Waist circumference","PCSK9 inhibitor",1,0.0422535211267606,0.0362496198690643,0.24376544866603,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD (cm)","Males and females","Mixed"
"1085","Waist-to-hip ratio","PCSK9 inhibitor",1,0.0824949698189135,0.0362173038229376,0.0227398209763687,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD","Males and females","Mixed"
"1086","Waist-to-hip ratio","PCSK9 inhibitor",1,0.0824949698189135,0.036340331846219,0.0232035487064864,25673412,2015,"Shungin D","GIANT","Anthropometric",NA,NA,224459,"SD","Males and females","Mixed"
"1087","Crohn's disease","PCSK9 inhibitor",1,0.0877177950052314,0.265612560973257,0.741213212224075,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",5956,14927,20883,"log odds","Males and females","European"
"1088","Crohn's disease","PCSK9 inhibitor",1,0.0877177950052314,0.265593561368209,0.741195362902076,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",5956,14927,20883,"log odds","Males and females","European"
"1089","Eczema","PCSK9 inhibitor",1,-0.433777007623742,0.178971420275382,0.0153623512857856,26482879,2014,"Paternoster","EAGLE","Autoimmune / inflammatory",10788,30047,40835,"log odds","Males and females","European"
"1090","Eczema","PCSK9 inhibitor",1,-0.433777007623742,0.17828055932495,0.0149695677500426,26482879,2014,"Paternoster","EAGLE","Autoimmune / inflammatory",10788,30047,40835,"log odds","Males and females","European"
"1091","Inflammatory bowel disease","PCSK9 inhibitor",1,-0.188941989338632,0.188329979879276,0.315740415263048,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",12882,21770,34652,"log odds","Males and females","European"
"1092","Inflammatory bowel disease","PCSK9 inhibitor",1,-0.188941989338632,0.188454258513801,0.316059659352611,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",12882,21770,34652,"log odds","Males and females","European"
"1093","Multiple sclerosis","PCSK9 inhibitor",1,-0.039844320515493,0.136476915125151,0.770325496913359,24076602,2013,"Beecham","IMSGC","Autoimmune / inflammatory",14498,24091,38589,"log odds","Males and females","European"
"1094","Multiple sclerosis","PCSK9 inhibitor",1,-0.039844320515493,0.136484544057287,0.77033797420156,24076602,2013,"Beecham","IMSGC","Autoimmune / inflammatory",14498,24091,38589,"log odds","Males and females","European"
"1095","Psoriasis","PCSK9 inhibitor",1,-0.160347623559759,0.234292755751005,0.493728916925429,23143594,2012,"Tsoi",NA,"Autoimmune / inflammatory",10588,22806,33394,"log odds","Males and females","European"
"1096","Psoriasis","PCSK9 inhibitor",1,-0.160347623559759,0.234220771887324,0.493596143034613,23143594,2012,"Tsoi",NA,"Autoimmune / inflammatory",10588,22806,33394,"log odds","Males and females","European"
"1097","Rheumatoid arthritis","PCSK9 inhibitor",1,-0.23447447938833,0.335328949211268,0.484403799007799,24390342,2014,"Okada Y",NA,"Autoimmune / inflammatory",19234,61565,80799,"log odds","Males and females","Mixed"
"1098","Rheumatoid arthritis","PCSK9 inhibitor",1,-0.23447447938833,0.335436460170025,0.484543845006731,24390342,2014,"Okada Y",NA,"Autoimmune / inflammatory",19234,61565,80799,"log odds","Males and females","Mixed"
"1099","Systemic lupus erythematosus","PCSK9 inhibitor",1,-0.689115309752515,0.243531587275654,0.00465952705575397,26502338,2015,"Bentham",NA,"Autoimmune / inflammatory",7219,15991,23210,"log odds","Males and females","European"
"1100","Systemic lupus erythematosus","PCSK9 inhibitor",1,-0.689115309752515,0.244807129595217,0.004878762614707,26502338,2015,"Bentham",NA,"Autoimmune / inflammatory",7219,15991,23210,"log odds","Males and females","European"
"1101","Ulcerative colitis","PCSK9 inhibitor",1,-0.0837093558452716,0.232997987927565,0.719392573070804,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",6968,20464,27432,"log odds","Males and females","European"
"1102","Ulcerative colitis","PCSK9 inhibitor",1,-0.0837093558452716,0.233017711232319,0.719415320202274,26192919,2015,"Liu","IIBDGC","Autoimmune / inflammatory",6968,20464,27432,"log odds","Males and females","European"
"1103","Alcohol dependence","PCSK9 inhibitor",1,0.251351519991952,0.450030363175659,0.576488499491,22978509,2012,"Olfson",NA,"Behavioural",1897,1932,3829,"log odds","Males and females","Mixed"
"1104","Alcohol dependence","PCSK9 inhibitor",1,0.251351519991952,0.449938282629779,0.576410472901128,22978509,2012,"Olfson",NA,"Behavioural",1897,1932,3829,"log odds","Males and females","Mixed"
"1105","Melanoma","PCSK9 inhibitor",1,-0.221404638247485,0.424824175129375,0.602249952921786,21926416,2011,"Amos CI","MDACC","Cancer",1804,1026,2830,"log odds","Males and females","European"
"1106","Melanoma","PCSK9 inhibitor",1,-0.221404638247485,0.424748490945674,0.602185268497887,21926416,2011,"Amos CI","MDACC","Cancer",1804,1026,2830,"log odds","Males and females","European"
"1107","Coronary heart disease","PCSK9 inhibitor",1,-0.51610060362173,0.115208853118712,7.47495294379466e-06,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",60801,123504,184305,"log odds","Males and females","Mixed"
"1108","Coronary heart disease","PCSK9 inhibitor",1,-0.51610060362173,0.116715304013903,9.78476010437758e-06,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",60801,123504,184305,"log odds","Males and females","Mixed"
"1109","Myocardial infarction","PCSK9 inhibitor",1,-0.713587525150906,0.140337052474626,3.67990432796264e-07,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",43676,128199,171875,"log odds","Males and females","Mixed"
"1110","Myocardial infarction","PCSK9 inhibitor",1,-0.713587525150905,0.13793681447002,2.30004190430786e-07,26343387,2015,"Nikpay","CARDIoGRAMplusC4D","Cardiovascular",43676,128199,171875,"log odds","Males and females","Mixed"
"1111","Type 2 diabetes","PCSK9 inhibitor",1,0.179986036860966,0.116124110077264,0.121154607862369,22885922,2012,"Morris","DIAGRAMplusMetabochip","Diabetes",34840,114981,149821,"log odds","Males and females","Mixed"
"1112","Type 2 diabetes","PCSK9 inhibitor",1,0.179986036860966,0.11630692672529,0.121740512457834,22885922,2012,"Morris","DIAGRAMplusMetabochip","Diabetes",34840,114981,149821,"log odds","Males and females","Mixed"
"1113","Years of schooling","PCSK9 inhibitor",1,0.0120724346076459,0.0221371150855405,0.585514098614867,27225129,2016,"Okbay","SSGAC","Education",NA,NA,293723,"SD (years)","Males and females","European"
"1114","Years of schooling","PCSK9 inhibitor",1,0.0120724346076459,0.0221327967806841,0.585440934568927,27225129,2016,"Okbay","SSGAC","Education",NA,NA,293723,"SD (years)","Males and females","European"
"1115","Microalbuminuria","PCSK9 inhibitor",1,-0.0439904808060362,0.273808853118712,0.872360187304122,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,54116,"log odds","Males and females","European"
"1116","Microalbuminuria","PCSK9 inhibitor",1,-0.0439904808060362,0.273813488318868,0.87236232950414,26631737,2015,"Teumer","CKDGen","Kidney",NA,NA,54116,"log odds","Males and females","European"
"1117","HDL cholesterol","PCSK9 inhibitor",1,0.076056338028169,0.0338028169014084,0.0244489453100894,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187167,"SD (mg/dL)","Males and females","Mixed"
"1118","HDL cholesterol","PCSK9 inhibitor",1,0.076056338028169,0.0339148640935488,0.0249247826119325,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187167,"SD (mg/dL)","Males and females","Mixed"
"1119","LDL cholesterol","PCSK9 inhibitor",1,-1,0.0362173038229376,8.184566017795e-168,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,173082,"SD (mg/dL)","Males and females","Mixed"
"1120","LDL cholesterol","PCSK9 inhibitor",1,-1,0.0512190022589853,6.86424652372424e-85,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,173082,"SD (mg/dL)","Males and females","Mixed"
"1121","Total cholesterol","PCSK9 inhibitor",1,-0.672233400402415,0.0348088531187123,4.24619320303617e-83,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187365,"SD (mg/dL)","Males and females","Mixed"
"1122","Total cholesterol","PCSK9 inhibitor",1,-0.672233400402415,0.042478316906904,2.08103803043686e-56,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,187365,"SD (mg/dL)","Males and females","Mixed"
"1123","Triglycerides","PCSK9 inhibitor",1,-0.0124748490945674,0.0340040241448692,0.713720536387557,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,177861,"SD (mg/dL)","Males and females","Mixed"
"1124","Triglycerides","PCSK9 inhibitor",1,-0.0124748490945674,0.0340070255412634,0.713744689698779,24097068,2013,"Willer CJ","GLGC","Lipid",NA,NA,177861,"SD (mg/dL)","Males and females","Mixed"
"1125","Amyotrophic lateral sclerosis","PCSK9 inhibitor",1,0.151911468812877,0.146381097258419,0.299372191999928,27455348,2016,"van Rheenen","Project MinE","Psychiatric / neurological",12577,23475,36052,"log odds","Males and females","European"
"1126","Amyotrophic lateral sclerosis","PCSK9 inhibitor",1,0.151911468812877,0.146277665995976,0.299030614762065,27455348,2016,"van Rheenen","Project MinE","Psychiatric / neurological",12577,23475,36052,"log odds","Males and females","European"
"1127","Autism","PCSK9 inhibitor",1,0.0293820068086519,0.259154929577465,0.909732290301333,NA,2015,NA,"PGC","Psychiatric / neurological",4949,5314,10263,"log odds","Males and females","European"
"1128","Autism","PCSK9 inhibitor",1,0.0293820068086519,0.259157114338,0.909733048026174,NA,2015,NA,"PGC","Psychiatric / neurological",4949,5314,10263,"log odds","Males and females","European"
"1129","Bulimia nervosa","PCSK9 inhibitor",1,1.63380281690141,0.678640913770885,0.0160637946153167,23568457,2013,"Wade TD",NA,"Psychiatric / neurological",151,2291,2442,"log odds","Females","European"
"1130","Bulimia nervosa","PCSK9 inhibitor",1,1.63380281690141,0.676056338028169,0.0156633536428976,23568457,2013,"Wade TD",NA,"Psychiatric / neurological",151,2291,2442,"log odds","Females","European"
"1131","Schizophrenia","PCSK9 inhibitor",1,0.119915921299799,0.101609657947686,0.237935538339374,25056061,2014,"Ripke S","PGC","Psychiatric / neurological",35476,46839,82315,"log odds","Males and females","Mixed"
"1132","Schizophrenia","PCSK9 inhibitor",1,0.119915921299799,0.101702431188225,0.238363899391041,25056061,2014,"Ripke S","PGC","Psychiatric / neurological",35476,46839,82315,"log odds","Males and females","Mixed"
"1133","Age at menarche","PCSK9 inhibitor",1,0.010473698631328,0.270857408477819,0.96915454394206,25231870,2014,"Perry JR","ReproGen","Reproductive aging",NA,NA,182416,"years","Females","European"
"1134","Age at menarche","PCSK9 inhibitor",1,0.010473698631328,0.270857142857143,0.969154513708011,25231870,2014,"Perry JR","ReproGen","Reproductive aging",NA,NA,182416,"years","Females","European"
"1135","Chronotype","PCSK9 inhibitor",1,-0.00457456740442656,0.029815291750503,0.878058998195908,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"1136","Chronotype","PCSK9 inhibitor",1,-0.00457456740442656,0.0298157520705442,0.878060866094931,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"1137","Sleep duration","PCSK9 inhibitor",1,-0.0385647887323944,0.030017907444668,0.198888019359881,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
"1138","Sleep duration","PCSK9 inhibitor",1,-0.0385647887323944,0.0300503839183508,0.199373811629333,27494321,2016,"Jones","UK Biobank","Sleeping",NA,NA,128266,NA,"Males and females","European"
